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ABSTRACT 
The U.S. Nuclear Regulatory Commission (NRC) is considering a revision of the 
existing system of radiation protection regulations with respect to ICRP Publication 103. 
It is expected that there will be a change in the current NRC regulations to require the 
implementation of concept of dose constraints for members of the public and for 
occupationally-exposed workers at the U.S. nuclear power plants (NPPs). Under the 
paradigm of regulatory science, the use of dose constraints is still highly debatable.  
This study addressed two objectives. The first objective was determining whether 
or not dose constraints are necessary for members of the public and occupationally-
exposed workers at the U.S. NPPs. The second objective was determining, if dose 
constraints were needed, the optimal numerical values of dose constraints at the U.S. NPPs. 
To achieve these objectives, several areas were investigated and analyzed: 1) the 
establishment of a regulatory-science framework; 2) a system of radiation protection 
which would incorporate the concept of dose constraints; 3) methodologies and 
regulations for public and occupational dose assessment; 4) approaches to the 
establishment of dose constraints; 5) the actual doses for members of the public living 
around NPPs; and 6) the range of doses for occupationally-exposed workers in NPPs.  
As a result of analysis of exposure data, the annual median and maximum doses to 
a maximally-exposed individual (MEI) for members of the public were 10-4 and 10-1 mSv, 
respectively. The corresponding annual excess risks (ER) for the median and maximum 
doses were calculated to be on the order of 10-8 and 10-6, respectively. These excess risks 
are low and should be considered acceptable. For occupationally-exposed workers, the 
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average and maximum measurable doses were 1.3 mSv and 24.8 mSv, respectively. The 
annual excess risks for the average and maximum doses were 10-5 and 10-3, respectively. 
These excess risks are also acceptable from the perspective of occupational risks. This 
analysis showed that some individuals received relatively higher annual doses than all 
others. The fraction of the workers in this category was negligible (0.01%) and the 
economic cost of further dose reduction based on dose constraints will have no net positive 
benefit. Thus, it is concluded that dose constraints are not necessary for members of the 
public or occupationally-exposed workers at the U.S. NPPs. 
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NOMENCLATURE 
ALARA As low as reasonably achievable 
ALI Annual limits on intake  
BSS Basic Safety Standards 
Bq Becquerel 
BWR Boiling water reactor 
CDRH Center for Devices and Radiological Health 
CEDE Committed effective dose equivalent 
CFR Code of Federal Regulations 
Ci Curie (1 Ci = 3.7×1010 Bq) 
CINDY Code for internal dosimetry 
cm Centimeter 
d Day 
DAC Derived air concentration 
DCF Dose conversion factor 
DDE Deep dose equivalent 
DDREF Dose and dose-rate effectiveness factor 
DOE U.S. Department of Energy 
EAR Excess absolute risk 
EC European Commission 
EPA U.S. Environmental Protection Agency 
ERR Excess relative risk 
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EU European Union 
EURATOM European Atomic Energy Community 
FDA U.S. Food and Drug Administration 
FOIA Freedom of Information Act  
FSAR Final safety analysis report 
ft Foot 
GIT Gastrointestinal Tract 
h Hour 
HEEE High-end exposure estimate 
IAEA International Atomic Energy Agency 
ICR International Congress of Radiology 
ICRP International Commission on Radiological Protection 
ICRU International Commission on Radiological Units and 
Measurements 
IXRPC International X-ray and Radium Protection Committee 
kg kilogram 
L Liter 
lb Pound 
LDE Lens dose equivalent 
LNT Linear-non-threshold 
LOCA Loss of coolant accident 
LWR Light water reactor 
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MEI Maximally exposed individual 
mL Milliliter 
MPBB Maximum permissible body burden 
MPC Maximum permissible concentration 
mrem Millirem 
mSv Millisievert  
NCRP National Council on Radiation Protection and Measurements 
NESHAP National emission standards for hazardous air pollutants 
NPP Nuclear power plant 
NRC U.S. Nuclear Regulatory Commission 
NUREG NRC technical report designation (NUclear REGulatory) 
ODCM Offsite dose calculation manual 
PWR Pressurized water reactor 
RBE Relative biological effectiveness 
rem rem 
REMP Radiological Environmental Monitoring Program 
RETS Radiological Effluent Technical Specifications 
RG Regulatory guide 
RWP Radiation work permit 
SDE Shallow dose equivalent  
SECY Secretary of the Commission, Office of the NRC 
SRM Staff requirements memorandum 
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Sv Sievert (1 Sv = 100 rem) 
SWP Special work permit 
TEDE Total effective dose equivalent 
TLD Thermoluminescent dosimeter 
TUBE Theoretical upper bounding estimate 
UN United Nations 
UNSCEAR UN Scientific Committee on the Effects of Atomic Radiation 
w Week 
y Year 
°C Celsius 
°F Fahrenheit 
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INTRODUCTION 
The concept of regulatory science 
The term “regulatory science” does not originate from radiological or nuclear 
sciences and its origin is not clear (Jasanoff 2011). However, regulatory science is 
commonly used by the medical and pharmaceutical industry involving the study of safety 
and efficacy of drugs and medical devices. According to the U.S. Food and Drug 
Administration (FDA), regulatory science is defined as the science of developing new 
tools, standards, and approaches to assess the safety, efficacy, quality, and performance of 
all FDA-regulated products (USFDA 2010). This definition also includes regulated 
activities. Based on the FDA definition of regulatory science, efficacy is a key factor. 
However, regulatory science studies the tradeoff between risk and benefits.  If a medical 
device or pharmaceutical drug were to require the highest level of safety or efficacy 
without uncertainty, then the R&D costs would be unaffordable. Therefore, in regulatory 
science it is important to balance these two variables, safety and efficacy, to maximize the 
benefits of drugs and devices and to minimize the cycle cost.   
Sheila Jasanoff discussed in detail the characteristics of regulatory science with 
regard to differences between research science and regulatory science (Jasanoff 1995). 
Jasanoff explained that research science is usually determined by theoretical paradigms 
and clear scientific methodologies. But regulatory science is relatively flexible, 
contentious and dependent on socio-economic factors and political considerations. 
Therefore, from the customary point of view of science, the determination of “good” or 
“bad” research science relies entirely on the stable repetitive result according to an 
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orthodox rule. On the other hand, regulatory science focuses on the consensus of selecting 
among different possible evaluations of observations and experiments. Therefore, the 
determination of goodness or badness of the regulatory science relies on negotiation and 
compromise, risk analysis and social needs. The differences between regulatory and 
research science are summarized in Table 1 (Jasanoff 1995). 
 
 
 
Table 1. Comparison between regulatory science and research science. 
 
Factors Regulatory Science Research Science 
Aims Certainty taking into account policy Certainty taking into account 
originality and importance 
Institutes Government agencies, industry Universities, national laboratories 
Outcomes Data analysis, often unpublished Published papers 
Motivations Compliance with legal demands Professional recognition 
Time-frame Legal timetables Flexible 
Choices Acceptance of data 
Rejection of data 
Delay for more data 
Acceptance of data 
Rejection of data 
 
Responsible 
Institutes 
Congress, courts, media Review peers 
Process Regulatory peer review 
Inspection and audit 
Public hearing 
Legal review and approval 
Peer review 
Criteria Absence of deception or distortion 
Conformity to protocols and agency 
guidelines 
Legal tests of sufficiency 
Absence of deception or distortion 
Conformity to methods accepted 
by peer scientists 
Statistical significance 
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Regulatory science and radiological protection under the FDA 
Regarding radiation exposure from diagnostic and therapeutic radiation producing 
devices, the FDA’s Center for Devices and Radiological Health (CDRH) has been at the 
forefront of regulatory science (Leszczynski 2014). Current scientific evidence is very 
clear regarding acute high doses of radiation. However, little is known regarding the risk 
and health effects at protracted cumulative low doses. CDRH, under the Clinical Path 
Initiative and Advancing Regulatory Path Initiative, is currently seeking and 
implementing new tools and methods to provide scientific evidence on the early and late 
effects of cumulative low doses of ionizing radiation by means of predictive omics 
approaches, including from multiple combined hazards, such as radiation and chemical 
exposures (Chen and McKone 2001). Thus, the use of regulatory science in radiological 
protection is a well-established area of research in CDRH. 
Exposure of patients or subjects to ionizing radiation is regulated by the FDA 
under 21 CFR Part 361, which is limited in scope as shown in Table 2, and it is based on 
a clear benefit-analysis of the radiographic study (USFDA 2015). NCRP Report 160 
provides a succinct description of the absorbed doses received by the U.S. population 
(cumulative and per capita) due to medical exposures indicating that doses have increased 
steadily due to the predominant use of CT and other interventional modalities, such as 
fluoroscopy (NCRP 2009). The effective dose per individual (EUS) was estimated at 3 mSv 
in 2006, a factor 5.7 higher than that received between 1980 and 1982. Therefore, medical 
patients implicitly accept the risk from medical exposures due to their immediate health 
benefits. However, there are no restrictions on the number of times a radiological device 
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can be used on an individual patient as it is under the prerogative of a physician to assess 
the need for a diagnostic or therapeutic radiological study or treatment. 
 
 
 
Table 2. Limits on radiation absorbed dose established by the FDA as described in 21 
CFR Part 361 for diagnostic procedures. 
 
Organ Dose (mSv) 
Whole body, active blood-forming organs, lens of the eye, and gonads  
Single dose 30 
Annual and total dose commitment 50 
Other organs:  
Single dose 50 
Annual and total dose commitment 150 
 
 
 
The lack of knowledge in risk assessment for patients and medical occupational 
workers has led the National Cancer Institute (NCI) to establish the Radiation 
Epidemiology Branch (REB) under the Division of Cancer Epidemiology and Genetics. 
The Radiation Epidemiology Branch (REB) was established to identify, understand, and 
quantify the risk of cancer in populations exposed to medical, occupational, or 
environmental radiation, and to advance understanding of radiation carcinogenesis, 
including occupational exposures such as those from NPPs. The methods for risk analysis 
used by the REB vary considerably depending on multiple factors including 
environmental exposures, such as chemical and biologics. Thus, the REB has established 
the Radiation Risk Assessment Tool – Lifetime Cancer Risk from Ionizing Radiation, 
among many other risk assessment programs, which is based on the BEIR VII Report for 
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the eleven cancer sites described in the report (Preston et al. 2002; National Cancer 
Institute 2003; Kocher et al. 2008; Gonzalez et al. 2012). For occupational radiation 
exposure, the REB is studying four population groups for assessing cancer risk. These are 
1) Chernobyl Clean-up Workers, 2) Mayak Nuclear Facility Workers, 3) U.S. Radiologic 
Technologists, and 4) Interventional Fluoroscopists.  These epidemiological studies will 
serve to address the risk associated with protracted low-radiation exposures compared to 
those of the general population.  
 
Regulatory science and radiological protection from NPPs 
The application of ionizing radiation, including that from NPPs, provides both 
risks and benefits. Although NPPs provide significant benefits to the society by electricity 
production, the general public is very sensitive to exposure from radiological sources. 
Radiation exposure is the unavoidable byproduct of nuclear-electric generation. It is a 
well-known fact that high radiation exposure causes severe health effects in humans and 
can lead to development of different types of cancer that may be fatal. Therefore, the 
operation of NPPs has been considered to need special regulatory requirements to ensure 
that it is properly used and controlled.  
On the other hand, most of activities during the operation of NPPs involve very 
low radiation doses. Nothing can be said with certainty about the effects of low dose levels. 
Thus, it is debatable whether or not it is reasonable to apply the precautionary principle to 
nuclear industry, especially for NPPs. The precautionary principle recommends that action 
should be taken to prevent serious potential hazard despite the lack of full scientific 
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evidence (Reis et al. 2007). This principle has been used widely by international 
organizations, such as ICRP and IAEA, and European nations to prevent environmental 
problems due to radiation exposure from nuclear facilities. Most of the standards 
associated with radiation exposure are not based on this precautionary approach but 
consider the probability of an effect due to radiation exposure. Since there are still no 
definite data to prove the risk at low doses of radiation, the use of the precautionary 
principle for decision-making is controversial issue. The question is does the 
precautionary principle and regulatory science have a place in radiological protection at 
nuclear power facilities?  
For radiological safety from all nuclear industrial activities, the International 
Commission on Radiological Protection (ICRP) introduced the use of cost-benefit analysis 
to determine the reasonable level of dose reduction below the recommended limits and 
introduced the concept of collective dose equivalent to facilitate cost-benefit analysis 
(OECD NEA 2011). The collective dose equivalent is the sum of all the dose equivalents 
received by the individual members of a population and is generally used for calculating 
the stochastic effects of radiation exposure of a large group or a population (Cember and 
Johnson 2009). According to ICRP Publication 26, the net benefit is calculated using the 
following equation:  
 
B =V - (P+ X +Y ) (1) 
 
where B is the net benefit of a practice involving radiation exposure, V is its gross benefit, 
P is the basic practice cost, X is the cost of achieving a selected level of protection, and Y 
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is the cost of the detriment involved in the practice (ICRP 1977). The ICRP also 
recommended the use of differential cost-benefit analysis to find the optimum net benefit 
from the practice using the collective dose equivalent as the independent variable. The 
optimum net benefit can be calculated using the following equation:  
 
dV
dS
-
dP
dS
+
dX
dS
+
dY
dS
æ
èç
ö
ø÷
= 0  (2) 
 
where S is the collective dose equivalent from the practice (ICRP 1977). Equation (2) is 
also reduced to Equation (3) because V and P can be regarded as a constant with S for a 
given practice:  
 
dX
dS
æ
èç
ö
ø÷
S*
= -
dY
dS
æ
èç
ö
ø÷
S*
. (3) 
 
Therefore, the increase in the cost of protection per unit dose equivalent balances the 
decrease of detriment per unit dose equivalent at a certain collective dose equivalent S* 
(ICRP 1977). This cost-benefit analysis can be more useful if a monetary value is assigned 
to the unit of collective dose equivalent, but the ICRP does not provide such a monetary 
value, since it is very complicated to quantify some of the components of the detriment, 
taking into account socio-economic factors (OECD NEA 2011). 
This is an optimization process, and it is used by regulatory bodies to provide 
reasonably achievable regulatory guides for the nuclear power industry. In the Publication 
60, the ICRP emphasized the importance of optimization again, especially taking into 
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account economic and social factors (ICRP 1991). Therefore, regulatory science related 
to radiological protection is not limited to the pure research outcomes, but it involves the 
social and economic considerations.  
 
Issues of regulatory science for radiation protection in the nuclear power 
industry 
One of the most important issues in the nuclear power industry is the 
implementation of new ICRP recommendations on radiological protection published in 
ICRP Publication 103. In 2007, the ICRP revised its previous recommendations stated in 
ICRP Publication 60 to the new ICRP Publication 103. This revision adopted new 
biological and physical findings and trends in the setting of radiation safety standards, 
including the radiological protection of the environment (ICRP 2007). ICRP Publication 
103 provided consolidated standards for all controllable exposure situations in accordance 
with new technical findings published in supplementary reports after ICRP Publication 60. 
The new recommendations updated radiation and tissue weighting factors and radiation 
risk coefficients based on the latest available scientific data. In terms of protection 
methodology, the previous process-based protection approach using practices and 
interventions was changed into three exposure situations: planned, emergency, and 
existing (ICRP 2007). Furthermore, the revised recommendations emphasized the use of 
dose constraints for planned exposure situations and reference levels for emergency and 
existing exposure situations as the most important features of the principle of optimization 
(ICRP 2007).  
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According to ICRP Publication 103, dose constraints are defined as prospective 
and source-related limits on individual doses from a radiological source under planned 
exposure situations (ICRP 2007). This application of ICRP Publication 103 will probably 
be the most difficult for the nuclear power industry to implement in the field (Kong et al. 
2014). Dose constraints are expected to have an impact on NPP operation since constraints 
are involved in radiation dose to both occupational workers and members of the public. 
For example, it is expected to provide more measures or equipment to reduce the radiation 
dose to workers. Moreover, a nuclear licensee may have a burden to more strictly control 
the release of radioactive materials to the environment to meet the dose constraint for 
members of the public living around a NPP. However, it is important to point out that the 
ICRP 103 recommendations, including dose constraints, are not yet part of the Code of 
Federal Regulations.  
The IAEA has continuously provided its basic safety standards (BSS) on radiation 
safety to establish basic requirements for protecting people and the environment against 
the risks associated with radiation exposure (IAEA 1996). These BSSs have been used by 
IAEA member nations to make their own national regulatory programs even though the 
approval of BSSs within their national legal system is not mandatory. Many member 
nations used the BSS published in 1996 (hereinafter referred to as the ‘BSS of 1996’) as a 
benchmark for regulations on radiological protection prior to the issue of new ICRP 
recommendations in 2007. This new publication let the IAEA Commission on Safety 
Standards and IAEA sponsoring organizations, such as the European Commission and the 
OECD Nuclear Energy Agency, request the IAEA Secretariat to revise the BSS of 1996, 
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ensuring consistency with the new ICRP recommendations (IAEA 2014a). In 2014, the 
IAEA finally published the new BSS as General Safety Requirements No. GSR Part 3, 
which supersedes the BSS of 1996, with regards to the new findings of UNSCEAR and 
the new ICRP recommendations (IAEA 2014a). The IAEA expects that the new BSS will 
also play a major role as an international benchmark for radiation safety requirements. The 
acceptance and implementation by IAEA member nations will create better consistency 
in radiation safety of different member nations. In particular, the new BSS is aimed at the 
use by regulatory bodies in IAEA member nations; thus, the nuclear power industry, 
including NPPs, whose activities are under the regulations, will be greatly influenced by 
the issue of new IAEA BSS.  
To establish practical requirements for radiation safety, the new BSS incorporates 
three different types of exposure situations: planned, emergency, and existing, which were 
introduced in ICRP Publication 103. In particular, planned exposure situations arise from 
deliberately introduced and fully controlled activities that result in exposures due to 
radiation sources (ICRP 2007; IAEA 2014a). Therefore, the routine radiation exposures 
involving activities in NPPs, including maintenance and the discharge of radioactive 
effluents, belong to planned exposure situations. In terms of planned exposure situations, 
the new BSS specifies that dose constraints should be applied to occupational and public 
exposure as optimization tools for radiation safety (IAEA 2014a). According to the new 
BSS, dose constraints will play a role as boundary settings in outlining the range of options 
for the purposes of optimization of radiation safety. Therefore, implementation of dose 
constraints in radiation protection activities in NPPs is inevitable for nuclear licensees. 
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However, it is important to understand that implementation of the new BSS, including 
dose constraints, has not yet been required by the U.S. NRC regulations. 
In 2013, the European Commission (EC) provided the Basic Safety Standards 
(BSS) Directive for radiation protection, as Council Directive 2013/59/Euratom which 
combines five existing Euratom Directives: 89/618/Euratom, 90/641/Euratom, 
96/29/Euratom, 97/43/Euratom and 2003/122/Euratom (Council of the European Union 
2013). The European Atomic Energy Community (Euratom) is a legal organization 
separate from the European Union (EU), and was established in 1957 by the Euratom 
Treaty for the peaceful uses of nuclear energy (EC 2015). According to the Euratom Treaty, 
one of the primary tasks of Euratom is instituting uniform safety standards to protect the 
health of workers and the general public from ionizing radiation (EU 2012). Therefore, 
the Euratom is closely connected with regulations for radiation safety in the EU nuclear 
power industry. The revision of Euratom Directives originates from three motives (HSE 
2015). First, the ICRP issued the new recommendations on radiological protection in 2007. 
Second, the IAEA has revised its own BSS based on the new ICRP recommendations. 
Finally, the Euratom also participated in the revision of IAEA BSS as a cosponsor, with 
the purpose of working towards harmonization between the IAEA BSS and the Euratom 
BSS Directives. In other words, the new BSS Directive integrates the latest ICRP 
recommendations and harmonizes the EU regulations with the IAEA BSS (HSE 2015).     
According to Council Directive 2013/59/Euratom, all EU member nations must 
establish dose constraints with the objective of optimizing radiological protection, taking 
into account their social criteria (Council of the European Union 2013). A nuclear licensee 
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can voluntarily set dose constraints for occupational exposure as a prospective upper 
bound of individual doses and implement the dose constraint in practice under the 
supervision of a regulatory body. On the other hand, a regulatory body should set dose 
constraints for members of the public living around nuclear facilities, assuming the 
planned operation of a specified radiation source. However, the BSS Directive does not 
provide a specific dose constraint for each type of exposure (Council of the European 
Union 2013). Therefore, the establishment of dose constraints with consideration of 
international guidance and good practices elsewhere will be an imperative assignment for 
both regulatory bodies and nuclear licensees, including NPP operators. 
In 2001, the staffs of the U.S. NRC submitted a Policy Issue Notation Vote Paper, 
SECY-01-0148, to their Commissioners. They requested the revision of the current Title 
10 Code of Federal Regulation (CFR) Part 20 with regard to the adoption of ICRP 
Recommendation in 1990 (Publication 60) on occupational dose limits and dosimetric 
models and parameters (USNRC 2001b). The next year, the NRC made a decision to 
postpone the revision of the current 10 CFR Part 20 until the ICRP completes the issuing 
of the new recommendations (Publication 103) (USNRC 2002). After the issuance of the 
ICRP new recommendation in 2007, the NRC staff proposed several ways to revise the 
basic system of radiation protection regulations, taking into account ICRP Publication 103 
(USNRC 2008b). As a result, in the SRM to SECY-08-0197, the NRC finally determined 
that they would revise the whole system of radiation protection regulation and guidance 
with respect to ICRP Publication 103. The NRC also decided to immediately begin 
engagement with stakeholders and interested parties to initiate development of the 
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technical basis for possible revision of the NRC radiation protection regulations (USNRC 
2009b). In particular, this revision would affect the NRC regulatory framework, including 
1) 10 CFR Part 20, “Standards for Protection Against Radiation,” 2) 10 CFR Part 50, 
“Domestic Licensing of Production and Utilization Facilities,” and 3) Appendix I to 10 
CFR Part 50, “Numerical Guides for Design Objectives and Limiting Conditions for 
Operation to Meet the Criterion ‘As Low As Reasonably Achievable’ for Radioactive 
Material in Light-Water-Cooled Nuclear Power Reactor Effluents” (USNRC 2015e). In 
2012, the staff of the NRC proposed policy and technical directions to revise the NRC 
radiation protection regulations and guidance by SECY-12-0064 (USNRC 2012d). In the 
SRM to SECY-12-0064, the NRC accepted the NRC staff’s development of a draft 
regulatory basis for a revision to 10 CFR Part 20 to harmonize with the most recent 
methodology and terminology in ICRP Publication 103 (USNRC 2012g). However, the 
NRC rejected the NRC staff's recommendations to reduce the annual occupational dose 
limit to 20 mSv y-1 and the elimination of traditional units, such as rem and Ci, from the 
NRC regulations (USNRC 2012g). Rather, the NRC decided to use both traditional and 
International System units in the NRC regulations (USNRC 2015e). Furthermore, since 
the ICRP was currently developing new biokinetic and dosimetric models and dose 
coefficients for both workers and public exposure to radionuclides based on ICRP 
Publication 103, and it is predicted that this information will be available after 2015, the 
NRC would not initiate rulemaking to reflect these changes until the new ICRP 
methodology for dosimetry was available (USNRC 2014e, 2015f). 
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In the United States, the term “dose constraint” is already used in the NRC 
regulations, but it has a somewhat different meaning than the ICRP concept (McGarry 
2011). The term “constraint” is defined in 10 CFR Part 20 as a control of the air emission 
of radioactive material from non-reactor facilities to the environment. Title 10 CFR Part 
20 stipulates that this constraint is the value at which the licensee should take appropriate 
corrective action to ensure the dose limit to members of the public was not exceeded 
(USNRC 1991c). Contrary to the licensees of non-reactor facilities, the NRC does not 
require the licensees of reactor facilities to establish dose constraints (USNRC 2010a). In 
other words, the dose constraint used by the NRC focuses on the control of radioactive 
materials from non-reactor facilities released to the environment to reduce the dose to 
members of the public. However, the ICRP recommends that dose constraints be 
implemented for all nuclear facilities and for both occupational and public exposure. 
Although the NRC does not currently require NPP licensees to set dose constraints, some 
licensees in the United States are familiar with the concept of dose constraint since they 
establish planning values, such as self-imposed administrative limits, in their radiation 
protection programs or ALARA analysis (USNRC 2010a; USNRC 2014a). In general, 
some licensees used planning values voluntarily as an operational tool to reduce the dose. 
However, since the NRC staff recommended revision of the radiation protection 
regulations and guidance with respect to ICRP Publication 103, it is expected that there 
will be a change in the current regulations to require that all nuclear licensees establish 
and apply constraints to their radiation protection program. Therefore, the appropriate 
method to implement dose constraints into regulatory programs will be actively discussed 
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among regulatory bodies, stakeholders, and interested parties (USNRC 2014a). One of the 
most important issues in this discussion will probably be setting numerical values for the 
dose constraints for both occupational and public exposure.  
 
Objectives of present research 
This research was conducted as a preparation of the revision of current NRC 
regulations according to ICRP Publication 103, which requires the implementation of 
concept of dose constraints for members of the public and for occupationally-exposed 
workers at the U.S. NPPs. Under the paradigm of regulatory science, the use of dose 
constraints is still highly debatable. This research addressed two objectives. The first 
objective was determining whether or not dose constraints are necessary for members of 
the public and occupationally-exposed workers at the U.S. NPPs. The second objective 
was determining, if dose constraints were needed, the optimal numerical values of dose 
constraints at the U.S. NPPs. To achieve these objectives, several areas were investigated 
and analyzed: 1) the establishment of a regulatory-science framework; 2) a system of 
radiation protection which would incorporate the concept of dose constraints; 3) 
methodologies and regulations for public and occupational dose assessment; 4) 
approaches to the establishment of dose constraints; 5) the actual doses for members of 
the public living around NPPs; and 6) the range of doses for occupationally-exposed 
workers in NPPs.  
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REGULATIONS 
The concept of dose constraints 
ICRP Publication 103 replaced the previous process-based approach of practices 
and interventions to the situation-based approach to cover all possible radiation exposure 
situations, including planned exposure situations, emergency exposure situations, and 
existing exposure situations (ICRP 2007; OECD NEA 2011). Planned exposure situations 
involve the intentional introduction and operation of sources. These situations include 
typical licensed activities where planning and controls are prepared in advance of radiation 
exposure (ICRP 2007). Therefore, these situations correspond to the concept of practice, 
and the routine radiation exposures involving activities in NPPs, including maintenance 
and the discharge of radioactive effluents. Emergency exposure situations are unpredicted 
situations which may arise during the operation of a planned exposure situation or from a 
malevolent action (ICRP 2007). It is necessary to take immediate action to prevent the 
spread of the radiation exposure. Existing exposure situations indicate that radiation 
exposure already exists before a measure of control has to be taken (ICRP 2007). These 
situations normally involve radon exposure in homes and, in aspects of nuclear operation, 
decommissioning NPP sites, which need remedial action to reduce radiation exposure. 
The three principles of radiological protection in ICRP Publication 60 were 
continuously used in ICRP Publication 103. However, in the revised recommendations, 
the ICRP categorized the principles to the source-related and individual-related principles 
to show how these principles apply to sources and to the individual (ICRP 2007). Two 
principles, including justification and optimization of protection, belong to a source-
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related approach and apply to all radiation exposure situations. In particular, the ICRP 
underlined that dose constraints and reference levels are the main parts in the optimization 
process and should be used to ensure that all radiation exposures are kept as low as 
reasonably achievable (ALARA), taking into account societal and economic factors (ICRP 
2007). One principle, application of dose limits, belongs to an individual-related approach 
and applies only in planned exposure situations (ICRP 2007). The differences in concept 
between the use of individual dose limits in planned exposure situations and the use of 
dose constraints or reference levels for protection from a source in all radiation exposure 
situations are displayed in Fig. 1 (ICRP 2007). The source-related approach focuses on 
the radiation exposure of all the individuals exposed from a single source, while the 
individual-related approach focuses on the radiation exposure of one individual from 
several sources. Dose limits are applicable to individual-related approach, and dose 
constraints or reference levels are applicable to source-related approach. 
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Fig. 1. Differences between individual-related dose limits and source-related dose 
constraints or reference levels.  
 
 
 
In ICRP Publication 103, the ICRP regards the source-related principle of 
optimization below the dose constraint or reference level as the most effective tool for 
protection regardless of exposure situations (ICRP 2007). Dose constraints are prospective 
and source-related restrictions on the individual dose from a source in planned exposure 
situations except in radiation exposure for medical treatment. In particular, the doses to be 
compared with the dose constraint are potential doses that may be received in the future 
and can be affected by decisions and protective measures (OECD NEA 2011). For 
occupational exposure, a dose constraint can be used to select better optimization options 
in the field to achieve ALARA. For public exposure, a dose constraint becomes a 
maximum value of the annual dose limit for the members of the public during the planned 
operation of any controlled source. Therefore, licensees should take possible measures to 
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keep the dose for the members of the public below the dose constraint. The ICRP 
emphasized that dose constraints are not to be used or understood as strict regulatory limits 
(ICRP 2007). Although, contrary to ICRP Publication 60, ICRP Publication 103 
recommends using dose constraints as a requirement for licensees, the ICRP focuses on 
the intent of dose constraints to reduce the dose, without penalty for exceeding dose 
constraints. That is, a dose constraint is an operational tool for licensees to help themselves 
to reduce the dose. Therefore, exceeding a dose constraint is not a violation of regulations. 
If a dose constraint is exceeded, a licensee is required to take measures to check whether 
the protection had been optimized, whether the appropriate dose constraint had been set 
up, and whether additional steps to reduce doses to acceptable levels would be proper. 
Similar to dose constraints in planned exposure situations, reference levels play a 
role as the level of dose or risk that protection measures should be planned and optimized 
to reduce the dose, in emergency or existing controllable exposure situations (ICRP 2007). 
The use of different terminology, dose constraints for planned exposure situations and 
reference levels for emergency or existing exposure situations, is due to the characteristics 
of exposure situations. That is, in planned exposure situations, the constraint on individual 
dose can be applied at the planning stage, and the dose can be estimated to confirm that 
the dose will not exceed the constraint. On the other hand, in emergency or existing 
exposure situations, radiation exposure can exist with wide ranges of individual doses, and 
optimization actions may apply to initial levels of individual doses beyond the reference 
level. The different types of restrictions on individual doses, used in ICRP Publication 103, 
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depend on exposure situations and categories of exposure as shown in Table 3 (ICRP 
2007). 
 
 
 
Table 3. Application of dose constraints and reference levels depending on exposure 
situations and categories of exposure. 
 
Exposure 
situations 
Occupational exposure Public exposure Medical exposure 
Planned 
Dose limit 
Dose constraint 
Dose limit 
Dose constraint 
Diagnostic reference levela 
(Dose constraintb) 
Emergency Reference levelc Reference level Not applicable 
Existing Not applicabled Reference level Not applicable 
a Patients. 
b Carers, comforters, and volunteers in research only. 
c Long-term recovery operations belong to planned occupational exposure. 
d Exposures resulting from long-term remediation operations or from extended work in 
contaminated areas should be treated as part of planned occupational exposure, although 
the source of radiation is ‘existing.’ 
 
 
 
The dose constraint for occupational exposure is set voluntarily by a nuclear 
licensee, taking into account the optimization process necessary to lower individual doses 
below the dose constraint. For public exposure, the dose constraint should be set by the 
regulatory body, taking into account an upper bound of the annual doses for members of 
the public during the planned operation of a specified controlled source. In terms of the 
assignment of specific values for dose constraints or reference levels, ICRP Publication 
103 provides guidance to help licensees or regulatory bodies to select appropriate values 
for their purposes (ICRP 2007). First, it is necessary to characterize the related exposure 
situation with regard to its nature, the benefits to individuals and society, and the feasibility 
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of reducing or avoiding the exposure. These characteristics can be compared with the 
features in Table 4, which is provided in ICRP Publication 103, to choose the appropriate 
range for the dose constraint or reference level (ICRP 2007; OECD NEA 2011). Finally, 
the specific value for the dose constraint or reference level can be determined by an 
optimization process with regards to national or regional features together with a 
consideration of international guidance and good practice elsewhere (ICRP 2007). For 
example, the ICRP suggests that acceptable dose constraint levels for occupational and 
public exposure in planned exposure situations are less than 20 and 1 mSv y−1, respectively 
(ICRP 2007). In the case of radioactive waste disposal and prolonged exposure, levels of 
less than 0.3 mSv y−1 and less than 0.3-1 mSv y−1 are suggested, respectively, as a dose 
constraint for public exposure (ICRP 1998; ICRP 2007). 
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Table 4. ICRP guidance on the selection of appropriate ranges of dose constraints and 
reference levels. 
 
Ranges of 
constraints and 
reference levelsa 
(mSv) 
Features of the 
exposure situation 
Radiological 
protection 
requirements 
Examples 
Over 20 to 100b, c Not controllable 
sources. 
Controlled by action 
on the exposure 
pathways. 
Information on 
radiation risk and on 
actions to reduce 
doses. 
Assessment of 
individual doses. 
Reference level 
for evacuation in 
a radiological 
emergency. 
Over 1 to 20 Direct individual 
benefit from the 
situation but not from 
the exposure itself.  
Controlled at source 
or by action in the 
exposure pathways. 
Available 
information on dose 
reduction. 
Assessment of 
individual doses and 
training for planned 
situations. 
Constraints for 
occupational 
exposure. 
Constraints for 
comforters and 
caregivers. 
Reference level 
for radon in 
dwellings. 
1 or less No individual benefit 
but benefits to 
society in general. 
Controlled by action 
on the source. 
Available 
information on the 
level of exposure. 
Periodic checks on 
the exposure 
pathways as to the 
level of exposure. 
Constraints for 
public exposure in 
planned 
situations. 
a Acute or annual effective dose. 
b In exceptional situations, informed volunteer workers may receive doses above this band 
to save lives, prevent severe radiation-induced health effects, or prevent the development 
of catastrophic conditions. 
c Situations in which the dose threshold for deterministic effects in relevant organs or 
tissue could be exceeded should always require action. 
 
 
 
In terms of a result of the optimization process, it is imperative to know the reason 
that the ICRP introduced the concept of dose constraints and reference levels in the 
principle of optimization of protection. The ICRP recognized that the benefits and 
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detriments from radiation exposure are not likely to be distributed equally through 
individuals and a considerable inequity of radiation exposure between one individual and 
another does occur (ICRP 1991; ICRP 2007). The ICRP states that this inequity can be 
limited by integrating source-related restrictions on individual doses into the process of 
optimization (ICRP 1991; ICRP 2007). Therefore, dose constraints and reference levels 
will play a key role as a tool to reduce the doses of some individuals who are subject to 
much more radiation exposure than the average. The use of dose constraints or reference 
levels is illustrated in Fig. 2, which shows that the distribution of individual doses with 
time shift to low levels as a result of the optimization process (ICRP 2007). In Fig. 2, Step 
1, 2, and 3 indicate the dose distribution before, during, and after implementing dose 
constraints or reference levels, respectively. The dose levels beyond a dose constraint or 
a reference level indicate that the corresponding radiation risk can be tolerated, but if you 
make an additional effort, the risk can be reduced. Fig. 2 shows that the distribution 
becomes narrower after implementing dose constraints. 
ALARA and dose constraints generally have the same goal to reduce the radiation 
exposure as low as reasonably achievable. From the above it should be clear that ALARA 
is a goal or objective of radiation protection, and dose constraints are one of the operational 
tools to achieve ALARA. Specifically, under the principle of ALARA, the minimization 
of all radiation doses has been pursued to ensure an adequate level of radiation protection. 
On the other hand, dose constraints are aimed at minimizing radiation doses that are 
relatively higher than the average using the analysis of dose distribution. It should also be 
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noted that the application of ALARA and dose constraints involves highly subjective value 
judgments, which may include economic and other societal factors. 
 
 
 
 
 
Fig. 2. Evolution of the distribution of individual doses with time as a result of the use of 
dose constraints or reference levels. Step 1, 2, and 3 indicate the dose distribution before, 
during, and after implementing dose constraints or reference levels, respectively. 
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Dose estimation for members of the public due to releases at nuclear power plants 
To estimate the dose to members of the public arising from radiation sources, it is 
imperative to determine the number of factors that affect individual doses, including 
exposure time, location, transport of radionuclides through the environment, and the 
characteristics of individuals. The characteristics of individuals include information such 
as physiological parameters, dietary data, residence data, recreational activities, and many 
other individual-specific data. In general, a specific set of these characteristics can be 
referred to as an exposure scenario (ICRP 2006). Therefore, the estimated dose to 
individual members of the public can be very different depending on the selected exposure 
scenario, and to have accurate dose estimation, it is important to develop a reasonable 
exposure scenario and to obtain the reliable data for that scenario. However, in the real 
world, gathering of actual data is impractical or extremely expensive since individuals 
have a great variety of characteristics, which are very difficult to quantify. Despite these 
difficulties, regulatory bodies or related institutes have tried to develop a quantitative 
exposure scenario from an environmental regulation perspective to facilitate regulatory 
decision-making for protecting the public from unnecessary radiation exposure. As a part 
of this effort, the Environmental Protection Agency (EPA) developed the concept of a 
hypothetical “maximally exposed individual” (MEI) as a means of dealing with dose 
estimation for members of the public in the United States (USEPA 1992). The Nuclear 
Regulatory Commission (NRC) also adopted this concept to estimate the dose to members 
of the public living around nuclear facilities, including NPPs. 
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Maximally exposed individual (MEI) 
The concept of the MEI was first introduced to assess the potential human health 
risks associated with exposure to environmental contaminants with regard to the national 
emission standards for hazardous air pollutant (NESHAP) regulations. These standards 
were established in 1989 by the EPA to protect the public from exposure to airborne 
contaminants (Hawkins 1991). According to the EPA guidelines for exposure assessment, 
the MEI is defined as the single individual with the highest exposure in a given population 
(USEPA 1992). The MEI has often been used as a worst case that represents an extreme 
set of exposure conditions. Therefore, the calculation of the MEI exposure has involved a 
variety of conservative assumptions. The most conservative and controversial of the 
assumptions was that the MEI lived for 70 years at the location considered by the 
dispersion model to receive the heaviest annual average concentration, that the person 
stayed there 24 hours per day, and that there is no difference between outdoor and indoor 
concentrations (NRC 1994). In practice, it is hard to imagine such a person. In terms of 
the individual exposure distribution, the MEI exposure level falls at the 99.99th percentile 
of the distribution, which means the exposure is the highest in a given population 
(Hawkins 1991).  
Due to the somewhat unclear definitions of the MEI, it was once replaced with two 
other estimators of the upper end of the individual exposure distribution, a high-end 
exposure estimate (HEEE) and the theoretical upper bounding estimate (TUBE) (USEPA 
1992). These concepts were introduced to reflect the more reliable distribution of exposure, 
not implausible estimates of exposure. In the distribution of exposure, the high end extends 
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beyond the 90th percentile of the population distribution, but not higher than the individual 
in the population who has the highest exposure (USEPA 1992). This restriction implies 
that the use of an individual exposure distribution is necessary for estimating the dose to 
members of the public and the HEEE is a value in the upper tail of that distribution. 
However, the EPA did not provide the precise percentile for the HEEE, but recommended 
selecting the percentile, taking into account the population size in the specific application 
(NRC 1994). Meanwhile, the TUBE was introduced as a bounding estimate for the 
purpose of easy calculation of exposure. According to the EPA guidelines, the TUBE is 
calculated by assuming limits for all the variables used to calculate exposure and dose that, 
when combined, will result in the mathematically highest exposure or dose (USEPA 1992). 
However, in terms of the use of these concepts, the National Research Council raised the 
concern that the EPA did not provide sufficient technical background to determine the 
desired percentile of the individual exposure distribution, especially when the data are 
sparse (NRC 1994; 2009). Finally, as a response to this concern, the EPA returned its 
approach to the MEI (NRC 1994). 
As mentioned above, the NRC also applies the MEI for estimating the dose to 
members of the public living around nuclear facilities. Since the MEI represents an 
individual who may be exposed to the highest concentrations of radioactive materials from 
radioactive effluents, the parameters and postulations used in this estimation normally 
include conservative assumptions that are inclined to overestimate the dose. Therefore, 
the real dose received by a real individual is often much less than that estimated (USNRC 
2013d). In terms of regulations, 10 Code of Federal Regulation Part 63.312, “Required 
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characteristics of the reasonably maximally exposed individual,” provides specific 
conditions for the MEI and defines the MEI as a hypothetical person who meets the 
following criteria: 1) living in the accessible environment beyond the highest 
concentration of radionuclides in the plume of contamination, 2) having a diet and life 
style which represents the residents in the town of Amargosa Valley, Nevada, 3) using 
well water with average concentrations of radionuclides based on an annual water demand 
of 3000 acre-feet, 4) drinking 2 liters of water per day from wells drilled into the ground 
water at the town of Amargosa Valley, Nevada, and 5) being an adult with metabolic and 
physiological respects consistent with current knowledge of adults (USNRC 2001a). The 
interesting thing here is that the MEI represents the diet and living style of residents in the 
town of Amargosa Valley, Nevada. The reason why the MEI focuses on this specific 
location is that the MEI was originally developed to estimate the potential human exposure 
resulting from release of radioactive materials from a geologic repository at Yucca 
Mountain. Therefore, the MEI was selected to represent those persons in the vicinity of 
Yucca Mountain who are expected to receive the highest exposure to radioactive materials 
released from a geologic repository. 
On the other hand, the ICRP recommends using a somewhat different concept, the 
“representative person,” for the purpose of protection of the public. According to ICRP 
Publication 101, the representative person is defined as a hypothetical individual who 
receives the dose that represents the more highly exposed individuals in the population 
(ICRP 2006). This representative person replaces the previous concept of the critical group, 
which is a group of people who receive the highest exposure from a particular radiation 
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source or set of sources. In terms of characteristics of the representative person, the ICRP 
recommends selecting reasonable individual habits (e.g., consumption of foodstuffs, 
breathing rate, location, etc.) of highly exposed individuals, but not the extreme habits of 
a single member of the population, like the MEI. The information and values can be 
derived from the national or regional population data. ICRP Publication 101 suggests 
using the 95th percentile of behavior in deterministic calculations. In other words, in a 
prospective probabilistic assessment of dose to individuals, the ICRP recommends that the 
representative person should be defined such that the probability is less than around 5% 
that a person drawn at random from the population will receive a higher dose. Therefore, 
the difference between the representative person and the MEI is that the exposure level of 
the representative person falls at the 95th percentile of its distribution, whereas the MEI’s 
exposure is the highest exposure in a given population. Methods used for determining the 
dose to the representative person are summarized in Table 5 (ICRP 2006).  
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Table 5. Methods used for determining the dose to representative person. 
 
Factors 
Calculation method  
Deterministic Probabilistic 
Environmental 
concentration 
data 
Single values for parameters Distribution of estimated or 
measured concentration 
Habit data Mean value for the more highly 
exposed group or 95th percentile 
of national or regional data 
Range or fixed values for habit 
data 
Dose 
coefficient 
Fixed value based on age Fixed value based on age 
Dose to the 
representative 
person 
Product of above values Method selected by licensee 
or regulator; 
Probability of less 
than about 5% that a person 
drawn at random from the 
population will receive a higher 
exposure 
 
 
 
To calculate potential doses to members of the public from exposure to radioactive 
materials during the routine operation of NPPs, it is necessary to characterize the transport 
of radioactive materials from the facility to the individual through the environment. This 
information includes the nuclides, activities, release rates, types of radiation emitted and 
migration to humans by the various possible exposure routes. The routes through which 
individuals may be exposed to radioactive materials are called exposure pathways (NRC 
2012). In terms of radioactive effluents from NPPs, the effluent pathways are identified in 
NRC regulatory guide (RG) 1.109, “Calculation of annual doses to man from routine 
release of reactor effluents for the purpose of evaluating compliance with 10 CFR Part 50, 
Appendix I” (USNRC 1977b). In general, surface water and atmosphere are the main 
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pathways for radioactive effluents from NPPs to the public (USNRC 1977b, 2013d). All 
liquid and gaseous radioactive effluents from NPPs are monitored before release to the 
environment to determine whether the limits on release can be met or not. 
When individuals are exposed to these radioactive effluents by water or air 
pathways, their doses are estimated to some extent by the amount of time spent in the 
vicinity of the radiation source or the amount of time that the radionuclides inhaled or 
ingested are retained in their bodies. The main exposure pathways for residents living 
around NPPs are as following: 1) inhalation of radioactive gases, 2) drinking milk or 
eating meat from animals that graze on open pasture on which radioactive materials may 
be deposited, 3) eating vegetables grown near the NPP site, and 4) drinking water or eating 
fish caught near the point of release of liquid radioactive effluents (USNRC 2013b). The 
dose is estimated based on the MEI, and site-specific data are typically used for dose 
estimation. If site-specific data are not available, conservative parameters are used to 
estimate the dose. In addition, if other exposure pathways, which contribute significantly 
to the individual dose are found by studies and observations of radionuclide movement 
through the environment or food chains, those exposure pathways should be considered 
for estimating the dose to members of the public. 
Radioactive effluents released from NPPs are generally classified as several groups 
based on their physical characteristics and their contribution on internal or external 
radiation doses (USNRC 2013b). First, liquid radioactive effluents include tritium, fission 
products (e.g., strontium, iodine), and activation and corrosion products (e.g., sodium, iron, 
cobalt). These radionuclides usually contribute to the internal radiation dose through water 
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pathways, such as fish consumption, drinking water, and consumption of meat or 
vegetables grown near a NPP. Second, noble gases (e.g., krypton, xenon, argon) in gaseous 
radioactive effluents neither deposit on the ground nor are absorbed and accumulated 
within living organisms. Therefore, these radionuclides act mainly as radiation sources of 
direct external exposure emanating from the effluent plume. Dose estimation for noble 
gases is conducted for the site boundary, where the highest external radiation doses to 
members of the public are expected to occur (USNRC 2013b). Third, radioiodine and 
tritium in gaseous radioactive effluents can be deposited on the ground or inhaled during 
respiration. For these effluents, both external and internal exposure may occur. A main 
pathway of external radiation dose is the direct exposure from ground deposits of 
radioiodine. For internal exposure, inhalation of contaminated air or consumption of meat, 
milk, or vegetables are the main pathways. Lastly, particulates in gaseous radioactive 
effluents, including fission products (e.g., cesium, strontium) and activated corrosion 
products (e.g., cobalt, chromium) contribute to both direct external and internal radiation 
doses. Pathways of particulates are similar to those of radioiodine. Calculations for most 
pathways are limited to a radius of 80 km from the NPP site (USNRC 2013b).  
According to the NRC Regulatory Guide (RG) 1.109 methodology, the doses are 
calculated for the individuals receiving the highest whole body and organ doses (USNRC 
1977b, 2013d). Therefore, these doses are frequently referred to as the maximum whole 
body and the maximum organ doses. In terms of doses to the whole body or total body, 
the NRC uses somewhat different terminology, “total effective dose equivalent (TEDE),” 
in 10 CFR Part 20 and 50 compared to ICRP Publication 26. This term was defined by the 
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NRC to refer to the summation of internal and external exposure (USNRC 2015f). On the 
other hand, ICRP Publication 26 recommended using the phrase “the sum of the dose-
equivalent from external exposure and the committed effective dose equivalent from the 
intake of radionuclide” (ICRP 1977). In terms of organ doses, nuclear licensees are 
required to calculate these for 6 separate organs in the human body: bone, liver, thyroid, 
kidney, lung, and intestines (USNRC 2013d). The organ which is most susceptible to 
radiation damage is referred to as the critical organ. The concept of critical organ is based 
on ICRP Publication 2, and the whole body or total body can also be a critical organ, if it 
receives the largest radiation dose (ICRP 1977). To control the dose to the whole body 
and any organ of members of the public, the NRC provides the dose criteria for the whole 
body and corresponding organs depending on the types of radioactive effluents.  
In terms of dose estimation, it was recognized that the MEI may not be an adult 
because infants, children, and teenagers may have higher rates of intake per unit body 
mass (USNRC 1977a). Therefore, numerous studies were conducted to find dose 
coefficients for specific age groups in the population. ICRP also began developing age-
dependent dose coefficients for members of the public in the mid-1980s (ICRP 2006). A 
series of publications was issued giving dose coefficients for specific age groups, based 
on biokinetic and dosimetric models. As a result, the available dose coefficients for 
different age groups offered the chance to calculate the numerical values for public 
exposure to radioactive effluents in a more comprehensive manner, as compared to the 
previous calculations based primarily on an adult member of the public. The NRC 
currently uses four age groups: infant (< 1 year), child (1-10 years), teenager (11-17 years), 
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and adult (> 17 years) (NRC 2012). The child is represented by a typical 4-year old, the 
teenager by a 14-year old and the adult by the definition for Standard Man as described in 
ICRP Publication 2 (ICRP 1959; USNRC 1977a). On the other hand, ICRP Publication 
60 recommended using six age groups: newborn (<1 year), infants (1-2 years), young 
children (3-7 years), older children (8-12 years), teenagers (13-17 years), and adults (> 17 
years) (ICRP 1991, 2006). However, ICRP Publication 101 recommended using more 
simple age groups for assessing doses in comparison with the relevant dose constraint, 
especially in prospective assessments (ICRP 2006). These groups are infant (< 5 years), 
child (6-15 years), and adult (16-70 years). For practical application of these age groups, 
the use of dose coefficients and metabolism data for a 1-year-old infant, a 10-year-old 
child, and an adult were recommended to represent the three age categories (ICRP 2006). 
The differences between the MEI and the representative person are summarized in Table 
6 (ICRP 1959; USNRC 1977a; Hawkins 1991; USEPA 1992; NRC 1994; ICRP 2006). 
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Table 6. Comparison between the maximally exposed individual and the representative 
person. 
 
Factors Maximally exposed individual Representative person 
Aim Assessment of the potential 
human health risks associated 
with exposure to environmental 
contaminants 
Dose estimation for members of 
the public 
Institute U.S. EPA and U.S. NRC ICRP 
Definition Single individual with the highest 
exposure in a given population 
Hypothetical individual who 
receives the dose that represents 
the more highly exposed 
individuals in the population 
Assumption Living for 70 years at the location 
considered to receive the heaviest 
annual average concentration (24 
hours per day) 
95th percentile of behaviors of 
residents 
Habit data Person in the vicinity of Yucca 
Mountain who are expected to 
receive the highest exposure to 
radioactive materials released 
from a geologic repository 
Mean value for the more highly 
exposed group or 95th percentile 
of national or regional data 
Dose 
quantity 
Total effective dose equivalent 
(TEDE) 
Effective dose  
Percentile 99.99th percentile of the 
distribution or the highest 
95th percentile of the distribution 
Age groups Four age groups: infant (< 1 year), 
child (1-10 years), teenager (11-17 
years), and adult (> 17 years) 
Six age groups: newborn (<1 
year), infants (1-2 years), young 
children (3-7 years), older 
children (8-12 years), teenagers 
(13-17 years), and adults (> 17 
years) 
Physiological 
model 
Standard Man  
(ICRP Publication 2) 
Reference Person 
(ICRP Publication 89) 
Dose 
coefficient 
Fixed value based on age groups 
(NRC NUREG-0172) 
Fixed value based on age groups 
(ICRP Publications 56, 67, 69, 71, 
72) 
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U.S. Regulation and guidance for public dose estimation 
In the United States, dose estimation to members of the public living around NPPs 
is generally controlled by three basic regulations: 1) 10 CFR Part 20, “Standards for 
Protection Against Radiation,” 2) 10 CFR Part 50, “Domestic Licensing of Production and 
Utilization Facilities,” including Appendix I to 10 CFR Part 50, “Numerical Guides for 
Design Objectives and Limiting Conditions for Operation to Meet the Criterion ‘As Low 
As Reasonably Achievable’ for Radioactive Material in Light-Water-Cooled Nuclear 
Power Reactor Effluents,” and 3) 40 CFR Part 190, “Environmental Radiation Protection 
Standards for Nuclear Power Operations” (USNRC 2015f). These regulations are based 
on a common concept that radiation exposure for members of the public is due to the 
release of radioactive effluents from nuclear facilities. Other dose contributions by natural 
radiation background, medical exposure, etc. are not considered in the consideration of 
the public dose. Therefore, it is important to control the release of radioactive effluents 
from nuclear facilities in order to keep the public doses as low as reasonably achievable 
(ALARA).  
The NRC main radiation protection regulations are in 10 CFR Part 20. The purpose 
of these regulations is to establish the criteria of protection for both members of the public 
and occupationally-exposed workers from nuclear activities conducted under licenses 
issued by the NRC. The current 10 CFR Part 20 is based on ICRP Publication 26, 
published in 1977, which introduced a risk-based system of radiation protection with three 
principles: justification, optimization, and dose limitation (USNRC 2014e). The 
summation of internal and external exposure in 10 CFR Part 20 also was first introduced 
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in ICRP Publication 26. In addition, the technical basis for the annual limits on intake 
(ALIs) and derived air concentrations (DACs) for a large number of radionuclides was 
based on ICRP Publication 30, “Limits for Intakes of Radionuclides by Workers,” and 
ICRP Publication 32, “Limits for Inhalation of Radon Daughters by Workers” (USNRC 
2014e).  
In terms of public dose estimation, 10 CFR Part 20.1301, “Dose limits for 
individual members of the public,” established the annual dose limit for members of the 
general public of 1 mSv (USNRC 1991c). In particular, in 10 CFR Part 20.1301(e) the 
NRC requires that a licensee comply with the EPA environmental standards for uranium 
fuel-cycle facilities, 40 CFR part 190 (USNRC 1991c). 10 CFR Part 20.1302, 
“Compliance with dose limits for individual members of the public,” also requires that a 
licensee demonstrate compliance with the public dose limit set forth in 10 CFR Part 
20.1301 by showing that the annual average concentrations of radioactive material 
released in gaseous and liquid effluents at the boundary of the unrestricted area do not 
exceed the values specified in Appendix B to 10 CFR Part 20. Appendix B to 10 CFR Part 
20 provides concentration limits for gaseous and liquid radioactive effluents released to 
the environment. These values correspond to the radionuclide concentrations which, if 
inhaled or ingested continuously over the course of a year, would produce a TEDE of 0.5 
mSv per year (USNRC 1991c).  
As stated earlier, the term “dose constraint” is also used in 10 CFR Part 20, but its 
purpose is slightly different from that of the ICRP (McGarry 2011). 10 CFR Part 20.1101, 
“Radiation protection programs,” requires that a licensee should set a constraint on 
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gaseous radioactive effluents released from non-reactor facilities to the environment. This 
constraint ensures that the MEI of the public will not be expected to receive a TEDE in 
excess of 0.1 mSv per year from these effluents (USNRC 1991c). The dose constraint used 
by the NRC is focused on the control of radioactive materials from non-reactor facilities 
to the environment to reduce dose to members of the public. The ICRP uses the dose 
constraint in a different way. It is used as an operational tool to restrict both occupational 
and public exposure and to apply to all nuclear facilities. 
In the United States, all applicants or licensees should comply with 10 CFR Part 
50 to operate their nuclear facilities with regulatory approvals (USNRC 1956a). In 
particular, Appendix I to 10 CFR Part 50 provides numerical guides for design objectives 
and limiting conditions for operation to keep levels of radioactive effluents released from 
NPPs to the environment as low as reasonably achievable (USNRC 1956b). Appendix I 
was first published in 1975, and its terminology and methodology for dosimetry are based 
on ICRP Publication 2, published in 1959 (USNRC 2015f). Since Appendix I is based on 
ICRP Publication 2, its methodology for dosimetry is somewhat different from that of the 
current NRC general radiation protection regulations in 10 CFR Part 20. This difference 
causes some concern with the current 10 CFR Part 50, including its Appendix I in that the 
regulations, guidance, and computer software do not align with that used in 10 CFR Part 
20 (USNRC 2015f).  
According to 10 CFR Part 50, the evaluation of off-site radiological consequences 
is required during the licensing process for the construction and the operation of a new 
NPP (USNRC 1956a, 2004a). For a construction permit, dose levels at the boundary of 
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the exclusion area, from postulated accidents, such as loss of coolant accidents (LOCA), 
should comply with specific dose criteria. For postulated accidents, the evaluation must 
meet the following two criteria in 10 CFR Part 50.34, “Contents of applications; technical 
information.” First, an individual positioned at any point on the boundary of the exclusion 
area for any 2-hour period following the beginning of the postulated fission product 
release, would not receive a radiation dose in excess of 0.25 Sv TEDE (USNRC 1956a). 
Second, an individual positioned at any point on the outer boundary of the low population 
zone, who is exposed to the radioactive cloud resulting from the postulated fission product 
release during the entire period of its passage would not receive a radiation dose in excess 
of 0.25 Sv TEDE (USNRC 1956a).  
On the other hand, the dose standards for postulated normal operation, at the 
boundary of the exclusion area, are 0.75 mSv y-1 to the thyroid and 0.25 mSv y-1 to the 
whole body and any other organ (USEPA 1977). The values of dose standards originate 
from the EPA environmental protection standards, 40 CFR Part 190 (USEPA 1977; 
USNRC 1991c). These dose standards serve as practical dose constraints for a new NPP 
license and for its routine operation (Kong et al. 2014). 
In terms of effluent management, 10 CFR Part 50.34a, “Design objectives for 
equipment to control releases of radioactive material in effluents - nuclear power reactors,” 
requires that a licensee establish design objectives for equipment to control release of 
radioactive effluents produced during the normal operation of NPPs (USNRC 1956a). 
These releases should be reported to the NRC regularly in accordance with requirements 
set forth in 10 CFR Part 50.36a, “Technical specifications on effluents from nuclear power 
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reactors” (USNRC 1956a). Even though a design objective is different from a dose 
constraint in 10 CFR Part 20.1101, it has a similar function as a constraint on gaseous 
radioactive effluents released from non-reactor facilities to the environment. The 
difference between a design objective in 10 CFR Part 50 and a dose constraint in 10 CFR 
Part 20 is that the former covers both gaseous and liquid radioactive effluents released 
from reactor facilities while the latter focuses on gaseous radioactive effluents only 
released from non-reactor facilities. The design objectives of Appendix I in 10 CFR Part 
50 are summarized in Table 7 (USNRC 1956b). These objectives are also called system 
operating limits (USNRC 2013d). All numerical values in Table 7 apply to the highest off-
site dose calculated for a MEI within the model framework (Bevelacqua 2009). These 
design objectives are more restrictive than either the 1 mSv y-1 dose limit for members of 
the public in 10 CFR Part 20.1301(a) or the effluent concentration limits in Appendix B 
of 10 CFR Part 20 which corresponds to 0.5 mSv y-1 (USNRC 2015f). However, as 
indicated in 10 CFR Part 50.34a(a), the design objectives of Appendix I of 10 CFR Part 
50 are not radiation protection standards, but are design criteria to ensure that equipment 
designs keep radioactive effluents ALARA (USNRC 1956a). NPPs that meet these 
objectives are considered to be reducing dose to members of the general public from 
radioactive effluents to levels which are ALARA (USNRC 2014b). 
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Table 7. Design objectives of Appendix I of 10 CFR Part 50 for radioactive effluents 
released from each nuclear power reactor. 
 
Dose Type of effluents Limit per unit 
Total body from all pathways Liquid 0.03 mSv y-1 
Any organ from all pathways Liquid 0.1 mSv y-1 
Gamma dose in air Noble gas 0.1 mGy y-1 
Beta dose in air Noble gas 0.2 mGy y-1 
External dose to total body of an 
individual 
Noble gas 0.05 mSv y-1 
External dose to the skin of an 
individual 
Noble gas 0.15 mSv y-1 
Dose to any organ from all pathways Radioiodine & particulates in 
gas (including 3H and 14C) 
0.15 mSv y-1 
 
 
 
In 1979, the EPA established dose standards for uranium fuel-cycle facilities, 
including NPPs of 0.25 mSv y-1 to the whole body, 0.75 mSv y-1 to the thyroid, and 0.25 
mSv y-1 to any other organ of any member of the public (USEPA 1977). These standards 
apply to the whole site or facility, whether it has a single unit or multiple units (USNRC 
2012a). The values of these EPA standards are based on dosimetry concepts and dose 
calculation methods in ICRP Publication 2 (USNRC 2015f). The NRC integrated these 
EPA standards into its regulations 10 CFR Part 20.1301(e) in 1981, and all current NPPs 
should comply with these dose standards (USNRC 1991c; 2014b). The EPA established 
these standards by comparing the cost-effectiveness of various dose levels in reducing 
potential health risks from the operation of uranium fuel-cycle facilities. The EPA also 
presumed that the standards would be able to be met for up to four fuel-cycle facilities, for 
example four reactors, at a single site (USNRC 2014b). Table 8 shows the dose standards 
for members of the public as applied in the design of uranium fuel-cycle facilities (USEPA 
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1977). Although the EPA regulation uses the term dose standards instead of dose 
constraints, the terms have the same purpose and meaning. 
 
 
 
Table 8. Dose standards of 40 CFR Part 190 for Uranium Fuel-cycle Facilities. 
 
Dose Limit per site 
Whole body 0.25 mSv y-1 
Thyroid 0.75 mSv y-1 
Any other organ 0.25 mSv y-1 
 
 
 
To facilitate licensee implementation of the ALARA requirements of Appendix I 
to 10 CFR Part 50, the NRC provides a series of regulatory guides which describe methods 
for estimating the activity released in radioactive effluents, dispersion of effluents in the 
air and water, estimating potential doses to members of the public living around nuclear 
facilities, etc. Among these guides, the main guidance report is NRC RG 1.109, 
“Calculation of annual doses to man from routine release of reactor effluents for the 
purpose of evaluating compliance with 10 CFR Part 50, Appendix I” (USNRC 2015f). 
NRC RG 1.109 provides mathematical models and postulations for estimating doses to 
members of the public from liquid and gaseous radioactive effluents (USNRC 1977b). 
NRC RG 1.109 is also applicable to demonstrate compliance with 10 CFR Part 20 and 40 
CFR Part 190. NRC RG 1.109 was first published in 1976, and the modeling approach 
used was based on ICRP Publication 2. The dose factors of NRC RG 1.109 also originated 
from ICRP Publication 2; thus, it is expected to be revised sometime later as part of effort 
to align the NRC regulations with ICRP Publication 103 (USNRC 2015f). To estimate the 
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dose from each type of radioactive effluent, NRC RG 1.109 has two supporting computer 
codes: “LADTAP II: Technical Reference and User Guide” for liquid effluents and 
“GASPAR II: Technical Reference and User Guide” for gaseous effluents (USNRC 1986, 
1987). NRC RG 1.109 consists of seven sections, including 1) regulatory positions 
providing main equations for estimation of all liquid and gaseous exposure pathway doses, 
2) Appendix A for liquid effluent pathways, 3) Appendix B for noble gas pathways, 4) 
Appendix C for pathways of gaseous effluent particulate, iodine, tritium, and carbon-14, 
5) Appendix D for population doses which is no longer required, 6) Appendix E for 
numerical constants, dose conversion factors (DCFs), etc., and 7) Appendix F for the 
function used in computing gamma doses from noble gas releases (USNRC 1977b). 
The general approach to estimating dose in NRC RG 1.109 consists of three simple 
steps: 1) using effluent releases to calculate nuclide concentrations in environmental 
media of interest, usually air, water, and food stuffs, 2) multiplying media nuclide 
concentration by human intake and consumption rates to calculate radionuclide intake, 
and 3) multiplying nuclide intake by a DCF to determine resulting dose (Sejkora 2013). 
In NRC RG 1.109, four pathways are considered for liquid radioactive effluents, including 
potable water, aquatic foods, shoreline deposits, and irrigated foods (USNRC 1977b). All 
pathways except shoreline deposits contribute to internal radiation dose. For gaseous 
radioactive effluents, there are four pathways, such as noble gas exposure, ground 
deposition exposure, inhalation, and crop ingestion (USNRC 1977b). The former two 
pathways contribute to external radiation dose, while the latter two pathways contribute 
to internal radiation dose. NRC RG 1.109 also provides internal DCFs for four age groups 
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(infant, child, teen, and adult) and for six critical organs (bone, liver, thyroid, kidney, lung, 
and gastrointestinal tract), including total body. All these numerical values are derived 
from ICRP Publication 2 (Sejkora 2013). NRC RG 1.109 provides DCFs for only 72 
radionuclides, but two supporting computer codes, LADTAP and GASPAR, provide 
DCFs for 196 nuclides (Sejkora 2013).  
There is a series of regulatory guides supporting NRC RG 1.109 technically. First, 
NRC RG 1.110, “Cost-benefit analysis for radwaste systems for light-water-cooled 
nuclear power reactors,” provides methods to carry out cost-benefit analyses in assessing 
the performance of radioactive waste systems used in light water reactors (USNRC 2013a). 
NRC RG 1.111, “Methods for estimating atmospheric transport and dispersion of gaseous 
effluents in routine release from light-water-cooled reactors,” describes mathematical and 
postulations for estimating atmospheric transport, dispersion, and deposition of airborne 
effluents during normal NPP operation (USNRC 1977d). NRC RG 1.112, “Calculation of 
releases of radioactive materials in gaseous and liquid effluents from light-water-cooled 
nuclear power reactors,” demonstrates methods for calculating radioactive source terms 
for evaluating radioactive waste treatment systems (USNRC 2007a). NRC RG 1.113, 
“Estimating aquatic dispersion of effluents from accidental and routine reactor release for 
the purpose of implementing Appendix I,” describes mathematical models and methods 
for estimating aquatic dispersion of both routine and accidental releases (USNRC 1977c). 
NRC RG 1.21, “Measuring, evaluating, and reporting radioactive material in liquid and 
gaseous effluents and solid waste,” provides guidance for sampling and analysis of 
effluents from NRC-licensed NPPs (USNRC 2009a). In particular, NRC RG 1.21 
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recommends that licensees monitor all locations in the plant where greater than 1% of 
activity is discharged as liquid effluents, noble gases into the atmosphere, or anything else 
into the atmosphere (USNRC 2009a; NRC 2012).  
The NRC has also published some technical reports as a NUREG-series to support 
NRC RG 1.109 and Appendix I to 10 CFR Part 50. First, NRC NUREG-1301, “Offsite 
dose calculation manual guidance standard radiological effluent controls for pressurized 
water reactors,” and NRC NUREG-1302, “Offsite dose calculation manual guidance 
standard radiological effluent controls for boiling water reactors,” describe how to control 
radioactive effluent monitoring instrumentation, effluent releases, and radiological 
environmental monitoring for pressurized water reactors (PWRs) and boiling water 
reactors (BWRs), respectively (USNRC 1991b, a). NRC NUREG-0543, “Methods for 
demonstrating LWR compliance with the EPA uranium fuel-cycle standard (40 CFR Part 
190),” presents the specifications that implement 40 CFR Part 190 and Appendix I to 10 
CFR Part 50 (USNRC 1980). NRC NUREG-0133, “Preparation of radiological effluent 
technical specifications for nuclear power plants,” describes methods for the calculation 
of certain key values required in the preparation of proposed radiological effluent technical 
specifications for light-water-cooled NPPs (USNRC 1978). NRC NUREG-1301 and NRC 
NUREG-1302 are the basic guides for the offsite dose calculation manual (ODCM), which 
includes locations of monitoring instrumentation with respect to plant effluent systems, 
inspection requirements for effluent monitoring systems, sampling frequency and analysis 
for effluent monitoring, types of activity analysis of effluent samples, detection limits, etc. 
(USNRC 1991a, b). Since these reports are basic guides, site-specific effluent monitoring 
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programs can differ from the guidance in these NUREGs with suitable justifications and 
approvals (NRC 2012). Therefore, all NPP licensees have their own site-specific ODCMs.  
The NRC requires that licensees of NPPs and fuel-cycle facilities monitor and 
report releases of radioactive effluents. The monitoring and reporting systems for NPPs 
are specified in the Radiological Effluent Technical Specifications (RETS) (NRC 2012). 
These specifications require the operator to monitor the discharge of radioactive effluents 
at every significant release point at the NPP. Effluent monitoring is composed of 
continuous measurements of some effluent streams, periodic measurement of radioactive 
particles trapped on filters, and measurement of samples from effluents released in batches 
(NRC 2012). Among those measurements, continuous and batch monitoring are the major 
processes in the RETS program at NPPs. Continuous releases of radioactive effluents are 
normally monitored by measuring gross activity with a continuously indicating radiation 
monitoring system (e.g., sodium iodide detector) (NRC 2012). These measurements can 
be used to sound alarms and halt effluent releases if the levels of activity exceed 
permissible limits. In addition, continuous measurements are combined with analyses of 
radioactive particulates trapped on filters or air samples from the effluent stream to acquire 
estimates of the radionuclide concentrations in the effluent stream (NRC 2012). Such 
samples are typically taken at specified frequencies, the period of which is determined by 
the variability of activity in the effluent stream. In contrast, effluent samples of batch 
releases are taken prior to purging or discharging. Analysis for “hard-to-detect” 
radionuclides, such as iron-55, strontium-89, and strontium-90, can be conducted after the 
effluent release (NRC 2012). Detailed information about the RETS program for a specific 
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NPP is incorporated into the licensee’s ODCM, which is part of an operator’s application 
for a NRC license. 
In addition to RETS, the NRC requires that all NPPs have the Radiological 
Environmental Monitoring Program (REMP) to ensure that there are no harmful effects to 
the environment from NPP operations (NRC 2012). Therefore, all NPP licensees should 
submit an annual report to the NRC on the results of their monitoring programs. To 
determine if the releases of radioactive materials are detectable in the offsite environment, 
the NRC requires the NPP operators to collect air samples at numerous locations around 
the NPP. In general, measurements are conducted at five locations: three near the NPP 
boundary in the direction of most likely wind transport, one in the residential area likely 
to have the highest chance of radiation exposure, and one at the control location 15 to 30 
km distant in the upwind direction of prevailing winds (USNRC 1991b; NRC 2012). 
Measurement for radioiodine is conducted weekly, and gross beta activity of particulates 
trapped on filters is measured quarterly. Weekly analysis is also conducted to identify 
gamma-ray-emitting radionuclides. In terms of flexibility of REMP, licensees are allowed 
to make changes to their programs without prior NRC approval (NRC 2012). However, 
licensees should notify the NRC of any changes of their REMP. 
As mentioned earlier, the evaluation of the off-site radiological consequences is 
also required during the licensing process for applicants of a new NPP (USNRC 1956a, 
1989, 2004a). NPPs were originally licensed under the two-step licensing process: 
construction permit and operating license. In 1989, the NRC also established a combined 
license which combines a construction permit and an operating license into a single license 
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(USNRC 2004a). For the two-step process, the requirements for acquiring an operating 
license are described in 10 CFR Part 50. In this process, the applicant submits a final safety 
analysis report (FSAR) to the NRC, and this FSAR includes the NPP’s final design, safety 
evaluation, operational limits, anticipated response of the NPP to postulated accidents, and 
plans for coping with emergencies (USNRC 2004a). In terms of radioactive waste 
management in the FSAR, Appendix I to 10 CFR Part 50 provides the numerical guides 
for design objectives and limiting conditions to meet the criteria of radioactive effluents 
(USNRC 1956b). On the other hand, a combined license approves construction and 
conditional operation of a NPP at the same time. The requirements for acquiring a 
combined license are described in 10 CFR Part 52, “Licenses, certifications, and approvals 
for nuclear power plants” (USNRC 1989). However, the application for a combined 
license should basically include the same information required in an application for an 
operating license issued under 10 CFR Part 50 (USNRC 2004a). Therefore, 10 CFR Part 
50 includes the basic requirements for the NPP licensing process regardless of the types 
of licensing processes. From the perspective of dose criteria, an applicant for NPP license 
should meet the requirements of 10 CFR Part 50.34 under the conditions of postulated 
accidents and the requirements of 10 CFR Part 20.1301(e) and design objectives in 
Appendix I to 10 CFR Part 50 under the condition of a postulated normal operation. In 
particular, the values of 10 CFR Part 20.1301(e) originate from the EPA dose standards 
(USEPA 1977; USNRC 1991c). In practice, these dose standards can serve as dose 
constraints for the license of new NPPs and for the normal operation of existing NPPs 
(Kong et al. 2014). 
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Computer codes for public dose estimation 
The NRC uses computer codes to model and evaluate the release of radioactive 
effluents and the dose to members of the public during various operating conditions in 
NPPs. In terms of the calculation of radioactive effluents discharged from NPPs, the 
GALE code is normally used to estimate the quantities of activity released by a NPP 
through liquid and gaseous discharges during routine operation of PWRs and BWRs 
(USNRC 2015b). The GALE code, which stands for gaseous and liquid effluents, is based 
on the Fortran programming language. The NRC developed two GALE codes depending 
on the reactor type: 1) PWR-GALE code given in NRC NUREG-0017, Revision 1, 
“Calculation of releases of radioactive materials in gaseous and liquid effluents from 
pressurized water reactors (PWR-GALE Code)” and 2) BWR-GALE code given in NRC 
NUREG-0016, Revision 1, “Calculation of releases of radioactive materials in gaseous 
and liquid effluents from boiling water reactors (BWR-GALE Code)” (USNRC 1979, 
1985). These codes are mainly used for the NRC to determine the license’s conformance 
with the requirements of Appendix I to 10 CFR Part 50. These codes are also used for 
NPP design certification and combined license applications submitted under 10 CFR Part 
52. In particular, NRC NUREG-0016 and NUREG-0017 identify liquid and gaseous 
source terms and specific analytical parameters used by the codes, including types of 
processing methods and flow rates, characteristics of filtration, ion-exchange resins, 
adsorbent media to treat process and effluent streams, decontamination factors, etc. 
(USNRC 1979, 1985). These parameters are based on accumulated data generated from 
operating reactors, field tests, laboratory tests, and plant-specific design considerations to 
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decrease the amount of radioactive materials which may be released to the environment. 
The results of GALE code, which are calculated activities of effluents, are used as input 
data for estimating the dose to the public.   
NRCDose 2.3.20, “Code system for evaluating routine radioactive effluents from 
NPPs with Windows interface” can be used for the evaluation of the dose to members of 
the public (RSICC 2015). The NRCDose program was developed to conduct dose 
calculations for up to 169 radionuclides, six organs (bone, liver, thyroid, kidney, lung, and 
gastrointestinal tract) including the total body, and four age groups (infant, child, teenager, 
and adult). The DCFs used in the code are based on NRC RG 1.109 which is supplemented 
with additional DCFs from NRC NUREG-0172 (USNRC 1977b; 1977a; RSICC 2015). 
NRCDose consists of three following codes: LADTAP ІІ for dose calculations due to 
liquid effluents, GASPAR ІІ for dose calculations due to gaseous effluents, and XOQDOQ 
for calculations of the atmospheric diffusion parameters. Originally, LADTAP II, 
GASPAR II, and XOQDOQ were developed for mainframe computers used for bulk data 
processing, and written using the Fortran programming language. The methods of 
LADTAP ІІ and GASPAR ІІ are based on NRC RG 1.109, and XOQDOQ methods are 
based on NRC RG 1.111 (USNRC 1977b; 1977d; RSICC 2015). To facilitate users of 
these codes, the NRC provides additional technical reference and user guides, NRC 
NUREG/CR-4013, NUREG/CR-4653, and NUREG/CR-2919 for LADTAP II, GASPAR 
II, and XOQDOQ, respectively (USNRC 1982, 1986, 1987). The simplified chart of the 
ODCM and its process, including computer codes, is summarized in Table 9 and Fig. 3 
(USNRC 1982; 1986, 1987; USNRC 1991b, 1991a; CEC1999). 
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Table 9. Simplified chart of offsite dose calculation manual (ODCM). 
 
Category Nuclides Pathway Receptor Limits Frequency 
Gaseous 
effluents 
Noble 
gases 
Plume γa Total body 5 mSv y-1 Instantaneousg As required by 
NPP procedure Plume γa and βb Skin 30 mSv y-1 Instantaneousg 
Plume γa Air 0.05 mGy q-1, 0.1 mGy y-
1h 
Monthly 
Plume βb 0.1 mGy q-1, 0.2 mGy y-1h 
Non-noble 
gases 
Inhalationb Adult (any organ) 15 mSv y-1 Instantaneousg As required by 
NPP procedure 
Ground depositionc Total body 75 μSv q-1, 0.15 mSv y-1h Monthly and 
annually Inhalation 4 Age groups  
(all organs) Leafy vegetablesc 
Producec, milkd, meatd 
Liquid 
effluents 
All Water Total body 10 times 10 CFR Part 20 
Appendix B and RETS 
As required by 
NPP procedure 
Non-noble 
gases 
Watere and fishf Total body 15 μSv q-1, 0.3 mSv y-1h Monthly 
Watere and fishf 4 Age groups (all 
organs) 
50 μSv q-1, 0.1 mSv y-1h 
Watere Adult (whole body and 
all organs) 
40 μSv y-1i When required 
by RETS 
Uranium 
fuel cycle 
All All release plus direct 
radiation from 
contained sources 
Whole body 0.25 mSv y-1j Annually 
Thyroid (adult) 0.75 mSv y-1j 
All other organs (Adult) 0.25 mSv y-1j 
TEDE All External (DDE) + 
internal (CEDE) 
Total body + organs 
(adults) 
0.25 mSv y-1k Annually 
a Evaluated at the unrestricted area boundary; b Evaluated at the location of maximum atmospheric dispersion parameter (X/Q). 
c Evaluated at the location of maximum offsite deposition parameter (D/Q). d Evaluated for the nearest producer within 8 km. 
e Evaluated for the nearest downstream community water supply. f Evaluated for fish caught in the near-field region downstream. 
g Radiological effluent technical specifications; h 10 CFR Part 50; i 40 CFR Part 141; j 40 CFR Part 190; k 10 CFR Part 20.
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Fig. 3. Process of offsite dose calculation (ODCM) based on multiple codes for liquid and 
gaseous effluents. 
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Dose calculation for occupational workers at nuclear power plants 
To calculate radiation dose in the human body, it is essential to identify the exposed 
individual and obtain his or her physiological data, regardless of types of exposure: 
external or internal radiation. To calculate the external radiation dose, the individual’s 
mass and dimensions, and basic compositions of the organs is generally enough for most 
circumstances. On the other hand, for internal radiation exposure, much more biological 
information of the exposed individual is required to calculate the dose due to intake or 
inhalation of radioactive materials. This information includes respiration rates, excretion 
rates, removal rates of the radioactive material from various organs or from the body, etc. 
Due to the wide variety of data for each individual, it is difficult to use accurate 
physiological data of each individual for dose calculation. However, the levels of dose to 
individuals during routine NPP operations are sufficiently low so that the differences 
among individuals can be neglected for dose calculation (ICRP 1975). Furthermore, if a 
reference individual is defined well enough to represent a typical worker in the nuclear 
industry, this reference individual can facilitate routine dose calculation for occupational 
workers. Therefore, to meet the need of identifying a reference individual for the 
calculation of low-level doses, the ICRP issued ICRP Publication 23, “Report of the Task 
Group on Reference Man,” which provided detailed information on the anatomical, 
morphological and physiological characteristics of humans related to the biokinetics or 
dosimetry of internally deposited radionuclides (ICRP 1975).  
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Reference man 
The NRC uses the concept of the Reference Man, which originated from ICRP 
Publication 23, for dose calculation, especially for the calculation of ALIs and DACs for 
occupational exposure (ICRP 1975; USNRC 1991c). According to 10 CFR Part 20, the 
Reference Man is defined as “a hypothetical aggregation of human physical and 
physiological characteristics arrived at by international consensus” (USNRC 1991c). In 
addition, the Reference Man is defined in more detail as “a person with the anatomical 
and physiological characteristics of an average individual that is used in calculations 
assessing internal dose” (USNRC 2015g). These definitions indicate that the Reference 
Man is not a real person, and it was made mainly for calculating internal dose. 
The Reference Man was originally called the Standard Man. In 1949, the concept 
of the Standard Man was first introduced at the Chalk River Conference on Permissible 
Dose to represent a typical or average adult who is exposed occupationally (NRC 2012). 
Specific data for organ masses and for the chemical composition of the total body and the 
various organs were attained from several previous studies. The characteristics of intake 
and excretion and the duration of occupational exposure were determined at the Chalk 
River Conference such that these data, including water balance, respiration, duration of 
exposure, and retention of particulates in lungs, should be average for normal activity in 
the temperate zone (ICRP 1975). These characteristics led to the use of the Standard Man 
as the basis for ICRP Publication 2 on permissible doses to workers from internally 
deposited radionuclides (ICRP 1959). 
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In 1963, a task group of ICRP Committee 2 was established to revise the concept 
of the Standard Man, and the term was also altered later from the Standard Man to the 
Reference Man (ICRP 1975). The ICRP stated that the characteristics of radionuclides in 
the human body must be specified clearly to apply the ICRP body burden and MPC 
correctly. Similar to the Standard Man, the Reference Man represented a typical radiation 
worker. Furthermore, to extend the concept of the Reference Man, ICRP Publication 23 
provided information for individual variation depending on age, sex, and some other 
factors (ICRP 1975). Even though the data for the Reference Man were acquired from a 
wide variety of sources of various geographical areas and races, the ICRP selected data 
principally to represent a typical Western European or North American individual. 
According to ICRP Publication 23, the Reference Man is defined as a person who is a 
Caucasian, between 20-30 years old, 170 cm (5.58 ft.) in height, and 70 kg (154.32 lb.) in 
weight, and lives in an area of Western Europe or North America with an average 
temperature between 10-20 °C (50-68 °F) (ICRP 1975). 
Although the Reference Man is still used in radiation regulations in the United 
States, numerous data related on the biokinetics and dosimetry of radionuclides have been 
accumulated since the issue of ICRP Publication 23 in 1975. In addition, there was a strong 
need to establish reference characteristics for children or other subgroups of the population. 
In 1984, the ICRP organized the new task group on the Reference Man and started to 
update its reference values. As a result, the ICRP issued, in 2002, ICRP Publication 89, 
“Basic anatomical and physiological data for use in radiological protection: reference 
values,” which provides reference values for both male and female in six age groups: 
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newborn, 1-year, 5-years, 10-years, 15-years, and adult (ICRP 2002). The reference values 
given in this publication are based on three general sources of data: 1) anatomical and 
physiological data not published previously by the ICRP; 2) data in ICRP Publication 66 
on the human respiratory, ICRP Publication 70 on the skeleton, and ICRP Publication 88 
on the human embryo and fetus; and 3) data in Publication 23, which is still regarded 
effective for radiation dosimetry purposes (ICRP 1994; ICRP 1995; ICRP 2001; ICRP 
2002). The name of the Reference Man was also changed to the Reference Person. 
According to ICRP Publication 103, the Reference Person is defined as a hypothetical 
person who uses the reference data of the Reference Male and the Reference Female in 
ICRP Publication 89 for the calculation of organ or tissue equivalent doses and effective 
dose (ICRP 2007). Most nations in the world currently use the concept of the Reference 
Person for dosimetry calculations, and the NRC is also considering adopting the Reference 
Person for the basis of dose calculation in radiation regulations (USNRC 2014e). The 
differences between the MEI and the representative person are summarized in Table 10 
(ICRP 1975; USNRC 1991c; ICRP 2007). 
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Table 10. Comparison between the Reference Man and the Reference Person. 
 
Factors Reference Man Reference Person 
Aim Occupational dose calculation, 
especially for internal radiation 
exposure 
Dose calculation for an 
individual 
Institute ICRP ICRP 
Definition Hypothetical person with the 
anatomical and physiological 
characteristics of an average 
individual that is used in 
calculations assessing internal 
dose 
Hypothetical person who uses 
the reference data of the 
Reference Male and the 
Reference Female in ICRP 
Publication 89 for the calculation 
of organ or tissue equivalent dose 
and effective dose 
Characteristics Typical radiation worker Idealized person for whom the 
organ or tissue equivalent doses 
are calculated by averaging the 
corresponding doses of the 
Reference Male and Reference 
Female 
Anatomical 
criteria 
ICRP Publication 23 ICRP Publication 89 
Dose 
coefficients 
ICRP Publications 30, 32 ICRP Publications 56, 67, 69, 71, 
72 
 
 
 
U.S. Regulation and guidance for occupational dose calculation 
Occupational dose indicates the dose received by an individual during work 
involving radiation or radioactivity. Occupational dose does not include the dose received 
from background radiation, from medical treatments, and as a member of the public. In 
terms of NPP operation, regulations for occupational dose are mainly provided by 10 CFR 
Part 20 (USNRC 1991c). The dose to the whole body in 10 CFR Part 20 is the weighted 
dose for tissues or organs (USNRC 2014e). The dose to the whole body is expressed as 
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TEDE, which represents a single value obtained from summation of external and internal 
radiation dose (USNRC 1991c). However, the dose equivalents for the lens of the eye, the 
skin, and the extremities are not applicable to this summation rule, and they have their 
own separate limits. In terms of external dosimetry, 10 CFR Part 20 stresses that if the 
external radiation dose is measured by an external personal monitoring device, such as a 
thermoluminescent dosimeter (TLD), the effective dose equivalent should be the deep-
dose equivalent (DDE) (USNRC 1991c). This DDE also indicates the highest dose that 
the body receives. The occupational dose limits for adults, minors, and embryos or fetuses 
are described in 10 CFR Part 20.1201 through Part 20.1208, and these are summarized in 
Table 11 (USNRC 1991c; Cember and Johnson 2009). 
 
 
 
Table 11. Occupational dose limits in 10 CFR Part 20. 
 
Exposed subjects Limits 
Whole body 50 mSv y-1  
Lens of the eye 150 mSv y-1  
Any other organ or tissue 500 mSv y-1 
Extremities (Limbs, fingers, etc.) 500 mSv y-1  
Skin (averaged over 10 cm2) 500 mSv y-1 
Minors 10 % of adult dose 
Embryo or fetus 5 mSv a  
a Over the gestation period.  
 
 
 
In terms of internal dosimetry, the regulations in 10 CFR Part 20 are primarily 
based on several ICRP reports: first, ICRP Publication 30, “Limits for intakes of 
radionuclides by workers,” including its four parts, four supplements, and index, which 
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were published during the period of 1979 through 1988 and second, ICRP Publication 32, 
“Limits for inhalation of radon daughters by workers” (ICRP 1979b; 1979a, 1980, 1981a, 
c, b, 1982b, a, 1988; USNRC 2014e). These ICRP Publications are used to guide the 
calculation of the inhalation values for the ALIs and DACs of radionuclides in Appendix 
B to 10 CFR Part 20. In particular, Table 1, “Occupational Values,” in Appendix B to 10 
CFR Part 20 provides the values for oral ingestion ALI, inhalation ALI, and DAC for the 
Reference Man (USNRC 1991c). All of these values assumed that the radioactive material 
taken into the body is an aerosol with an activity median aerodynamic diameter of 1 μm. 
In addition, this has three clearance half-times from the respiratory system. These are 
Class D, Class W, and Class Y, which indicate retention times in the pulmonary region of 
the lung, approximately days, weeks or years, respectively (USNRC 1991c).  
The NRC has issued several regulatory guides which provide methods for 
calculating and reporting occupational dose to facilitate the licensee’s compliance with 
the requirements of 10 CFR Part 20. Among these guides, NRC RG 8.34, “Monitoring 
criteria and methods to calculate occupational radiation doses,” describes in detail how to 
calculate external and internal radiation doses for workers and how to report those results 
to the NRC (USNRC 1992). All methods described in NRC RG 8.34 are based on ICRP 
Publication 26 and 30, which are also the basis of 10 CFR Part 20. According to 10 CFR 
Part 20.1502, “Conditions requiring individual monitoring of external and internal 
occupational dose,” external radiation monitoring for a worker is required if the external 
occupational dose is expected to exceed 10% of the dose limits or an individual enters a 
high or very high radiation area (USNRC 1991c). Internal radiation monitoring for a 
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worker is also required if the intake of radioactive material is likely to exceed 0.1 ALI 
during the year or if committed effective dose equivalent (CEDE) is expected to surpass 
the 0.5 mSv for the occupationally-exposed minor or declared pregnant woman (USNRC 
1991c). As stated earlier, the dose to the whole body in the NRC regulations is expressed 
as TEDE. This TEDE is obtained through the summation of DDE for external radiation 
exposure and CEDE for internal radiation exposure.  
According to 10 CFR Part 20.1502, individual monitoring devices are required to 
monitor external radiation exposure to workers, whereas they are not necessary for internal 
dose monitoring (USNRC 1991c). The requirements of external radiation exposure are 
applied individually depending on the types of external radiation dose: DDE to the whole 
body, shallow dose equivalent (SDEs) to the skin or extremities, and lens dose equivalent 
to the eye (LDE). To determine whether external dose monitoring is required or not, the 
prospective occupational dose to the worker for the year is used as the basis for evaluating 
the likelihood of doses exceeding 10% of the dose limit (USNRC 1992). If the conditions 
of radiation exposure to the worker change during the year, the necessity for external dose 
monitoring should be reevaluated. Although some doses are measured below 10% of the 
dose limit, all doses measured during the monitoring must be recorded since the 
monitoring was conducted to meet 10 CFR Part 20.1502 (USNRC 1992). 
In terms of external dose monitoring, 10 CFR Part 20 provides three dose limits: 
1) 50 mSv of DDE to the whole body, 2) 500 mSv of SDE to the skin or extremities, and 
3) 150 mSv of LDE to the lens of the eye (USNRC 1991c). The definitions of these doses 
are described in 10 CFR Part 20.1003, “Definitions” (USNRC 1991c). First, the DDE is 
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defined as the external whole-body dose equivalent at a tissue depth of 1 cm (1000 mg 
cm-2). The SDE is defined as the dose to the skin or extremities at a tissue depth of 0.007 
cm (7 mg cm-2). Finally, the LDE is defined as the dose to the eye at a tissue depth of 0.3 
cm (300 mg cm-2). As mentioned earlier, external radiation dose is generally measured by 
individual monitoring devices, such as TLDs. The monitoring device for the whole body 
dose is typically placed on the chest of a worker since the chest is expected to receive the 
highest dose during work when the whole body is exposed homogeneously (USNRC 
1992). If the radiation field is not homogeneous, the monitoring device should be placed 
on the location where a specific part is expected to receive the highest dose. In some cases 
when the radiation field is highly heterogeneous, two or more dosimeters are used to 
determine the DDE to the whole body. Several dosimeter algorithms were developed from 
previous studies to calculate the real DDE, but NRC RG 8.34 recommends using the 
highest value as the DDE among several measured values of multiple dosimeters (USNRC 
1992; Kim and Kong 2010). If the local radiation exposure to extremities, such as fingers, 
is expected, an extremity dosimeter may be used to monitor the SDE to the extremities. 
However, in a normal case when exposure is uniform, especially for NPPs, the SDE to 
extremities can be replaced by the SDE measured by a chest dosimeter, and additional 
extremity monitoring would not be necessary unless the whole body dose exceeds its limit 
(USNRC 1992; Kim and Kong 2013). 
In internal dose monitoring, the dose is expressed as CEDE. The CEDE is defined 
as the 50-year effective dose equivalent for intake of radioactive material into the body 
through inhalation, ingestion, absorption through the skin, accidental injection, or 
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introduction through a wound (USNRC 1992). To calculate the total CEDE, all 
occupational intakes through these modes of intake are added over the yearly time period. 
According to 10 CFR Part 20.1204, “Determination of internal exposure,” it is assumed 
that the inhalation of one ALI, or an exposure of 2,000 DAC-hours, results in a CEDE of 
50 mSv for radionuclides that have their ALIs or DACs based on this limit (USNRC 
1991c). To calculate the CEDE for the inhalation of radioactive material, NRC RG 8.34 
provides the five acceptable methods: 1) use of Federal Guidance Report No.11, 2) use of 
stochastic inhalation ALIs from 10 CFR Part 20, 3) use of DACs from 10 CFR Part 20, 4) 
use of ICRP Publication 30, and 5) use of individual or material-specific information 
(USNRC 1992).  
First, Federal Guidance Report No. 11, “Limiting values of radionuclide intake 
and air concentration and dose conversion factors for inhalation, submersion, and 
ingestion,” provides the CEDE per unit intake by inhalation in its Table 2.1 (USEPA 1988). 
Second, Table 1 in Appendix B to 10 CFR Part 20 provides ALIs for individual 
radionuclides (USNRC 1991c). The CEDE can be calculated using these ALI values using 
Equation (4): 
 
i
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where CEDEi is the CEDE for radionuclide i (rem), Ii is the intake of radionuclide i by 
inhalation during the calendar year (μCi), ALIi is the value of the stochastic inhalation ALI 
from Column 2 of Table 1 in Appendix B to 10 CFR Part 20 (μCi), and 5 is the CEDE 
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from intake of 1 ALI (rem) (USNRC 1992). The stochastic ALIs in Appendix B to 10 
CFR Part 20 were derived to result in a risk due to irradiation of organs and tissues, 
comparable to the risk related with the DDE to the whole body of 50 mSv. The non-
stochastic ALIs were derived to prevent deterministic effects, such as immediate damage 
to tissues (USNRC 1991c). For an intake of more than one radionuclide, the total CEDE 
is calculated as the sum of the CEDEs for all radionuclides. Third, Table 1 in Appendix B 
to 10 CFR Part 20 also provides stochastic DACs for individual radionuclides (USNRC 
1991c). The CEDE can be calculated using these DAC values using Equations (5) and (6): 
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where DACi is the stochastic DAC for radionuclide i (μCi cm-3), ALIi is the stochastic ALI 
for radionuclide i (μCi), 2.4×109 is the volume of air inhaled by a worker in a work year 
(cm3), CEDEi is the CEDE from radionuclide i (rem), Ci is the airborne concentration of 
radionuclide i to which the worker is exposed (μCi cm-3), t is the duration of the exposure 
(h), 2000 is the number of hours in a working year (8h×5d×50w), and  5 is the CEDE from 
annual intake of 1 ALI or 2000 DAC-hours (rem) (USNRC 1992). According to 10 CFR 
Part 20.1204, when radionuclides exist as a mixture in the air, certain radionuclides in the 
mixture can be disregarded if the following conditions are met: 1) the concentration of 
radionuclide ignored is below 10% of its DAC, 2) the sum of these percentages for all of 
the radionuclides ignored in the mixture does not surpass 30%, and 3) the licensee uses 
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the total activity of the mixture in demonstrating compliance with the dose limits and 
monitoring requirements (USNRC 1991c). Fourth, the supplements to ICRP Publication 
30 provide the weighted CEDE to target organs or tissues per unit intake by inhalation 
(ICRP 1979a, 1981b, 1982a, b). According to ICRP Publication 30, the weighted CEDE 
is defined as the product of the weighting factor and the CEDE for a specified organ or 
tissue (ICRP 1979b). Finally, it is possible to use individual or material-specific 
information to calculate the CEDE for the inhalation of radioactive material. 10 CFR Part 
20.1204 allows the licensee to use specific data on the physical and biochemical properties 
of the radionuclides taken into the body or the behavior of the material in an individual 
without prior NRC approval (USNRC 1991c). However, since this approach requires the 
licensee to do significantly more work, it is not generally used for small routine inhalation 
(USNRC 1992).  
Ingestion is another main intake pathway for radioactive material into the body. 
Contrary to inhalation, only one ingestion ALI is provided for each radionuclide, and this 
value is used for all chemical forms of that radionuclide (USNRC 1992). Similar to the 
methods used for calculating the CEDE by inhalation, NRC RG 8.34 provides the four 
acceptable methods: 1) use of Federal Guidance Report No.11, 2) use of stochastic 
ingestion ALIs from 10 CFR Part 20, 3) use of ICRP Publication 30, and 4) use of 
individual or material-specific information (USNRC 1992). First, Federal Guidance 
Report No. 11 provides the CEDE per unit intake by ingestion in its Table 2.2 (USEPA 
1988). Second, Table 1 in Appendix B to 10 CFR Part 20 provides stochastic ingestion 
ALIs for individual radionuclides (USNRC 1991c). The CEDE can also be calculated 
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using Equation (4) using the ingestion ALI value instead of the inhalation ALI value. Third, 
the supplements to ICRP Publication 30 list the weighted CEDE to target organs or tissues 
per unit intake by ingestion (ICRP 1979a, 1981b, 1982a, b). Finally, the use of individual 
or material-specific information is also used to calculate the CEDE for the ingestion of 
radioactive material. 
To demonstrate compliance with dose limits for an individual organ or tissue in 10 
CFR Part 20.1201, the licensee should calculate the organ-specific CEDE (USNRC 
1991c). The calculation of organ-specific CEDE is necessary only if the CEDE exceeds 
10 mSv or if an over exposure has occurred (USNRC 1992). If the CEDE is below 10 mSv 
and no overexposure has occurred, the organ-specific CEDE cannot surpass its limit of 
500 mSv (USNRC 1992). To calculate the organ-specific CEDE, NRC RG 8.34 provides 
the five acceptable methods: 1) use of Federal Guidance Report No.11, 2) use of non-
stochastic inhalation ALIs from 10 CFR Part 20, 3) use of non-stochastic DACs from 10 
CFR Part 20, 4) use of ICRP Publication 30, and 5) use of individual or material-specific 
information (USNRC 1992).  
First, Federal Guidance Report No. 11 provides the organ-specific exposure-to-
dose conversion factors in Table 2.1 for inhalation and Table 2.2 for ingestion (USEPA 
1988). Then, the organ-specific CEDE can be calculated using these factors and Equation 
(7): 
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where CEDET is the CEDE to the tissue or organ from radionuclide i (rem), Ii is the intake 
of radionuclide i (μCi), DCFi is the dose conversion factor for radionuclide i from Table 
2.1 or 2.2 in Federal Guidance Report No. 11 (Sv Bq-1), and 3.7×106 is the conversion 
factor to convert from Sv Bq-1 to rem μCi-1 (USNRC 1992). Second, Table 1 in Appendix 
B to 10 CFR Part 20 provides non-stochastic inhalation ALIs for individual radionuclides 
(USNRC 1991c). The CEDE can also be calculated using Equation (4) and both the non-
stochastic ALI value instead of the stochastic ALI value and 50 rem instead of 5 rem 
(USNRC 1992). Third, the corresponding DAC in Appendix B to 10 CFR Part 20 for the 
non-stochastic ALI of a radionuclide can be used to calculate the organ-specific CEDE 
(USNRC 1991c). The CEDE can also be calculated using Equation (6) and both these 
DAC values instead of the stochastic inhalation DAC value and 50 rem instead of 5 rem 
(USNRC 1992). Fourth, the supplements to ICRP Publication 30 provide the CEDE in 
target organs or tissues per unit intake to significantly exposed organs (ICRP 1979a, 1981b, 
1982a, b). Finally, the use of individual or material-specific information is also allowed in 
calculating the organ-specific CEDE. 
In terms of calculating the dose from intakes through wounds or skin, the intake 
by skin absorption of airborne radioactive materials is generally not required since, in 
practice, it is trivial compared to the intake from inhalation (USNRC 1992). However, if 
the radionuclide is in a solution containing dissolved radioactive material, such as tritium, 
absorption through the skin is not negligible and the calculation of its dose is necessary. 
Internal radiation exposure from tritium at pressurized, heavy-water reactors, such as the 
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CANDU reactor, accounts for 20-40% of the total occupational dose (Kim and Kong 
2012b). 
10 CFR Part 20.2106, “Records of individual monitoring results,” requires that the 
occupational dose recording be done on NRC Form 5 or equivalent (USNRC 1991c). This 
recording form is based on annual dose. The monitoring period for occupational dose, 
especially for NPPs, is generally from January 1 to December 31 (USNRC 1992). Detailed 
instructions for filling out NRC Form 5 are given in NRC RG 8.7, Revision 2, 
“Instructions for recording and reporting occupational exposure data” (USNRC 2005a). 
According to 10 CFR Part 20.1202, “Compliance with requirements for summation of 
external and internal doses,” the TEDE is obtained through the summation of external 
radiation dose (DDE) and internal radiation dose (CEDE) (USNRC 1991c). However, this 
summation method is not applicable to the SDE to the skin or extremities or to the eye 
dose equivalent. The minimum value of recording on NRC Form 5 is 0.1 mSv, since such 
small values are trivial relative to the dose limits (USNRC 1992).  
 
Computer codes for occupational dose calculation 
Contrary to public dose estimation, computer codes are not often used to calculate 
the occupational dose, especially for external radiation exposure, because most workplace 
conditions are well known and personal monitoring devices provide relatively precise 
radiation measurements. In NPPs, the whole body dose is generally determined from 
personal dosimeter readings which provide the DDE unless the worker has intakes of 
radioactive materials through inhalation, ingestion, or skin absorption. Regarding 
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compliance with the requirements of SDE in 10 CFR Part 20, the NRC provides the 
computer code VARSKIN to be used to calculate skin dose from both beta and gamma 
radiation sources (USNRC 2015b). NRC NUREG/CR-6918, “VARSKIN 5: A computer 
code for skin contamination dosimetry,” describes how to use VARSKIN for the 
calculation of tissue dose at various depths as the result of skin contamination (USNRC 
2014h). The area of 10 cm2 is set as a default for skin dose calculations in VARSKIN to 
meet requirements of 10 CFR Part 20.1201. However, the user can select any dose-
averaging area for specific uses. In general, the level of radiation exposure to a worker 
during normal NPP operation is low enough to neglect the SDE to the skin. Therefore, 
skin dose calculations are rare and the use of VARSKIN is also not common in the field 
at NPPs (Kim and Kong 2012a). 
In terms of internal radiation exposure, several computer codes are used for 
bioassay program in NPPs. The code for internal dosimetry (CINDY) is one of the codes 
used for bioassay calculation, which is based on the respiratory system and GI tract models 
in ICRP Publication 30 (ICPR 1979b; 1979a, 1980, 1981a, c, b, 1982b, a, 1988; PNNL 
2009). This code can be used to calculate intake using curve-fitting of bioassay data; 
committed organ, tissue, and effective dose equivalents; and bioassay projections. 
Although CINDY was originally developed by the Pacific Northwest National Laboratory 
in the late 1980s and early 1990s with the U.S. DOE funding, it is now commercially 
available through Canberra Nuclear, Incorporation (PNNL 2009). Since the CINDY code 
is based on ICRP Publication 30, it is not widely used in the world except the United States. 
One of the other popular codes is the integrated modules for bioassay analysis (IMBA) 
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developed by the Public Health England in the UK to evaluate bioassay data and calculate 
internal radiation doses from intakes of radioactive materials (PHE 2015). This code is 
based on the Human Respiratory Tract Model (HRTM) in ICRP Publication 66, biokinetic 
models in ICRP Publication 78, and the GI tract model in ICRP Publication 30 (ICRP 
1979a, 1980, 1981a, c, b, 1982b, a, 1988, 1994; 1997). The code consists of a series of 
independent modules that are used for specific tasks and communicate with each other 
though input and output files. IMBA is widely used in the world for bioassay calculations 
due to its technical basis of 1990 ICRP Recommendation on Radiological Protection 
(ICRP Publication 60).  
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METHODOLOGY 
Risk attributable to ionizing radiation 
Risk assessment is associated with evaluating probability and impact of individual 
detriment. Probability is the likelihood of a certain outcome. Impact is the severity or 
effect of the outcome. Risk assessment is widely used in evaluating the health effects of 
radiation exposure. Most industrial activities including the operation of NPPs involve low 
radiation doses. For several decades, an effort has been exerted to discover the dose-
response curve at low radiation doses, but nothing can be said with certainty about low 
dose levels (Romerio 2002). There are still no definite data to prove the risk of low doses, 
below approximately 100 mSv. However, it is generally acceptable to linearly extrapolate 
the risk at low doses to estimate the probability of incurring cancer or genetic effects 
attributable to radiation. The linear-non-threshold (LNT) model implies that a given 
increment in dose will produce a directly proportionate increment in risk (ICRP 2007). 
ICRP considers that the LNT model is the best practical approach to managing risk from 
radiation exposure (ICRP 2007). 
In addition to the LNT model, a dose and dose-rate effectiveness factor (DDREF) 
is used for risk estimation to provide realistic estimates of the effects of radiation exposure 
at low annual doses. The DDREF is defined as a factor that simplifies the lower biological 
effectiveness (per unit of dose) of radiation exposures at low doses and low dose rates as 
compared with exposures at high doses and high dose rates (ICRP 2007). This means that 
the risk estimates at low doses are not based on a simple extrapolation of effects seen with 
the range of high doses, such as 1 to 2 Sv, and the cancer risk at these low doses and low 
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dose rates is judged to be reduced by the value of the factor ascribed to DDREF. A DDREF 
of 2 is currently used by the ICRP to derive the nominal risk coefficients for stochastic 
effects (ICRP 1991, 2007).  
The risk is expressed as the excess risk per Sv. This excess risk can be calculated 
using either excess relative risk (ERR) or excess absolute risk (EAR) models (ICRP 2007). 
The ERR is the proportional increase in risk over the background absolute risk in the 
absence of exposure, and it is expressed as 
  
ERR =
RRadiation
RBackground
-1.        (8) 
 
The EAR is the additional risk above the background absolute risk given by 
 
EAR = RRadiation - RBackground        (9) 
 
where RRadiaiton is the risk of radiation exposure and RBackground is the risk of background. 
A weighting of the ERR and EAR was used to estimate radiation risk for each organ: 
ERR:EAR weights of 0:100% for breast and bone marrow, 100:0% for thyroid and skin, 
30:70% for lung, and 50:50% for all others organs (ICRP 2007).  
On the basis of the above assumptions, the detriment-adjusted risk is calculated 
using Equation (10) (ICRP 2007). 
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where RI is nominal risk coefficient (cases per 10,000 person per Sv) from fatal (RF) and 
non-fatal (RNF) cancers, RD is the detriment-adjusted risk, q is the lethality, 
))1(( minmin qqq  is the weight given to non-fatal cancers, and l is relative cancer-free 
life lost. Here, qmin is the minimum weight for non-fatal cancers. Nominal risk coefficients 
RI result from averaging sex and age-at-exposure lifetime risk estimates in representative 
populations. Radiation risk estimates are derived for incidence data for specific tumor sites 
using dose response data from the Japanese Life Span Study (LSS). These risk estimates 
were reduced by a factor of 2 with respect to DDREF. These nominal risks are calculated 
for each site of interest and summed to give the population total nominal risk. A summary 
is provided in Table A.4.1 in ICRP Publication 103 (ICRP 2007). 
A detriment-adjusted risk RD indicates the probability of the occurrence of a stochastic 
effect, modified to allow for the different components of the detriment to express the 
severity of the consequence. ICRP also notes that these risk coefficients are based on direct 
human epidemiological data. ICRP risk coefficients for stochastic effects after radiation 
exposure at low dose rates are provided in Table A.4.4 in ICRP Publication 103. Table 12 
presents a summary of the detriment-adjusted nominal risk for the adult and whole 
populations, which will be used in future analysis to assess the excess risk for members of 
the public and occupational workers in NPPs (ICRP 2007). It is important to mention that 
the ICRP does not provide an uncertainty of the risk coefficients shown in Table 12; 
however, the uncertainty was estimated by the United Nations Scientific Committee on 
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the Effects of Atomic Radiation to be a factor of approximately 2 (a ± 2a) (UNSCEAR 
2000; ICRP 2005; 2007). The excess risk incurred by a given dose will be given as 
   
DRDER   (11) 
 
where ER is the excess risk, D is the radiation dose, RD is the detriment-adjusted nominal 
risk coefficient as shown in Table 12.  
 
 
 
Table 12. Detriment-adjusted nominal risk coefficients (per mSv) for stochastic effects 
after radiation exposure at low dose rates as determined in ICRP Publication 103.   
 
Exposed subject Whole populationa Adult populationb 
Cancer 5.5×10-5 4.1×10-5 
Heritable effects 0.2×10-5 0.1×10-5 
Total 5.7×10-5 4.2×10-5 
a Whole population, including members of all ages. 
b Adult age population (18 – 64 years). 
 
 
 
Determination of a single source 
The definition of dose constraints indicates that a dose constraint originates from 
a single source. Therefore, the first step is to determine a single source, which will be a 
target for applying a dose constraint prior to the determination of numerical value for that 
constraint. A single source can be a physical subject or an activity which results in 
radiation exposure (ICRP 2007). In general, a single source is determined broadly, such 
as a NPP or a radiation generating device or routine operation in nuclear facilities such as 
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non-destructive inspection, to prevent subdividing the source for the sake of avoiding the 
protection requirements. If a single source for applying a dose constraint is a radiation 
source with very small activity or a small part of the work, which results in trivial radiation 
exposure, it is not necessary to implement a dose constraint for that source, because its 
radiation level is already low enough to be neglected. 
In terms of the dose to members of the public living around NPPs, a single source 
can be a single unit, which has only one reactor, or a site, which includes multiple units. 
In the United States, NPPs generally consist of two units on a single site, and the number 
of NPP units in some single sites is expected to increase up to four (WNA 2015b). In some 
nations, the number of NPP units increases up to six due to the difficulty of finding new 
NPP sites (Kong et al. 2014; WNA 2015a). In this situation, if a single unit is determined 
as a single source for establishing a dose constraint for the public, several single sources 
can exist in a single site. It will be difficult to control each single source independently 
since, for some NPPs, two units share some radioactive waste processing facilities, and it 
is difficult to distinguish the origin of the radioactive wastes from two units (USNRC 
2013d). This also makes it difficult to control the public dose. The way to prevent these 
problems is to assume that a site is a single source. Furthermore, the dose standards for 
NPP operation in NRC regulations are based on a particular site. Specifically, the NRC 
reports that the EPA dose standards, which are stipulated in 10 CFR Part 20.1301(e), are 
applicable for up to four reactors at one location or a single site (USNRC 2014b). That is, 
the EPA dose standards are also based on a particular site. 
 75 
 
A single site is also a better choice as a single source for an occupational dose 
constraint. In NPPs, it is common that a worker conducts maintenance jobs at two units, 
and he or she occasionally conducts radiation work at other units in the same site. In these 
circumstances, if a single unit is chosen as a single source for establishing a dose constraint 
for workers, the control of occupational doses will be more complicated since it is almost 
impossible to distinguish the origin of the radiation exposure of workers from each unit. 
In some ways, the determination of a single site as a single source can cause 
confusion in that it is difficult to distinguish between the concepts of source-related dose 
constraints and individual dose limits. However, the targets for the implementation of dose 
constraints and dose limits are different. For the source-related approach, a dose constraint 
focuses on the control of the radiation source to prevent exceeding a dose constraint, such 
as the use of other low-level radiation sources. For the individual-related approach, a dose 
limit focuses on control of the exposed person to prevent exceeding a dose limit, which 
might require the replacement of the worker.  
In practice, selecting a single site as a single source for the dose constraint is 
expected to facilitate management of occupational doses in NPPs. It is also possible to 
select certain jobs, which result in very high radiation exposure to workers, as additional 
single sources for dose constraints to reduce their dose levels. However, this approach can 
cause complexity in the management of occupational doses in NPPs. In addition, since 
NPPs usually issue a radiation work permit (RWP) or special work permit (SWP) prior to 
conducting radiation work to protect the worker from receiving unnecessary doses, 
selecting certain jobs as additional single sources with a single site is not necessary.  
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Dose distribution related to the operation of nuclear power plants 
NPP licensees are required, under the regulations in 10 CFR Part 20, to evaluate 
public and occupational doses and to report their doses to the NRC annually. Therefore, 
NPPs conduct routine monitoring of public and occupational radiation exposure to 
demonstrate compliance with dose limits. All records of these results are maintained until 
the NRC terminates their NPP licensees. Since the data of public and occupational doses 
are available, the analysis of past and present dose records can be a useful tool to evaluate 
the trend of radiation exposures related to NPP operation. These data will also be helpful 
to understand a dose distribution and to determine numerical values for dose constraints. 
In terms of public exposure, the NRC publishes the annual report of radioactive effluents 
from NPPs as a series of NUREG/CR-2907, which includes the dose to members of the 
public due to liquid and gaseous effluents (USNRC 2013d). For occupational exposure, 
the annual report of occupational radiation exposure at commercial nuclear power reactors 
and other facilities, which is a series of NUREG-0713, is issued by the NRC (USNRC 
2014d). In these reports, TEDE is mainly used to express the dose quantity and to 
demonstrate compliance with the dose limits since TEDE or effective dose is intended for 
ALARA and regulatory purposes (ICRP 2007). Therefore, it is also appropriate to use 
TEDE as a dose quantity for dose constraints.  
Dose estimation for members of the public basically originates from the release of 
radioactive effluents from NPPs. Other dose contributions by natural radiation background, 
medical exposure, etc., are not considered in the estimation of public dose. Therefore, the 
activities of radionuclides discharged from NPPs to the environment in liquid and in 
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gaseous effluents were analyzed to understand their effects on maximum annual doses to 
the public resulting from these effluent releases. The NRC has started providing annual 
summary reports, NRC NUREG/CR-2907, “Radioactive effluents from nuclear power 
plants,” since 2007, and the 2007, 2008, and 2009 summary reports are currently available 
(USNRC 2011b, 2012e, 2013d). All the radioactive effluents data are based on a single 
NPP site. Common radionuclides in radioactive effluents will be identified through the 
analysis, and their contributions to the total activities of radioactive effluents will also be 
evaluated. Since some NPPs have applied a specific method to reduce their radioactive 
effluents, this approach and its effect on the decrease of total activities of radioactive 
effluents will be analyzed. 
The annual TEDE to the public estimated for each NPP site was used for the 
analysis of dose distributions for public exposure during the years 2007-2009. According 
to the NRC annual summary reports for the public dose, NRC NUREG/CR-2907, the total 
number of NPP sites in the United States is currently 65, and its dose level is 
approximately 10-4 mSv (USNRC 2011b, 2012e, 2013d). Since outliers that have 
extremely high or low values occur due to the dose estimation using the specific exposure 
scenario for each NPP site, and the sample size is not large enough to neglect the influence 
by these outliers, the standard deviation of estimated doses to members of the public is 
normally larger than its average. In terms of probability distribution, measurements of 
radiation exposure are often treated as a skewed distribution (ICRP 2006). The skewed 
distribution is common when mean values are low, variances are large, and values of 
samples cannot be negative (Limpert et al. 2001). In particular, this skewed distribution 
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indicates that the tail on the right side is longer than the left side. Such skewed distributions 
are often well fitted by the lognormal distribution (Limpert et al. 2001). In this study, the 
lognormal distribution, which takes the natural logarithm and applies the normal 
distribution, is used for the analysis of dose distribution for public exposure. 
For occupational exposure, the annual total body doses to workers in NPPs were 
used for the analysis of occupational dose distributions during the years 2003-2012. 
According to the NRC annual reports for occupational exposure, NUREG-0713, 
approximately 200,000 workers were reported as the total number of monitored 
individuals in NPPs, and their dose levels were approximately 1-2 mSv (USNRC 2014d). 
Although the NRC annual reports provide the information on occupational doses in NPPs, 
they do not provide the raw data of occupational exposure due to requirement of 
maintaining the privacy of individual workers. Therefore, the exact figures of occupational 
dose and the standard deviation of the dose distribution cannot be known in the reports. 
However, this study requested the NRC to provide the raw data of occupational TEDEs 
during the years 2003-2012 through the Freedom of Information Act (FOIA). Therefore, 
instead of using the data from the NRC annual reports, the data of occupational exposures 
at commercial NPPs for years between 2003 and 2012 were used in this study to represent 
the typical doses to the occupational workers (USNRC 2016). The dose distribution for 
each year was calculated by counting the number of individuals in each dose range. 
The occupational dose distribution with regards to three classifications of 
individuals in NPPs was the focus of this study. The total number of monitored individuals 
during each year includes office workers, maintenance workers, contract individuals, and 
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even visitors to NPPs. However, since most office workers and visitors are not involved 
in radiation work in the field, their exposure levels are usually extremely low, and their 
radiation exposure may not be measured. Therefore, the number of individuals whose 
radiation exposure is measurable is needed to analyze the actual radiation dose due to 
radiation work in NPPs. According to the NRC annual report for occupational exposure, 
the percent of individuals with measurable dose to the total number of monitored 
individuals in NPPs is approximately 40-50% (USNRC 2014d). It means that only half of 
individuals in NPPs received a dose greater than the dose recording level (0.1 mSv). In 
reality, the total number of monitored individuals is overcounted because of transient 
individuals. Transient individuals are defined as individuals who worked at more than one 
nuclear facility during the year (USNRC 2014d). Each NPP licensee reports the 
occupational doses received by transient individuals at each facility separately to the NRC. 
These data look like separate individual doses although they belong to the same individual. 
To obtain the actual dose information, it is necessary to combine these dose records per 
individual. Contrary to the occupational exposure data obtained directly from the NRC 
through the FOIA, the data provided by the NRC annual reports for occupational exposure, 
taking into account transient individuals, were used to analyze the occupational dose 
distributions at the U.S. NPPs (USNRC 2004b, 2005b, 2006, 2007b, 2008a, 2010b, 2011a, 
2012c, 2013c; 2014d). The reason this study used the data provided by the NRC annual 
report is that it is necessary to access the individual’s identification information, such as a 
social security number, to combine occupational dose records per individual. However, 
the privacy act restricts disclosure of personally identifiable records maintained by federal 
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agencies (USDOJ 1974). Therefore, this study used the data from the NRC annual report 
for analyzing the occupational dose distributions with regards to transient individuals.  
In the analysis of individual dose, a dose distribution can be expressed in two 
general ways. First, the weighting of a dose distribution can be understood as a probability 
(ICRP 2006). For example, the probability that the annual dose to the particular individual 
does not exceed 20 mSv is 0.95 or 95%. This approach is useful to define a specific 
individual in the unknown exposed population, such as a maximally exposed individual 
(MEI). The other approach is the use of the fraction of the exposed population receiving a 
dose within that interval (ICRP 2006). In this case, the percentile can be used, such as ‘the 
95th percentile of the dose distribution is 20 mSv or 20 mSv is the dose that is not exceeded 
in 95% of the population.’ The second approach is often used to quantify the specific value 
in the dose distribution. It is also useful to divide parts or pieces of the distribution. The 
distribution can be divided elaborately by computing percentiles of the distribution. These 
quantities make it possible to find the specific value that is relatively extreme, either small 
or large in the distribution (Walpole et al. 2011). For instance, the 95th percentile divides 
the highest 5% from the bottom 95%. In this study, the percentile method was used to 
determine dose constraints in the dose distributions of public and occupational exposure 
at NPPs. 
To determine dose constraints using the dose distributions of public and 
occupational exposure at NPPs, appropriate numerical percentiles are necessary to find 
the specific value that is relatively inequitable in the distribution. However, there are no 
documents which provide the quantitative definition of inequitable or equitable doses. 
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According to the ICRP, inequity or equity is associated with the ethical concept of 
distributive justice which refers to social fairness (Lochard 2014). In this study, the two 
concepts of the EPA's MEI and the ICRP's representative person, which are used to define 
the reference individual for estimating the dose to members of the public, are used for a 
quantitative approach for determining inequitable dose. This is the first trial to quantify 
the "inequitable dose." 
In particular, the EPA used the 99.99th percentile of the distribution to establish the 
concept of the MEI for the public dose estimation (Hawkins 1991). The EPA considered 
the exposure level of the public could even fall to the 99.99th percentile of the distribution, 
although it is a very conservative assumption. Another interpretation might be that there 
is only a 0.01% chance that the radiation exposure is unexpected in the distribution. From 
the perspective of the optimization process, this highest 0.01% can be an inequitable 
radiation exposure in the distribution. On the other hand, the ICRP used the 95th percentile 
of the distribution to introduce the concept of the representative person that characterizes 
a hypothetical individual who is more highly exposed in the population (ICRP 2006). The 
ICRP observed that the exposure level of the public could even fall to the 95th percentile 
of the distribution, and the highest 5% can be an inequitable radiation exposure in the 
distribution. Although two organizations, the EPA and the ICRP, provided numerical 
percentiles of the exposure levels in the individual exposure distribution for a prospective 
assessment of dose to individuals, it is necessary to consider what numerical percentile in 
the individual exposure distribution is appropriate for the percentile of dose constraints at 
NPPs, taking into account national features.  
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RESULTS OF ANALYSIS 
Dose for members of the public living around nuclear power plants 
There are 104 commercial nuclear power plants (NPPs) located 65 sites in the 
United States, which are displayed in Fig. 4 (NRC 2012; USNRC 2013d). All NPPs 
monitor their radioactive effluents discharged to the environment regularly, and these 
monitoring results are reported to the Nuclear Regulatory Commission (NRC) annually. 
In particular, 10 CFR Part 50.36a requires that NPP licensees submit a report, including 
the activity of each of the main radionuclides discharged to the environment in liquid and 
in gaseous effluents during the past 12 months and maximum annual doses to the public 
or the maximally exposed individual (MEI) resulting from these effluent releases (USNRC 
1956a). All these data are used to demonstrate licensee compliance with applicable 
regulations, such as the NRC design objectives and dose limits and the Environmental 
Protection Agency (EPA) dose standards. 
In 2006, the NRC issued the staff requirement memorandum, SECY-06-0212, 
which directed the NRC staff to summarize the data of radioactive effluents, including the 
dose to members of the public, from all NPP sites (USNRC 2012f). In compliance with 
the SRM to SECY-06-0212, the NRC staff has started providing annual summary reports, 
NRC NUREG/CR-2907, since 2007, and the 2007, 2008, and 2009 summary reports are 
currently available (USNRC 2011b, 2012e, 2013d). These effluent data are also available 
through the NRC database website (http://www.reirs.com/effluent/) (USNRC 2015c). 
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Fig. 4. Operating NPPs in the United States. 
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Analysis of radioactive effluents released from nuclear power plants 
In general, NPP operation produces various radioactive materials. The amount of 
radioactive materials is expressed as activity whose units are Bq or Ci. Most of these 
radioactive sources originate from the fission of nuclear fuel. During the normal operation 
of NPPs, a small fraction of these radioactive sources is generally discharged to the 
environment through liquid and gaseous effluents. These radioactive effluents typically 
originate from several sources: 1) fission of tramp uranium which is dissolved from 
exposed fuel rods and plated out onto the structure of the coolant system, 2) leaks from 
failed fuel rods, 3) diffusion of radioactive gases through intact fuel rods, 4)  activation of 
materials in the reactor cooling water, and 5) erosion of activated materials from pipes, 
valves, pumps and ancillary equipment (NRC 2012). According to a series of NRC 
NUREG/CR-2907, some radionuclides are typically reported in effluent releases from 
NPPs, and these are shown in Table 13 (USNRC 2013d). 
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Table 13. Common radionuclides in radioactive effluents released from NPPsa. 
 
Type Category Radionuclide 
Liquid Mixed fission and 
activation products 
Iron (55Fe) 
Cobalt (58Co, 60Co) 
Cesium (134Cs, 137Cs) 
Manganese (54Mn) 
Zirconium (95Zr) 
Niobium (95Nb) 
Iodine (131I, 133I, 135I) 
 Tritium Hydrogen (3H) 
 Dissolved and 
entrained noble gases 
Krypton (85Kr, 85mKr, 87Kr, 88Kr) 
Xenon (131Xe, 133Xe, 133mXe, 135Xe, 135mXe) 
 Gross alpha Total alpha activity 
Gaseous Fission and activation 
gases 
Krypton (85Kr, 85mKr, 87Kr, 88Kr) 
Xenon (131Xe, 131mXe, 133Xe, 133mXe, 135Xe, 135mXe) 
Argon (41Ar) 
 Iodine and halogens Iodine (131I, 132I, 133I, 134I, 135I) 
Bromine (82Br) 
 Particulates Cobalt (58Co, 60Co) 
Cesium (134Cs, 137Cs) 
Chromium (51Cr) 
Manganese (54Mn) 
Niobium (95Nb) 
 Tritium Hydrogen (3H) 
 Gross alpha Total alpha activity from all alpha emitters 
a (USNRC 2013d).   
 
 
 
For analysis purposes, the median value among all NNPs for each radionuclide 
was used to indicate the activity of radioactive effluents in this study. The median is the 
number separating the higher 50% of the data sample from the lower 50%. That is, the 
amount of radioactive effluents discharged from half of the NPPs will be greater than the 
median and half will be lower than the median. Since the average can be distorted by 
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outliers that have extremely high or low values, the median is used to indicate the typical 
value of the activity of radioactive effluents. The NRC annual summary reports also use 
the median to estimate the typical value of NPP effluents (USNRC 2011b, 2012e, 2013d). 
The median will be zero if the majority of NPPs did not detect radionuclides.  
The activity of radioactive effluents released from NPPs, including both boiling 
water reactor (BWRs) and pressurized water reactors (PWRs) in the United States, was 
analyzed using the data from the NRC annual summary reports and the database website. 
The total activities of radioactive effluents discharged from BWRs and PWRs in 2007 
were 1.30×1012 Bq and 2.16×1013 Bq, respectively (USNRC 2011b, 2015c). The activity 
in effluents released from PWRs was approximately 17 times higher than that from BWRs. 
This phenomenon results from the higher production of tritium in PWRs. In general, boric 
acid is added to the PWR reactor coolant system as a chemical shim to control reactivity, 
and tritium is produced primarily from neutron capture by 10B (Martin 2009). On the other 
hand, tritium production is significantly lower in BWRs since boric acid is not used to 
control reactivity in BWRs. The activities in liquid and gaseous effluents discharged from 
BWRs in 2007 were 7.55×108 Bq and 1.30×1012 Bq, respectively (USNRC 2011b, 2015c). 
The percentages of each activity from liquid and gaseous effluents of the total activity 
were 0.06% and 99.94%, respectively. Therefore, most of the activity in radioactive 
effluents released from BWRs in 2007 resulted from gaseous effluents. For PWRs, the 
activities in liquid and gaseous effluents released in 2007 were 2.04×1013 Bq and 
1.22×1012 Bq, respectively (USNRC 2011b, 2015c). The percentages of each activity from 
liquid and gaseous effluents of the total activity were 94.35% and 5.65%, respectively. 
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Therefore, contrary to BWRs, most of the activity in radioactive effluents released from 
PWRs in 2007 resulted from liquid effluents. The main reason why BWRs and PWRs 
have different contributions of liquid and gaseous effluents to the total activity is the 
recycling of liquid waste at BWRs (USNRC 2013d). Many BWRs in the United States 
reuse either some or all of their liquid waste (USNRC 2013d). To decontaminate liquid 
radioactive wastes, BWRs use several waste treatment methods such as evaporation, 
chemical precipitation, and ion exchange. Furthermore, BWRs do not use boron in the 
reactor coolant unlike PWRs, and this also contributes to a reduction in liquid effluents 
from BWRs (USNRC 2013d). The main radionuclide, which primarily contributed to the 
activity in both liquid and gaseous effluents, was tritium. The activities of radionuclides 
in liquid and gaseous effluents for 2007 are displayed in Table 14 (USNRC 2011b). Table 
15 shows the total activities depending on the types of effluents and reactors. The percent 
contribution of each activity from liquid and gaseous effluents of the total activity in 
BWRs and PWRs are also shown in Table 15. 
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Table 14. Activities of nuclides in gaseous and liquid effluents released from NPPs during 2007a. 
 
Effluent Nuclide BWR (Bq)    PWR (Bq)    
  Median Minimum Maximum %b Median Minimum Maximum %b 
Liquidb 58Co 3.47×105 7.84×102 5.18×108 0.05 1.36×108 1.00×106 4.18×109 0.00 
 60Co 6.62×106 3.12×103 6.14×109 0.88 8.21×107 5.14×105 1.39×109 0.00 
 134Cs    0.00 2.20×105 1.49×104 1.97×108 0.00 
 137Cs 2.46×105 5.92×102 4.51×108 0.03 4.63×106 3.81×103 2.84×108 0.00 
 55Fe    0.00 1.07×108 3.28×106 1.67×109 0.00 
 3H 7.47×108 8.40×105 4.85×1012 99.04 2.04×1013 5.51×1012 6.55×1013 100.00 
 131I    0.00 2.54×104 2.54×104 4.44×107 0.00 
 Total 7.55×108 8.44×105 4.85×1012 100.00 2.04×1013 5.51×1012 6.55×1013 100.00 
Gaseousc 58Co 1.23×105 4.85×104 2.62×106 0.00    0.00 
 60Co 5.33×106 1.14×104 1.39×108 0.00    0.00 
 3H 9.58×1011 1.21×1011 5.11×1012 73.56 1.17×1012 1.10×1011 2.81×1013 95.53 
 131I 3.02×107 4.29×104 1.58×109 0.00 1.61×105 7.36×102 1.21×109 0.00 
 85Kr    0.00 9.62×108 2.36×107 2.65×1012 0.08 
 133Xe 2.21×1011 1.03×1010 1.35×1013 16.93 5.25×1010 9.95×105 1.22×1013 4.31 
 135Xe 1.24×1011 1.71×109 5.92×1012 9.51 1.02×109 1.49×103 4.88×1011 0.08 
 Total 1.30×1012 1.33×1011 2.45×1013 100.00 1.22×1012 1.10×1011 4.35×1013 100.00 
a (USNRC 2011b). 
b Blank cells are where the majority of NPPs did not detect a radionuclide. 
c Percentages are based on median values. 
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Table 15. Total activities of liquid and gaseous effluents released from NPPs during 
2007a.  
 
Effluents BWR  PWR  
 Bqb % Bqb % 
Liquid 7.55×108 0.06 2.04×1013 94.35 
Gaseous 1.30×1012 99.94 1.22×1012 5.65 
Total 1.30×1012 100.00 2.16×1013 100.00 
a (USNRC 2011b). 
b Median values are used to indicate the activities of radioactive effluents. 
 
 
 
In 2008, the total activities in gaseous and liquid radioactive effluents released 
from BWRs and PWRs were 1.31×1012 Bq and 2.07×1013 Bq, respectively (USNRC 
2012e, 2015c). The activity in effluents discharged from PWRs was approximately 16 
times higher than that from BWRs due to the higher production of tritium in PWRs. The 
activities in liquid and gaseous effluents released from BWRs in 2008 were 9.07×1010 Bq 
and 1.22×1012 Bq, respectively (USNRC 2012e, 2015c). The percentages of each activity 
from liquid and gaseous effluents of the total activity were 6.92% and 93.08%, 
respectively. Therefore, most of activity in radioactive effluents released from BWRs in 
2008 resulted from gaseous effluents. For PWRs, the activities in liquid and gaseous 
effluents released in 2008 were 1.95×1013 Bq and 1.22×1012 Bq, respectively (USNRC 
2012e, 2015c). The percentages of each activity from liquid and gaseous effluents of the 
total activity were 94.11% and 5.89%, respectively. Therefore, contrary to BWRs, most 
of the activity in radioactive effluents released from PWRs in 2008 resulted from liquid 
effluents. Tables 16 and 17 show the activities depending on the types of effluents and 
reactors during 2008 (USNRC 2012e). 
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Table 16. Activities of nuclides in gaseous and liquid effluents released from NPPs during 2008a. 
 
Effluent Nuclide BWR (Bq)    PWR (Bq)    
  Median Minimum Maximum %b Median Minimum Maximum %b 
Liquidb 58Co    0.00 2.21×108 2.41×106 4.85×109 0.00 
 60Co 7.18×106 1.24×106 7.88×108 0.01 1.14×108 4.11×106 1.01×109 0.00 
 134Cs    0.00 4.66×105 2.59×103 1.67×108 0.00 
 137Cs    0.00 8.07×106 3.70×104 5.00×108 0.00 
 55Fe    0.00 1.02×108 2.57×107 3.01×109 0.00 
 3H 9.07×1010 4.18×107 4.70×1012 99.99 1.95×1013 5.88×1012 6.14×1013 100.00 
 131I    0.00 7.47×104 1.72×104 8.18×107 0.00 
 Total 9.07×1010 4.30×107 4.70×1012 100.00 1.95×1013 5.88×1012 6.14×1013 100.00 
Gaseousc 58Co 2.96×104 3.01×103 3.81×107 0.00 3.77×104 1.62×103 3.66×107 0.00 
 60Co 2.19×106 1.39×104 2.22×106 0.00    0.00 
 137Cs 7.25×104 1.28×104 6.99×106 0.00    0.00 
 3H 1.11×1012 1.33×108 5.48×1012 90.74 1.13×1012 9.77×1010 3.22×1013 92.98 
 131I 2.69×107 1.31×106 2.19×109 0.00 6.96×105 2.16×101 3.20×108 0.00 
 85Kr    0.00 7.70×109 2.53×107 1.94×1012 0.63 
 133Xe 2.96×1010 8.44×108 1.05×1013 2.42 7.70×1010 1.17×108 2.31×1013 6.32 
 135Xe 8.33×1010 1.26×106 3.27×1012 6.83 8.84×108 5.99×105 4.63×1011 0.07 
 Total 1.22×1012 9.79×108 1.92×1013 100.00 1.22×1012 9.78×1010 5.76×1013 100.00 
a (USNRC 2012e). 
a Blank cells are where the majority of NPPs did not detect a radionuclide. 
b Percentages are based on median values. 
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Table 17. Total activities of liquid and gaseous effluents released from NPPs during 
2008a.  
 
Effluents BWR  PWR  
 Bqb % Bqb % 
Liquid 9.07×1010 6.92 1.95×1013 94.11 
Gaseous 1.22×1012 93.08 1.22×1012 5.89 
Total 1.31×1012 100.00 2.07×1013 100.00 
a (USNRC 2012e). 
b Median values are used to indicate the activities of radioactive effluents. 
 
 
 
In 2009, the activities in radioactive effluents released from BWRs and PWRs 
were 1.26×1012 Bq and 2.21×1013 Bq, respectively (USNRC 2013d, 2015c). The activity 
in effluents discharged from PWRs was approximately 18 times higher than that from 
BWRs due to the higher production of tritium in PWRs. The activities in liquid and 
gaseous effluents released from BWRs in 2009 were 3.43×1011 Bq and 9.14×1011 Bq, 
respectively (USNRC 2013d, 2015c). The percentages of each activity from liquid and 
gaseous effluents of the total activity were 27.31% and 72.69%, respectively. Therefore, 
activity in gaseous effluents was much higher than that in liquid effluents. For PWRs, the 
activities in liquid and gaseous effluents released in 2009 were 2.06×1013 Bq and 
1.54×1012 Bq, respectively (USNRC 2013d, 2015c). The percentages of each activity from 
liquid and gaseous effluents of the total activity were 93.03% and 6.97%, respectively. 
Therefore, contrary to BWRs, most of the activity in radioactive effluents released from 
PWRs in 2009 resulted from liquid effluents. The activities of radionuclides in liquid and 
gaseous effluents for 2009 are displayed in Table 18 (USNRC 2013d). Table 19 shows the 
total activities depending on the types of effluents and reactors. 
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Table 18. Activities of nuclides in gaseous and liquid effluents released from NPPs during 2009a. 
 
Effluent Nuclide BWR (Bq)    PWR (Bq)    
  Maximum Median Minimum %b Maximum Median Minimum %b 
Liquidb 58Co    0.00 4.07×109 1.90×108 3.46×105 0.00 
 60Co 1.72×109 2.44×107 3.96×106 0.01 4.88×108 7.70×107 2.76×106 0.00 
 134Cs    0.00 1.41×108 5.85×104 7.84×103 0.00 
 137Cs    0.00 7.22×108 7.77×106 3.89×104 0.00 
 55Fe    0.00 2.03×109 5.14×107 8.33×106 0.00 
 3H 3.89×1012 3.43×1011 4.48×105 99.99 7.66×1013 2.06×1013 3.56×1012 100.00 
 131I    0.00 4.18×107 4.96×104 1.76×103 0.00 
 Total 3.89×1012 3.43×1011 4.41×106 100.00 7.66×1013 2.06×1013 3.56×1012 100.00 
Gaseousc 58Co 1.47×107 2.02×105 1.23×104 0.00 2.86×108 9.99×103 4.03×103 0.00 
 60Co 1.14×108 3.41×106 1.83×105 0.00    0.00 
 137Cs 9.32×106 1.34×104 4.26×103 0.00    0.00 
 3H 4.40×1012 7.25×1011 6.48×1010 79.35 2.75×1013 1.51×1012 5.14×1010 97.96 
 131I 9.77×108 1.67×107 1.62×106 0.00 8.84×108 1.92×105 2.10×10-3 0.00 
 85Kr    0.00 1.55×1012 8.25×108 4.37×107 0.05 
 133Xe 2.50×1013 4.85×1010 5.96×108 5.30 1.26×1014 2.92×1010 7.99×106 1.89 
 135Xe 6.51×1012 1.40×1011 2.66×109 15.34 3.10×1012 1.40×109 4.14×105 0.09 
 Total 3.60×1013 9.14×1011 6.80×1010 100.00 1.58×1014 1.54×1012 5.14×1010 100.00 
a (USNRC 2013d). 
b Blank cells are where the majority of NPPs did not detect a radionuclide. 
c Percentages are based on median values. 
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Table 19. Total activities of liquid and gaseous effluents released from NPPs during 
2009.  
 
Effluents BWR  PWR  
 Bqb % Bqb % 
Liquid 3.43×1011 27.31 2.06×1013 93.03 
Gaseous 9.14×1011 72.69 1.54×1012 6.97 
Total 1.26×1012 100.00 2.21×1013 100.00 
a (USNRC 2013d). 
b Median values are used to indicate the activities of radioactive effluents. 
 
During the years 2007-2009, all the effluents discharged from NPPs met the NRC 
safety limits for radioactive effluents (USNRC 2011b, 2012e, 2013d). Although all the 
activities in effluents released from both BWRs and PWRs were lower than the limits, the 
total activities in radioactive effluents released from PWRs were approximately 16-18 
times higher than those from BWRs. The main reason for this phenomenon was the higher 
production of tritium in PWRs due to the use of boric acid to control reactivity. For BWRs, 
most of the activities resulted from gaseous effluents, while the contribution of gaseous 
effluents released from PWRs to the total activities in radioactive effluents were minor 
compared to liquid effluents. Since BWRs recycle some or all of their liquid radioactive 
waste, the contribution of liquid effluents to the total activity in radioactive effluents was 
limited. This is called “zero-release.” For many decades, a “zero-release” approach for 
liquid effluents has been very popular among BWRs (USNRC 2013d). Due to this 
approach, BWRs could reduce the activity and the dose from radioactive effluents very 
effectively. However, as a result of analysis for effluent data, it was found that the total 
activities in liquid effluents released from BWRs have increased gradually in recent years, 
which is shown in Fig. 5. Tritium was the primary source for this gradual increase of total 
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activity in liquid effluents. Based on 10 years of operating experience, these zero-release 
BWRs have shown a steady increase in the contribution of tritium to occupational 
exposure at some NPP sites (USNRC 2013d). As liquid radioactive wastes have been 
reused in BWRs, the tritium concentration in the water has accumulated over time 
(USNRC 2013d). Therefore, previously zero-release BWRs have begun to discharge 
liquid effluents again to avoid build-up of their tritium inventory in the facility (Harris 
2011). The activities of radionuclides in liquid and gaseous effluents during the years 
2007-2009 are displayed in Table 20 (USNRC 2011b, 2012e; 2013d). 
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Fig. 5. Activities in liquid and gaseous effluents released from NPPs during the years 2007-2009 (USNRC 2011b, 2012e; 
2013d). 
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Table 20. Total activities of liquid and gaseous effluents released from NPPs during 2007-2009a. 
 
Year 
Effluents BWR (Bq)    PWR (Bq)    
 Median Minimum Maximum %a Median Minimum Maximum %a 
2007 
Liquid 7.55×108 8.44×105 4.85×1012 0.06 2.04×1013 5.51×1012 6.55×1013 94.35 
Gaseous 1.30×1012 1.33×1011 2.45×1013 99.94 1.22×1012 1.10×1011 4.35×1013 5.65 
Total 1.30×1012 1.33×1011 2.94×1013 100.00 2.04×1013 5.62×1012 1.09×1014 100.00 
2008 
Liquid 9.07×1010 4.30×107 4.70×1012 6.92 1.95×1013 5.88×1012 6.14×1013 94.11 
Gaseous 1.22×1012 9.79×108 1.92×1013 93.08 1.22×1012 9.78×1010 5.76×1013 5.89 
Total 1.31×1012 1.02×109 2.39×1013 100.00 2.07×1013 5.98×1012 1.19×1014 100.00 
2009 
Liquid 3.43×1011 4.41×106 3.89×1012 27.31 2.06×1013 3.56×1012 7.66×1013 93.03 
Gaseous 9.14×1011 6.80×1010 3.60×1013 72.69 1.54×1012 5.15×1010 1.58×1014 6.97 
Total 1.26×1012 6.80×1010 3.99×1013 100.00 2.21×1013 3.61×1012 2.35×1014 100.00 
a (USNRC 2011b, 2012e; 2013d). 
b Percentages are based on median values. 
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Analysis of the dose for members of the public living around nuclear power 
plants 
To ensure compliance with the requirements of Appendix I to 10 Code of Federal 
Regulation (CFR) Part 50, all NPP licensees regularly estimate the public dose from 
radioactive effluents released from NPPs (USNRC 1956b). This estimation is based on 
both measurements and theoretical models, including 1) real measurements of radioactive 
effluents in the environment, 2) models for the dispersion and dilution of radioactive 
materials in the environment, 3) models for the incorporation of radioactive materials into 
animals, plants, and soil, and 4) biokinetic models for the human uptake and metabolism 
of radioactive materials (USNRC 2013d). These models intend to estimate the dose to a 
MEI who may be exposed to the highest activities from effluents. Therefore, the estimated 
dose is often much higher than the actual dose to the residents living around NPPs. All 
NPP licensees have established their procedures for estimating the public dose according 
to the NRC Regulatory Guide (RG) 1.109, and those procedures are combined into their 
offsite dose calculation manuals (ODCMs) (USNRC 1977b, 2013d).  
Similar to the analysis of effluent data, median values are also used to demonstrate 
the typical dose to members of the public in this study. The median is the midpoint of the 
data, and it is used to minimize the influence by outliers that have extremely high or low 
values. The median is also used in the NRC annual summary reports to estimate the typical 
value of dose to members of the public (USNRC 2011b, 2012e, 2013d). 
The total effective dose equivalent (TEDE) is often called “total body dose,” and 
it results from radioactive effluents released from NPPs in the United States. The TEDE 
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was analyzed using the data from the NRC annual summary reports and the database 
website. The median value of TEDE for members of the public living around NPPs in 
2007 was 9.69×10-4 mSv for all NPPs, specifically 3.33×10-4 mSv for BWRs and 1.07×10-
3 mSv for PWRs (USNRC 2011b, 2015c). The median TEDE for members of the public 
was much lower than the EPA dose standard for a site, 0.25 mSv y-1. In comparison with 
the NRC dose limit, the TEDE for members of the public in 2007 was only 0.1% of the 
annual TEDE limit for members of the public, 1 mSv y-1. The maximum and minimum 
TEDEs for the public in 2007 were reported to be 1.72×10-1 mSv and 1.98×10-7 mSv, 
respectively. The 95th percentile of the dose distribution for members of the public was 
5.59×10-2 mSv. The average radiation dose received by an individual from the natural 
radiation background in the United States is approximately 3.1 mSv y-1. The TEDE to the 
public due to radioactive effluents from NPPs in 2007 was only 0.03% of what the average 
person receives each year from natural background radiation (USNRC 2011b). The TEDE 
for members of the public living around NPPs in 2007 are displayed in Fig. 6 (USNRC 
2011b). Fig. 6 also indicates the NRC dose limit and EPA dose standard for the purpose 
of comparison. 
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Fig. 6. Total effective dose equivalent for members of the public living around NPPs 
during 2007 (USNRC 2011b). 
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In 2008, the median value of TEDE for members of the public living around NPPs 
was 7.17×10-4 mSv for all NPPs, specifically 4.11×10-4 mSv for BWRs and 7.56×10-4 
mSv for PWRs (USNRC 2012e, 2015c). The TEDE for members of the public was much 
lower than the EPA dose standard for a site, 0.25 mSv y-1, accounting for only 0.29%. In 
comparison with the NRC dose limit, the TEDE for members of the public in 2008 was 
only 0.07% of the annual TEDE limit, 1 mSv y-1. The maximum and minimum TEDEs 
for the public in 2008 were reported to be 1.63×10-1 mSv and 1.63×10-7 mSv, respectively. 
The 95th percentile of the dose distribution for members of the public was 4.50×10-2 mSv. 
Compared to the average radiation dose, 3.1 mSv y-1, received by an individual in the 
United States, the TEDE to the public due to radioactive effluents from NPPs in 2008 was 
only 0.02% of what the average person receives each year from natural background 
radiation (USNRC 2012e). The TEDE for members of the public living around NPPs in 
2008 are shown in Fig. 7, including the NRC dose limit and EPA dose standard for the 
purpose of comparison (USNRC 2012e). 
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Fig. 7. Total effective dose equivalent for members of the public living around NPPs 
during 2008 (USNRC 2012e). 
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In 2009, the median value of the TEDE for members of the public living around 
NPPs was 5.42×10-4 mSv for all NPPs, specifically 4.19×10-4 mSv for BWRs and 6.39×10-
4 mSv for PWRs (USNRC 2013d, 2015c). This TEDE for members of the public was 
much lower than the EPA dose standard for a site, 0.25 mSv y-1, accounting for only 0.22%. 
In comparison with the NRC dose limit, the TEDE for members of the public in 2009 was 
only 0.05% of the annual TEDE limit for members of the public, 1 mSv y-1. The maximum 
and minimum TEDEs for the public in 2009 were reported to be 1.68×10-1 mSv and 
1.66×10-7 mSv, respectively. The 95th percentile of the dose distribution for members of 
the public was 5.21×10-2 mSv. Compared to the average radiation dose, 3.1 mSv y-1, 
received by an individual in the United States, the TEDE to the public due to radioactive 
effluents from NPPs in 2009 was only 0.02% of what the average person receives each 
year from natural background radiation (USNRC 2013d). The TEDE for members of the 
public living around NPPs in 2009 are shown in Fig. 8 with the NRC dose limit and EPA 
dose standard for the purpose of comparison (USNRC 2013d). 
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Fig. 8. Total effective dose equivalent for members of the public living around NPPs 
during 2009 (USNRC 2013d). 
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During the years 2007-2009, the TEDEs for members of the public due to 
radioactive effluents released from NPPs met both the EPA dose standard and the NRC 
dose limit (USNRC 2011b, 2012e, 2013d, 2015c). Even though all TEDEs resulting from 
both BWRs and PWRs were much lower than the limits, the TEDEs from PWRs were 
approximately 2 or 3 times higher than those from BWRs. Since BWRs have discharged 
relatively small amounts of radioactive effluents compared to PWRs due to a zero-release 
approach, the TEDEs from PWRs were relatively higher than those from BWRs (USNRC 
2013d). Compared to the EPA dose standard for a site, 0.25 mSv y-1, all TEDEs for 
members of the public during the years 2007-2009 accounted for only 0.13-0.43%. In 
comparison with the NRC dose limit, 1 mSv y-1, the TEDEs for members of the public 
were only 0.03-0.11%. Therefore, the dose to members of the public due to radioactive 
effluents released from NPPs has been kept very low due to radioactive effluent control 
programs in NPPs. The TEDEs for members of the public during the years 2007-2009 
depending on the types of reactors were shown in Fig. 9 and Table 21 (USNRC 2011b, 
2012e, 2013d, 2015c). The percentages of each TEDE from all NPPs, BWRs, and PWRs 
to the EPA dose standard and the NRC dose limit are also displayed in Table 21. 
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Fig. 9. Total effective dose equivalent for members of the public due to radioactive effluents released from NPPs during the 
years 2007-2009 (USNRC 2011b, 2012e, 2013d). 
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Table 21. Comparison of total effective dose equivalent for members of the public during the years 2007-2009 with the EPA 
dose standard and the NRC dose limitsa. 
 
Year Type of 
reactors 
Total body dose (mSv) Percent of the EPA 
dose standarda,b (%) 
Percent of the NRC 
dose limita,c (%) Maximum Median Minimum 
2007 All NPPs 1.72×10-1 9.69×10-4 1.98×10-7 0.39 0.10 
 BWRs 1.72×10-1 3.33×10-4 1.98×10-7 0.13 0.03 
 PWRs 7.06×10-2 1.07×10-3 3.81×10-6 0.43 0.11 
2008 All NPPs 1.63×10-1 7.17×10-4 1.63×10-7 0.29 0.07 
 BWRs 1.63×10-1 4.11×10-4 1.63×10-7 0.16 0.04 
 PWRs 6.06×10-2 7.56×10-4 1.18×10-5 0.30 0.08 
2009 All NPPs 1.68×10-1 5.42×10-4 1.66×10-7 0.22 0.05 
 BWRs 1.68×10-1 4.19×10-4 1.66×10-7 0.17 0.04 
 PWRs 1.17×10-1 6.39×10-4 1.55×10-5 0.26 0.06 
a (USNRC 2011b, 2012e, 2013d). 
b Percentages are based on median values. 
c The EPA dose standard to the whole body for a site is 0.25 mSv y-1 .  
d The NRC dose limit for members of the public is 1 mSv y-1 .  
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Analysis of the dose for members of the public living around nuclear power 
plants for licensing 
As stated earlier, all applicants for acquiring a license for new NPP operation are 
required to evaluate the off-site radiological consequences during the licensing process 
(USNRC 1956a, 1989, 2004a). The NRC has established a combined license, including 
both a construction permit and an operating license (USNRC 2004a). This combined 
license approves construction and conditional operation of a NPP at the same time. The 
requirements for acquiring a combined license are described in 10 CFR Part 52, but these 
requirements basically include the same information required in an application for an 
operating license issued under 10 CFR Part 50 (USNRC 1989; 2004a). From the viewpoint 
of dose criteria, an applicant for NPP license should comply with the requirements of 10 
CFR Part 50.34 under the conditions of postulated accidents and the requirements of 10 
CFR Part 20.1301(e) and design objectives in Appendix I to 10 CFR Part 50 under the 
condition of a postulated normal operation. To estimate the dose for a postulated normal 
operation, dose is calculated by summing up the dose using the predictable source term 
for the main reactor and the maximum dose from the history of other reactors. In practice, 
the values of 10 CFR Part 20.1301(e), which originate from the EPA dose standards, play 
a key role in evaluating the licensee’s implementation of the requirements of as low as 
reasonably achievable (ALARA) for the safety of the public. Therefore, all applicants for 
acquiring a license for new NPP operation should demonstrate that their calculated doses, 
under the condition of a postulated normal operation, comply with the EPA dose standards. 
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In terms of NPP licensing, several applicants have submitted their applications for 
new reactors. Table 22 shows the current applications for a combined license which the 
NRC has received to date (USNRC 2015a). In total 18 applications were submitted to the 
NRC, and three applicants recently acquired a license to construct and operate NPPs from 
the NRC. The site locations of projected new NPPs, whose applications are currently 
under review or suspended, are displayed in Fig. 10 (USNRC 2015d). The early site permit 
application by PSEG (Public Service Electric and Gas) Power is also included in Fig. 10. 
With regards to issuing a combined license, the NRC currently authorized the three 
licensees to construct and operate NPPs, consistent with established laws and regulations. 
In 2008, South Carolina Electric & Gas Company submitted its application for combined 
licenses for two PWRs for the Virgil C. Summer Nuclear Station Units 2 and 3. In the 
same year, Southern Nuclear Operating Company submitted its application for combined 
licenses for two PWRs for Vogtle Electric Generating Plant Units 3 and 4. These two 
applications were passed by the NRC review, and combined licenses were finally issued 
in 2012 (USNRC 2015a). The latest combined license was issued in 2015 for Fermi Unit 
3 (USNRC 2015a). DTE Energy Company (previously Detroit Edison Company) also 
submitted its application for a combined license for a BWR designated as Fermi Unit 3 in 
2008. 
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Table 22. New NPP applications for combined license to the U.S. NRCa. 
 
Proposed new NPPs Design Applicant Status 
Bell Bend Nuclear 
Power Plant 
U.S. EPR PPL Bell Bend, LLC Under Review 
Bellefonte Nuclear 
Station, Units 3 and 4 
AP1000 Tennessee Valley Authority 
(TVA) 
Suspended 
Callaway Plant, Unit 2 U.S. EPR AmerenUE Suspended 
Calvert Cliffs, Unit 3 U.S. EPR Calvert Cliffs 3 Nuclear 
Project, LLC and UniStar 
Nuclear Operating Services, 
LLC 
Withdrawn 
Comanche Peak, Units 
3 and 4 
US-APWR Luminant Generation 
Company, LLC (Luminant) 
Suspended 
Fermi, Unit 3 ESBWR Detroit Edison Company Issued 
Grand Gulf, Unit 3 ESBWR Entergy Operations, Inc. (EOI) Suspended 
Levy County, Units 1 
and 2 
AP1000 Duke Energy Florida, Inc. 
(DEF) 
Under Review 
Nine Mile Point, Unit 3 U.S. EPR Nine Mile Point 3 Nuclear 
Project, LLC and UniStar 
Nuclear Operating Services, 
LLC (UniStar) 
Withdrawn 
North Anna, Unit 3 ESBWR Dominion Virginia Power 
(Dominion) 
Under Review 
River Bend Station, 
Unit 3 
ESBWR Entergy Operations, Inc. (EOI) Suspended 
Shearon Harris, Units 2 
and 3 
AP1000 Progress Energy Carolinas, Inc. 
(PEC) 
Suspended 
South Texas Project, 
Units 3 and 4 
ABWR Nuclear Innovation North 
America, LLC (NINA) 
Under Review 
Turkey Point, Units 6 
and 7 
AP1000 Florida Power and Light 
Company (FPL) 
Under Review 
Victoria County 
Station, Units 1 and 2 
ESBWR Exelon Nuclear Texas 
Holdings, LLC (Exelon) 
Withdrawn 
Virgil C. Summer, 
Units 2 and 3 
AP1000 South Carolina Electric & Gas 
(SCE&G) 
Issued 
Vogtle, Units 3 and 4 AP1000 Southern Nuclear Operating 
Company (SNC) 
Issued 
William States Lee III, 
Units 1 and 2 
AP1000 Duke Energy Under Review 
a (USNRC 2015a).
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Fig. 10. Locations of projected new NPPs (ABWR: Advanced Boiling Water Reactor, AP1000: Advanced Passive 1000, EPR: 
Evolutionary Pressurized Reactor, ESBWR: Economic Simplified Boiling Water Reactor, USAPWR: US Advanced Pressurized 
Water Reactor, ESP: Early Site Permit) (USNRC 2015d). 
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According to final safety analysis reports (FSARs) from these three applicants, 
their estimated doses for postulated accidents, including loss of coolant accidents (LOCA), 
complied with the requirements for a combined license. However, the values are not open 
to the public for the security reasons (SCE&G 2011; SC 2011; DTE Energy 2014). For 
postulated normal operations, estimated doses were shown in their FSARs, and all doses 
were less than those limits in the regulations. In particular, each site dose for the whole 
body from Virgil C. Summer Units 2 and 3, Vogtle Units 3 and 4, and Fermi Unit 3 
accounted for 8.8%, 95.2%, and 22.64% of the EPA dose standard, respectively. For the 
site dose of Virgil C. Summer Units 2 and 3, the estimated dose included the dose from 
the currently operating single reactor Unit 1 (SCE&G 2011). The estimated site doses of 
Vogtle Units 3 and 4 and Fermi Unit 3 also incorporated the doses from existing reactors 
Units 1 and 2 (SC 2011; DTE Energy 2014). Table 23 shows the result of dose estimation 
with the EPA dose standards (SCE&G 2011; SC 2011; DTE Energy 2014). The projected 
doses due to liquid and gaseous effluents released from new NPPs were also compared 
with corresponding design objectives in Table 24 (SCE&G 2011; SC 2011; DTE Energy 
2014).  
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Table 23. Comparison of site doses for the combined license of new NPP applications with the EPA dose standardsa. 
 
Dose Dose standardsb 
(mSv y-1) 
Virgil C. Summer Units 2 and 3 
(mSv y-1) 
Vogtle Units 3 and 4 
(mSv y-1) 
Fermi Unit 3 
(mSv y-1) 
Whole body 0.25 2.20×10-2 2.38×10-1 5.66×10-2 
Thyroid 0.75 1.40×10-1 1.40×10-2 1.39×10-1 
Other organ 0.25 3.50×10-2c 2.60×10-2d 2.32×10-2d 
a (SCE&G 2011; SC 2011; DTE Energy 2014). 
b The values are based on 40 CFR Part 190 and 10 CFR Part 20.1301(e). Limits are applicable to a single site. 
c Dose for bone. 
d Dose for skin. 
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Table 24. Comparison of projected doses to the public of new NPP applications for the combined license with design 
objectives in Appendix I to 10 CFR Part 50a. 
 
Dose Design objectivesb 
(mSv y-1) 
Virgil C. Summer Units 
2 and 3c (mSv y-1) 
Vogtle Units 3 and 4c 
(mSv y-1) 
Fermi Unit 3 
(mSv y-1) 
Total body dose from liquid 
effluents 
0.03  1.40×10-3  2.50×10-4 6.48×10-5 
Organ dose from liquid 
effluents 
0.1 1.90×10-3d 3.70×10-4c 8.77×10-4e 
Total body dose from 
gaseous effluents 
0.05 5.80×10-3 8.10×10-3 9.76×10-3 
Organ dose from radioactive 
iodine and particulates in 
gaseous effluents 
0.15 7.00×10-2f 8.10×10-3f 1.13×10-1f 
a (SCE&G 2011; SC 2011; DTE Energy 2014). 
b The values are based on Appendix I to 10 CFR Part 50. Limits are applicable to a single unit. 
c The values are based on a single unit. 
d Dose for GI-LLI (Gastrointestinal - Lower Large Intestine). 
e Dose for bone. 
f Dose for thyroid. 
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Dose for occupational workers in nuclear power plants 
Approximately 200,000 people are working at 104 commercial NPPs in the United 
States. These individuals are exposed to direct or indirect radiation (USNRC 2014d). For 
the safety of workers, all NPPs monitor individual doses regularly using radiation 
monitoring devices, such as thermoluminescent dosimeters (TLDs) and whole body 
counters. Similar to reporting radioactive effluents and the dose for members of the public, 
these occupational doses are reported to the NRC annually. In particular, 10 CFR Part 
20.1502 provides the conditions requiring individual monitoring of external and internal 
doses (USNRC 1991c). The occupational dose recording is based on the calendar year; 
thus, the monitoring period of occupational dose, especially for NPPs, is normally from 
January 1 to December 31 (USNRC 1992). According to 10 CFR Part 20.1202, the TEDE 
is calculated by the summation of external radiation dose (DDE) and internal radiation 
dose (CEDE) (USNRC 1991c). However, doses to the skin or extremities or to the eyes 
are not applicable to this summation method. The minimum limit for recording is 0.1 mSv 
because such a small value is negligible compared to the dose limit (USNRC 1992). All 
these recordings are used to demonstrate compliance with the NRC regulations, such as 
dose limits, and are maintained until the NRC terminates the NPP’s license. To 
disseminate radiation exposure information to the public, the NRC has published annually 
a series of NUREG-0713, “Occupational radiation exposure at commercial nuclear power 
reactors and other facilities” (USNRC 2014d). In these reports, TEDE is primarily used to 
express the quantity of occupational dose and to demonstrate compliance with dose limits 
(USNRC 2014d). For analyzing occupational exposures in the US NPPs, the study 
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described here used two types of data. First, the data of occupational exposures at 
commercial NPPs for the years between 2003 and 2012 obtained from the NRC through 
the Freedom of Information Act (FOIA) were used to analyze the typical occupational 
doses (USNRC 2016). Second, the data provided by the NRC annual reports for 
occupational exposure, taking into account transient individuals, were used to analyze the 
occupational dose distributions in NPPs (USNRC 2004b, 2005b, 2006, 2007b, 2008a, 
2010b, 2011a, 2012c, 2013c; 2014d). 
 
Analysis of occupational dose in nuclear power plants 
There are 104 NPPs operating in the United States, including 35 BWRs and 69 
PWRs. During the years 2003-2012, approximately between 164,000 and 200,000 people 
were reported each year to the NRC as the number of monitored individuals in NPPs 
(USNRC 2016). These reports included office workers, maintenance workers, contract 
individuals, and even visitors in NPPs. Since most office individuals and visitors are not 
involved in radiation work in the field, their exposure levels are usually extremely low, 
and their radiation exposure may not be measured due to the detection limits of monitoring 
devices. Therefore, the number of individuals whose radiation exposure was measurable 
is provided to analyze the actual radiation dose due to radiation work in NPPs. According 
to the NRC data for occupational exposure, the fraction of individuals with measurable 
dose to the total number of monitored individuals in NPPs was approximately 40-50% 
during the years 2003-2012 (USNRC 2016). This result means that only half of individuals 
in NPPs received a measurable dose.     
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Contrary to the use of median value for the analysis of public dose, an average 
value is used to demonstrate the typical occupational dose in this study. The number of 
samples, which is the number of monitored individuals, for occupational dose is much 
greater than those for public dose. Therefore, the average occupational dose is less affected 
by outliers, which may have extremely high or low values. The average is also used in the 
NRC annual report to estimate the typical occupational exposure (USNRC 2014d). 
Furthermore, three types of dose quantities are used to express occupational dose in NPPs. 
First, the collective dose is used to estimate the total dose to the exposed individuals in 
NPPs. The collective dose is calculated as the sum of all individual doses during the NPP 
operation. Second, the average individual dose is used to estimate the average dose to the 
total number of monitored individuals in NPPs. This dose is calculated by dividing the 
collective dose by the total number of monitored individuals. Finally, the average 
measurable dose is used to estimate the actual average dose to individuals with a 
measurable dose. In this case, it is calculated by dividing the collective dose by the number 
of individuals with a measurable dose. The average measurable dose is most commonly 
used for analyzing trends of occupational dose. Since the total number of monitored 
individuals includes the number of individuals whose dose is not measurable, the average 
individual dose is generally lower than the average measurable dose. 
The TEDE for individuals in NPPs, including both BWRs and PWRs in the United 
States, was analyzed using the data from the NRC for occupational exposure. The average 
individual dose during the years 2003-2012 was 0.4-0.8 mSv for all NPPs (USNRC 2016). 
For the average measurable dose, the dose range was distributed between 1.0-1.6 mSv for 
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all NPPs. The average measurable dose was 1.1-1.9 mSv for BWRs and 0.9-1.4 mSv for 
PWRs (USNRC 2016). The occupational doses in BWRs were higher than those in PWRs 
since the steam produced directly from the BWR reactor is used to drive turbines to 
produce electricity, which results in activity being present in both the reactor and the 
turbine systems, while PWR systems are designed to retain the activity within the reactor 
vessel and primary system and not in the turbine systems. In comparison with the NRC 
dose limit, the average measurable dose in NPPs accounted for only 2.0-3.2% of the annual 
occupational dose limit. The maximum and minimum average measurable doses during 
the years 2003-2012 were reported to be 1.6 and 1 mSv, respectively. The occupational 
doses in NPPs during the years 2003-2012 are shown in Table 25 and Fig. 11 (USNRC 
2016). The occupational doses depending on the types of reactors are also shown in Table 
26 and Fig. 12 (USNRC 2016). 
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Table 25. Occupational doses in NPPs during the years 2003-2012a. 
 
Year Number 
of NPPs 
Total number 
of monitored 
individualsb 
Number of 
individuals with 
measurable dosec 
Collective dose  
(Person-mSv)c 
Average 
individual 
dose (mSv)d 
Percent 
of limit 
(%)e 
Average 
measurable 
dose (mSv)d 
Percent 
of limit 
(%)e 
2003 104 163,802 78,206 123,291 0.8 1.5 1.6 3.2 
2004 104 159,013 72,901 105,928 0.7 1.3 1.5 2.9 
2005 104 171,431 81,395 115,845 0.7 1.4 1.4 2.8 
2006 104 168,831 80,619 109,876 0.7 1.3 1.4 2.7 
2007 104 170,516 80,803 101,771 0.6 1.2 1.3 2.5 
2008 104 176,896 80,890 92,067 0.5 1.0 1.1 2.3 
2009 104 181,698 82,677 100,274 0.6 1.1 1.2 2.4 
2010 104 186,452 76,178 86,436 0.5 0.9 1.1 2.3 
2011 104 198,096 83,183 88,135 0.4 0.9 1.1 2.1 
2012 104 200,634 81,174 81,350 0.4 0.8 1.0 2.0 
a (USNRC 2016). 
b Total number of individuals that NPP licensees reported as being monitored for external and internal radiation exposure 
during each year. 
c Number of individuals whose radiation exposure was measurable. 
d Total effective dose equivalent (TEDE). 
e NRC annual occupational dose limit: 50mSv. 
 119 
 
 
 
Fig. 11. Average individual and measurable occupational doses in NPPs during the years 2003-2012 (USNRC 2016).  
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Table 26. Occupational doses in BWRs and PWRs during the years 2003-2012a. 
 
Year  2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 
BWR Number of reactors 35 35 35 35 35 35 35 35 35 35 
 
Number of 
individuals with 
measurable doseb 
31,216 33,093 34,635 32,528 36,113 33,967 34,540 35,839 38,479 36,651 
 
Collective dose  
(Person-mSv)c 
58,559 53,604 61,410 48,603 52,377 44,917 51,154 46,574 49,639 40,699 
 
Average measurable 
dose (mSv)c 
1.9 1.6 1.8 1.5 1.5 1.3 1.5 1.3 1.3 1.1 
 Percent of limit (%)d 3.8 3.2 3.5 3.0 2.9 2.6 3.0 2.6 2.6 2.2 
PWR Number of reactors 69 69 69 69 69 69 69 69 69 69 
 
Number of 
individuals with 
measurable doseb 
46,990 39,808 46,760 48,091 44,690 46,923 48,137 40,339 44,704 44,523 
 
Collective dose  
(Person-mSv)c 
64,732 52,324 54,435 61,273 49,394 47,150 49,121 39,862 38,496 40,651 
 
Average measurable 
dose (mSv)c 
1.4 1.3 1.2 1.3 1.1 1.0 1.0 1.0 0.9 0.9 
 Percent of limit (%)d 2.8 2.6 2.3 2.5 2.2 2.0 2.0 2.0 1.7 1.8 
a (USNRC 2016). 
b Number of individuals whose radiation exposure was measurable. 
c Total effective dose equivalent (TEDE). 
d NRC annual occupational dose limit: 50mSv.  
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Fig. 12. Average measurable occupational doses in BWRs and PWRs during the years 2003-2012 (USNRC 2016). 
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The annual dose distributions in NPPs during the years 2003-2012 were also 
analyzed using the data from the NRC annual reports for occupational exposure to 
compare the number of individuals in certain dose ranges. These dose distributions were 
obtained by counting the number of individuals in certain dose ranges. As a result, the 
fractions of the number of individuals whose doses were less than 1 mSv to the number of 
individuals with measurable doses were approximately 58-70%. These percentages 
increased continuously from 58% in 2003 to 70% in 2012 (USNRC 2016). There was no 
individual who received the dose more than the NRC annual dose limit of 50 mSv. In 
particular, the fractions of the number of individuals whose doses exceeded 20 mSv to the 
number of individuals with measurable doses were less than 0.05%. The occupational dose 
distributions in NPPs during the years 2003-2012 are shown in Table 27 and Fig. 13 
(USNRC 2016). 
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Table 27. Occupational dose distributions in NPPs during the years 2003-2012a. 
 
Year Total 
number of 
individualsb 
Number of 
individuals 
with non-
measurable 
dosec 
Number of 
individuals 
with 
measurable 
dosed 
Number of individuals in the dose ranges (mSv)e 
    
< 1 
[1- 
2.5) 
[2.5- 
5) 
[5-
7.5) 
[7.5-
10) 
[10-
20) 
[20-
30) 
[30-
40) 
[40-
50) 
2003 163,802 85,596 78,206 45,161 17,770 9,805 3,226 1,278 928 38 0 0 
2004 159,013 86,112 72,901 43,889 16,142 8,443 2,735 1,014 663 15 0 0 
2005 171,431 90,036 81,395 49,047 18,389 9,301 2,911 1,069 659 19 0 0 
2006 168,831 88,212 80,619 48,983 18,321 9,237 2,652 899 525 2 0 0 
2007 170,516 89,713 80,803 51,119 17,836 8,297 2,317 817 404 13 0 0 
2008 176,896 96,006 80,890 53,187 17,542 7,499 1,817 572 268 5 0 0 
2009 181,698 99,021 82,677 53,503 17,580 8,335 2,117 732 410 0 0 0 
2010 186,452 110,274 76,178 50,748 16,083 6,623 1,797 598 324 5 0 0 
2011 198,096 114,913 83,183 57,198 16,762 6,729 1,653 570 271 0 0 0 
2012 200,634 119,460 81,174 57,190 15,707 6,100 1,525 383 248 21 0 0 
a (USNRC 2016). 
b Total number of individuals that NPP licensees reported as being monitored for external and internal radiation exposure 
during each year. 
c Number of individuals whose radiation exposure was not measurable. 
d Number of individuals whose radiation exposure was measurable. 
e Total effective dose equivalent (TEDE).  
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Fig. 13. Measurable occupational dose distributions in NPPs during the years 2003-2012 (USNRC 2016). 
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Analysis of occupational doses taking into account transient individuals in 
nuclear power plants 
According to 10 CFR Part 20.2206, “Reports of individual monitoring,” each NPP 
licensee reports the occupational dose received by individuals monitored at their NPPs 
(USNRC 1991c). These data demonstrate the typical individual doses in NPPs; however, 
in reality, the total number of monitored individuals is overcounted relative to its true level 
due to transient workers. Transient workers are defined as people who worked at more 
than one nuclear facility during the monitoring year and their occupational doses, received 
at each facility, are reported separately to the NRC by each NPP licensee (USNRC 2014d). 
These data appear to be separate individual doses when dose records are summed for all 
NPP licensees, although some of the dose records belong to the same individual. To obtain 
the actual dose information, it is necessary to combine these dose records for each 
individual. 
During the years 2003-2012, approximately 110,000-138,000 workers were 
reported to the NRC as the total number of monitored individuals except for multiple 
counting of transient workers in NPPs (USNRC 2004b, 2005b, 2006, 2007b, 2008a, 2010b, 
2011a, 2012c, 2013c; 2014d). These data indicated the actual total number of individuals 
that NPP licensees reported as being monitored for radiation exposure during each year. 
Therefore, the over-reporting of individuals who worked at more than one nuclear facility 
during the monitoring year was eliminated. In terms of the number of individuals with 
measurable doses, the fraction of individuals whose radiation exposure was measurable to 
the actual total number of monitored individuals in NPPs was approximately 42-51% 
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during the years 2003-2012 (USNRC 2004b, 2005b, 2006, 2007b, 2008a, 2010b, 2011a, 
2012c, 2013c; 2014d). These data indicate that only half of individuals in NPPs received 
a dose greater than zero.  
The TEDE for individuals, taking into account transient workers in NPPs, was 
analyzed using the data from the NRC annual reports for occupational exposure. The 
average measurable dose during the years 2003-2012 varied from 1.4 mSv to 2.1 mSv for 
all NPPs (USNRC 2004b, 2005b, 2006, 2007b, 2008a, 2010b, 2011a, 2012c, 2013c; 
2014d). These values were slightly higher than those with no regard for transient 
individuals, which were 1.0-1.6 mSv. In comparison with the NRC dose limit, the average 
measurable dose in NPPs was only 2.8-4.2% of the annual occupational dose limit. The 
maximum and minimum average measurable doses during the years 2003-2012 were 
reported to be 2.1 mSv and 1.4 mSv, respectively. The occupational doses, taking into 
account transient individuals in NPPs, during the years 2003-2012 are listed in Table 28 
and Fig. 14 (USNRC 2004b, 2005b, 2006, 2007b, 2008a, 2010b, 2011a, 2012c, 2013c; 
2014d). 
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Table 28. Occupational doses taking into account transient individuals in NPPs during the years 2003-2012a. 
 
Year Number of 
NPPs 
Actual total number 
of monitored 
individualsb 
Number of 
individuals with 
measurable dosec 
Collective dose  
(Person-mSv)d 
Average 
measurable dose 
(mSv)d 
Percent of 
limit (%)e 
2003 104 109,990 55,967 119,556 2.1 4.2 
2004 104 110,290 52,873 103,679 2.0 4.0 
2005 104 114,344 57,566 114,558 2.0 4.0 
2006 104 116,354 58,788 110,212 1.9 3.8 
2007 104 114,583 57,267 101,200 1.8 3.6 
2008 104 118,692 57,356 91,959 1.6 3.2 
2009 104 126,767 60,460 100,248 1.7 3.4 
2010 104 130,172 55,954 86,314 1.5 3.0 
2011 104 137,360 59,268 87,721 1.5 3.0 
2012 104 137,762 58,343 80,354 1.4 2.8 
a (USNRC 2004b, 2005b, 2006, 2007b, 2008a, 2010b, 2011a, 2012c, 2013c; 2014d). 
b Actual total number of monitored individuals who excluded the multiple counting of individuals who worked at more than 
one nuclear facility during the monitoring year. 
c Number of individuals whose radiation exposure is measurable. 
d Total effective dose equivalent (TEDE). 
e NRC annual occupational dose limit: 50mSv. 
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Fig. 14. Comparison of average occupational doses with and without taking into account transient individuals in NPPs during 
the years 2003-2012 (USNRC 2004b, 2005b, 2006, 2007b, 2008a, 2010b, 2011a, 2012c, 2013c; 2014d). 
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The occupational dose distributions in NPPs during the years 2003-2012 were also 
analyzed using the data with regards to transient individuals to compare the number of 
individuals in certain dose ranges. The dose distribution for each year was also obtained 
by summing the TEDE from the same individuals, and counting the number of individuals 
in each dose range. As a result, the fractions of the number of individuals whose dose was 
less than 1 mSv to the number of individuals with measurable dose were approximately 
52-64%. These percentages increased continuously from 52% in 2003 to 64% in 2012 
(USNRC 2004b, 2005b, 2006, 2007b, 2008a, 2010b, 2011a, 2012c, 2013c; 2014d). There 
were no individuals who received a dose above the NRC annual dose limit of 50 mSv. In 
particular, the percentages of individuals whose doses exceeded 20 mSv to the number of 
individuals with measurable doses were less than 0.4%. The occupational dose 
distributions with regards to transient individuals in NPPs during the years 2003-2012 are 
shown in Table 29 and Fig. 15 (USNRC 2004b, 2005b, 2006, 2007b, 2008a, 2010b, 2011a, 
2012c, 2013c; 2014d). 
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Table 29. Occupational dose distributions taking into account transient individuals in NPPs during the years 2003-2012a. 
 
Year Actual total 
number of 
individualsb 
Number of 
individuals 
with non-
measurable 
dosec 
Number of 
individuals 
with 
measurable 
dosed 
Number of individuals in the dose ranges (mSv)e 
    
< 1 
[1- 
2.5) 
[2.5-
5) 
[5-
7.5) 
[7.5-
10) 
[10-
20) 
[20-
30) 
[30-
40) 
[40-
50) 
2003 109,990 54,023 55,967 29,164 11,978 8,199 3,249 1,524 1,651 184 18 0 
2004 110,290 57,417 52,873 28,863 11,179 7,334 2,873 1,233 1,190 188 13 0 
2005 114,344 56,778 57,566 31,043 12,427 7,815 3,104 1,537 1,490 147 3 0 
2006 116,354 57,566 58,788 32,426 12,685 7,796 2,975 1,416 1,406 82 2 0 
2007 114,583 57,316 57,267 32,706 11,961 7,396 2,714 1,283 1,101 97 9 0 
2008 118,692 61,336 57,356 33,832 12,324 6,786 2,429 1,026 921 38 0 0 
2009 126,767 66,307 60,460 35,873 12,319 7,314 2,564 1,174 1,144 68 4 0 
2010 130,172 74,218 55,954 33,874 11,670 6,356 2,231 946 832 42 3 0 
2011 137,360 78,092 59,268 36,747 12,121 6,308 2,225 1,007 837 23 0 0 
2012 137,762 79,419 58,343 37,049 11,946 5,908 1,959 772 672 37 0 0 
a (USNRC 2004b, 2005b, 2006, 2007b, 2008a, 2010b, 2011a, 2012c, 2013c; 2014d). 
b Actual total number of monitored individuals who excluded the multiple counting of individuals who worked at more than 
one nuclear facility during the monitoring year. 
c Number of individuals whose radiation exposure was not measurable. 
d Number of individuals whose radiation exposure was measurable. 
e Total effective dose equivalent (TEDE). 
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Fig. 15. Occupational dose distributions taking into account transient individuals in NPPs during the years 2003-2012 (USNRC 
2004b, 2005b, 2006, 2007b, 2008a, 2010b, 2011a, 2012c, 2013c; 2014d). 
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DISCUSSION 
Determination of the need of dose constraint for members of the public 
An analysis of the estimated doses for members of the public (maximum exposed 
individual, MEI) living around nuclear power plants (NPPs) during the years 2007-2009 
was carried out showing that the estimated public doses have been kept very low by 
radioactive effluent control programs. Even though the estimated total effective dose 
equivalents (TEDEs) to the public differed slightly depending on the types of reactor, the 
annual dose level was approximately on the order of 10-4 mSv. When compared to the 
average dose from natural background radiation received by an individual in the United 
States of 3.1 ± 3.6 mSv y-1, the off-site doses correspond to an increase between 0.02 and 
0.03%. Furthermore, when compared to all sources of radiation (medical included) the 
absorbed dose received by an individual will be 6.2 mSv (NCRP 2009) corresponding to 
an increase between 0.0087% and 0.0156%. Also, when compared with the annual dose 
limit of 1 mSv y-1, the TEDEs to the public were between 0.03% and 0.11% of the annual 
dose limit. Therefore, the risk to the public from radioactive effluents released from NPPs, 
under normal operating conditions, is negligible compared to the dose limit or the typical 
background radiation dose.  
The data from individual doses in the form of a probability distribution and a 
cumulative probability distribution were used as the technical basis for finding whether a 
dose constraint for members of the public is necessary or not. The idea of establishing a 
threshold of inequitable doses, using numerical percentiles in the dose distribution, is 
based on the two concepts of the EPA MEI and the ICRP representative person. 
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Lognormal distributions of individual doses for members of the public during the 
years 2007-2009 are presented in Fig. 16. The solid and dotted lines indicate the best fit 
to the probability distribution and the cumulative probability distribution, respectively. 
Using the cumulative probability distribution, it is possible to find the doses at the 95th 
percentile (ICRP) and the 99.99th percentile (EPA) of a given dose distribution. As shown 
in Table 30, the 95th percentiles (ICRP) for the years 2007, 2008, and 2009 were 5.60×10-
2 mSv, 4.50×10-2 mSv, and 5.21×10-2 mSv, respectively, and the 99.99th percentiles (EPA) 
were 1.72×10-1 mSv, 1.63×10-1 mSv, and 1.68×10-1 mSv, respectively. The difference 
between the values for year from the 95th and the 99.99th percentiles were approximately 
the order of 10-1 mSv, which is negligible when compared when compared to the annual 
dose limit of 1 mSv. 
 
 
 
Table 30. Minimum, median, and maximum doses and individual doses at the 95th and 
the 99.99th percentiles of public dose distributions during the years 2007-2009. 
 
Year 2007 2008 2009 
Minimum dose (mSv) 1.98×10-7 1.63×10-7 1.66×10-7 
Median dose (mSv) 9.69×10-4 7.17×10-4 5.42×10-4 
Maximum dose (mSv) 1.72×10-1 1.63×10-1 1.68×10-1 
Dose at the 95th percentile (mSv) 5.59×10-2 4.50×10-2 5.21×10-2 
Dose at the 99.99th percentile (mSv) 1.72×10-1 1.63×10-1 1.68×10-1 
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Fig. 16. Lognormal distribution of individual doses for members of the public living around NPPs during the years 2007-2009. 
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The potential radiation exposure from natural background and NPPs to a MEI is 
illustrated respectively in Fig. 17 comparing their total doses. Since absorbed dose is 
proportional to excess risk, ER = D × RD (Equation 11), the total dose and corresponding 
relative increase in excess risk for a MEI is given by Equation (12). Under the LNT model, 
which shows that a given increment in a dose will produce a directly proportional 
increment in a risk, Equation (12) can be replaced by Equation (13).  
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Fig. 17. Potential radiation exposure from natural background (left) and NPPs (right) to 
MEI. 
 
 
 
In ICRP Publication 103 the total detriment-adjusted nominal risk coefficient for 
individual members of the public was estimated to be 5.7×10-5 per mSv (ICRP 2007). If 
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this risk coefficient is used to estimate the risk of individual doses for members of the 
public living around NPPs, the corresponding annual excess risk levels at the 95th and the 
99.99th percentiles of given individual dose distributions are computed as approximately 
the order of 10-6 using Equation (11). The excess risks for median and maximum doses, 
individual doses at the 95th and the 99.99th percentiles of a given dose distribution during 
the years 2007-2009, and the average dose from natural background in the United States 
are given in Table 31. The corresponding relative increases in excess risk are also 
calculated using Equation (13), as compared to the risk of the average dose from natural 
background in the United States (Table 32). 
 
 
 
Table 31. Comparison of excess risk, ER, for median and maximum doses, individual 
doses at the 95th and the 99.99th percentiles from public dose distributions during the 
years 2007-2009, and average dose from natural background in the United States. 
 
Year 2007 2008 2009 
Median dose (mSv) 9.69×10-4 7.17×10-4 5.42×10-4 
Risk 5.52×10-8 4.09×10-8 3.09×10-8 
Maximum dose (mSv) 1.72×10-1 1.63×10-1 1.68×10-1 
Risk 9.80×10-6 9.29×10-6 9.58×10-6 
Dose at the 95th percentile (mSv) 5.59×10-2 4.50×10-2 5.21×10-2 
Risk 3.19×10-6 2.57×10-6 2.97×10-6 
Dose at the 99.99th percentile (mSv) 1.72×10-1 1.63×10-1 1.68×10-1 
Risk 9.80×10-6 9.29×10-6 9.58×10-6 
Average dose from natural background (mSv) 3.10×100 3.10×100 3.10×100 
Risk 1.77×10-4 1.77×10-4 1.77×10-4 
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Table 32. Comparison of relative increase in excess risk for median and maximum doses 
and individual doses at the 95th and the 99.99th percentiles from public dose distributions 
during the years 2007-2009, as compared to the risk of average dose from natural 
background in the United States. 
 
Year 2007 2008 2009 
Median dose (mSv) 9.69×10-4 7.17×10-4 5.42×10-4 
Relative increase in risk (%) 0.03 0.02 0.02 
Maximum dose (mSv) 1.72×10-1 1.63×10-1 1.68×10-1 
Relative increase in risk (%) 5.55 5.26 5.42 
Dose at the 95th percentile (mSv) 5.59×10-2 4.50×10-2 5.21×10-2 
Relative increase in risk (%) 1.80 1.45 1.68 
Dose at the 99.99th percentile (mSv) 1.72×10-1 1.63×10-1 1.68×10-1 
Relative increase in risk (%) 5.55 5.26 5.42 
 
 
 
Annual risk levels of 10-5 and below are generally considered to be of low 
probability or low consequence by most people (Whipple 1988). On the basis of this fact, 
the ICRP has recommended the annual public dose limit of 1 mSv, whose associated 
excess risk is 5.7×10-5. The annual excess risk levels for median and maximum doses and 
individual doses at the 95th and the 99.99th percentiles of the actual individual dose 
distribution around NPPs were calculated to be on the order of 10-8 and 10-6. These results 
mean there is less than 1 in 1 million chance of an individual fatality per year of exposure 
(i.e., 10-6 y-1). The risk levels of 10-6 and below are widely regarded as acceptable risks 
(Spangler 1987; Martin and Sutton 2015). This level is sometimes referred to as a de 
minimis level, which means that the incremental risk produced by an exposure is 
sufficiently small so that there is no incentive to reduce the exposure (Whipple 1988). 
Furthermore, Table 32 shows that the relative increase in excess risk due to absorbed dose 
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accounted for only 0.03% for median dose and less than 6% for maximum dose. This 
indicates that the relative increase in risk due to radiation exposure from NPPs is trivial 
compared to the average dose from natural background in the United States.  
A chart of probability of death for an individual per year of exposure to hazards, 
which was devised by the Royal Commission on Environmental Pollution in the United 
Kingdom, is shown in Fig. 18. This figure compares risk levels in terms of acceptable or 
unacceptable risk (Wilson 1984). As is shown, risk levels above 10-3 are regarded as 
unacceptable. In contrast, risk levels of 10-6 and below are considered acceptable. The 
range between risk levels of 10-3 and 10-6 is designated as the zone where risk-cost-benefit 
analysis should be conducted by a social decision-making process to determine whether 
that risk is acceptable or not. Compared to the risk levels in this chart, the results of excess 
risk for median and maximum doses and individual doses at the 95th and the 99.99th 
percentiles of the actual individual dose distribution around NPPs would be regarded as 
acceptable. Although the ICRP has recommended that every reasonable effort should be 
made to maintain all radiation exposures as low as reasonably achievable, it would be 
unreasonable to reduce these very low levels of individual risks to levels of 10-10 or 10-12. 
In addition, the public doses realistically have been kept at very low levels by radioactive 
effluent control programs in the U.S. NPPs. As stated earlier, the annual dose level for 
members of the public was reported to be the order of 10-4 mSv, and such a dose is 
generally considered negligible. Even the maximum dose level of 10-1 mSv is one tenth of 
the dose limit (1 mSv) and is regarded as trivial compared to the dose limit. Therefore, it 
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is concluded, in this study, that a dose constraint is not necessary for members of the public 
living around the U.S. NPPs. 
If the NRC were to implement a dose constraint for members of the public, the 
population fraction that would be affected by such implementation (doses at the 95th or at 
99.99th percentiles) will be in fact negligible and the economic cost for such collective 
dose (S*) reduction will have no net benefit. This can be expressed as 
  
(
𝑑𝑋
𝑑𝑆
)
𝑆∗
> −(
𝑑𝑌
𝑑𝑆
)
𝑆∗
and (14) 
(
𝑑𝑋
𝑑𝑆
)
𝑆∗
≈ 0, (15) 
 
where X is the cost of protection and Y is the cost of detriment. Therefore, there is no net 
cost-benefit that can be attained by establishing dose constraints in this particular situation.  
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Fig. 18. Risk of death for an individual per year of exposure to hazards in terms of 
acceptable and unacceptable risk (orders of magnitude) showing the corresponding 
associated risk for members of the public living around NPPs.  
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Determination of the need of dose constraint for occupational workers 
The occupational exposure data from NPPs for a period of 10 years were 
investigated to evaluate the annual occupational dose levels resulting from the normal 
operation of NPPs. The data analysis showed that occupational doses during the period 
between 2003 and 2012 were kept low by effective radiation safety programs. Although 
the reported TEDEs for occupational workers differed slightly depending on the types of 
reactors, the average doses during the years 2003-2012 fell into the range of 0.4 to 0.8 
mSv for all NPPs. Since most office individuals and visitors in NPPs are not involved in 
radiation work in the field, their radiation exposures are generally not measured due to 
either no radiation exposure or extremely low levels of exposure. Therefore, measurable 
doses TEDEs greater than zero were used to analyze the actual occupational exposure. 
The average measurable doses during the years 2003-2012 fell into the range between 1.0-
1.6 mSv for all NPPs. These doses were only 16-25% of the average dose of 6.2 mSv y-1 
received from all radiation sources by an individual in the United States (NCRP 2009). 
Furthermore, these TEDEs were only 2.0-3.2% of the NRC occupational dose limit. 
Therefore, annual occupational doses resulting from the routine operation of the U.S. 
NPPs are considered negligible compared to the typical background radiation dose or the 
dose limit.  
The analysis results showed that the number of individuals with radiation exposure 
less than 1 mSv y-1 accounted for 58-70% of the total number of individuals with 
measurable doses. Therefore, the majority of individual workers received very little 
radiation exposure from the normal operation of NPPs, but some of them received 
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relatively higher radiation doses. This observation means that individual doses for 
occupational work in NPPs are distributed broadly despite their low average measurable 
doses. 
This study focused on two types of occupational dose distributions; one includes 
the occupational exposures reported by each NPP licensee, and the other includes the 
occupational exposures that were combined per individual, taking into account transient 
individuals who worked at more than one nuclear facility during the monitoring year. 
Since some of the reported doses belong to the same individual, it is necessary to combine 
these dose records per individual to obtain the actual occupational dose distribution. 
However, this study did not use the data, including transient individuals for determining 
the dose constraint for occupational workers in NPPs, even though the analysis of 
occupational doses, taking into account transient individuals, was already conducted in 
the Results of Analysis chapter.  
The ICRP introduced two types of assessments for the efficiency of protection: 
source-related and individual-related assessments (ICRP 1991). The former focuses on the 
radiation exposure of the individuals exposed from a single source, while the latter focuses 
on the radiation exposure of an individual from several sources. A dose constraint 
originates from a single source, and this single source is a single NPP site. That is, the 
dose records reported by each NPP licensee indicate the source-related radiation exposure 
resulting from a single source that exists at a single location. On the contrary, the dose 
records, taking into account transient individuals, are the sum of individual doses resulting 
from several sources that include multiple facilities at several locations, and these records 
 143 
 
indicate the individual-related radiation exposure. Therefore, the occupational exposures 
that were combined per individual, taking into account transient individuals, are not 
appropriate to be used as the data for determining a dose constraint.    
To apply numerical percentiles to the dose distribution, occupational doses were 
used in the form of probability distribution and cumulative probability distribution. These 
dose distributions were obtained by counting the number of individuals in certain dose 
ranges using the data from the NRC annual reports. The estimated distributions of 
occupational doses in NPPs during the years 2003-2012 are displayed in Fig. 19. In the 
figure, the solid and dotted lines indicate the probability distribution and the cumulative 
probability distribution, respectively. The cumulative probability distribution enables 
estimating the doses at the 95th and the 99.99th percentiles of a given dose distribution. 
The 95th percentiles of each dose distribution during the years 2003-2012 fell into the 
range of 3.8 to 5.9 mSv. On the other hand, relatively higher values, 16.5-24.2 mSv were 
calculated as the 99.99th percentiles of each dose distribution during the years 2003-2012. 
Although all values were lower than the NRC annual dose limit, the values from the 
99.99th percentiles in each year were approximately 4.5 times higher than those from 95th 
percentiles of a given distribution. The values of the average measurable and maximum 
doses and the doses at the 95th and the 99.99th percentiles of occupational dose 
distributions during the years 2003-2012 are given in Table 33.  
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Table 33. Comparison of the average measurable and maximum doses and the doses at 
the 95th and the 99.99th percentiles of occupational dose distributions during the years 
2003-2012. 
 
Year 
Average 
measurable dose 
(mSv) 
Maximum dose 
(mSv) 
Dose at 95th  
percentile 
(mSv) 
Dose at 99.99th  
percentile 
(mSv) 
2003 1.6 28.9 5.9 24.2 
2004 1.5 24.3 5.5 22.4 
2005 1.4 29.6 5.3 22.4 
2006 1.4 21.9 5.0 17.6 
2007 1.3 28.4 4.7 21.8 
2008 1.1 26.8 4.2 18.1 
2009 1.2 18.5 4.5 17.5 
2010 1.1 22.3 4.3 19.3 
2011 1.1 18.4 3.9 16.5 
2012 1.0 28.7 3.8 21.7 
Maximum 1.6 29.6 5.9 24.2 
Minimum 1.0 18.4 3.8 16.5 
Average 1.3 24.8 4.7 20.1 
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Fig. 19. Probability distribution and cumulative probability distribution of occupational exposure in NPPs during the years 
2003-2012. 
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As shown in Table 33, the average for the doses at 95th percentiles of dose 
distributions were approximately 5 mSv due to effective radiation safety programs in 
NPPs. Although Table 33 shows a gradually decreasing trend of the average, it is 
considered, in this study, inappropriate to use this value as the occupational dose constraint 
in NPPs. This value is not only one tenth of the current occupational dose limit, 50 mSv, 
but also even lower than the average dose, 6.2 mSv y-1, from all radiation sources received 
by a typical individual in the United States (NCRP 2009). Furthermore, even though the 
fraction of individuals with doses above 5 mSv accounted for only 5% of the total number 
of individuals with measurable doses in NPPs, the number of individuals whose annual 
doses were higher than 5 mSv was 2,177 in 2012 due to the very large number of workers 
in NPPs. Therefore, despite its small percentage in a dose distribution, the number of 
individuals whose dose levels fall into this highest 5% of the distribution was substantial. 
That is, if this 5 mSv is used as the occupational dose constraint in NPPs, the costs imposed 
by this dose constraint, which will be used for lowering individual doses below the dose 
constraint, can be a financial burden on the routine operation of NPPs. 
The doses at 99.99th percentiles of each dose distribution during the years 2003-
2012 were calculated to be 16.5-24.2 mSv, and their average was approximately 20 mSv. 
Since 20 mSv was almost the maximum dose level of occupational workers in NPPs, this 
value may provide more margin of operating flexibility for NPPs, as compared to the 
previous average for the doses at 95th percentiles of dose distributions. It is inappropriate 
to use the dose above 20 mSv y-1 as the occupational dose constraint because ICPP 
Publication 103 recommended 100 mSv in five years as the occupational dose limit. 
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Although the dose limit for a single year is still 50 mSv, an average of 20 mSv per year 
over a five-year period will play a role as an upper boundary on the expected dose to 
comply with the dose limit for occupational workers in NPPs. Therefore, the average dose 
at the 99.99th percentiles of dose distributions, i.e., 20 mSv, is considered more reasonable 
for the occupational dose constraint in NPPs than that for the doses at 95th percentiles. 
However, since the 20 mSv y-1 is the same as the average ICRP occupational dose limit 
over five years, it is concluded, in this study, a dose constraint is not needed for 
occupational workers in the U.S. NPPs. If the NRC was to implement a dose constraint 
for occupationally-exposed workers using the dose at 99.99th percentile, the dose 
constraint would be a redundant regulation. 
To analyze the consequences of the given dose level referring to the probability of 
detriment due to a potential exposure, the corresponding excess risks were estimated using 
the  (Equation 11). If the risk coefficient given in ICRP Publication 103, 
4.2×10-5 per mSv, is used to estimate the excess risk of individual doses for occupational 
workers in NPPs, the corresponding annual excess risk of 20 mSv y-1 is computed as 
8.4×10-4 (ICRP 2007). The excess risks for the dose limit, the average occupational 
measurable dose, the average individual doses at the 95th and the 99.99th percentiles of the 
occupational dose distributions, and the average dose received from all radiation sources 
by an individual in the United States are given in Table 34. 
 
  
ER = D´ RD
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Table 34. Comparison of excess risks for the occupational dose limit, the average 
occupational measurable dose, the average individual doses at the 95th and the 99.99th 
percentiles of occupational dose distributions, and the average dose received from all 
radiation sources by an individual in the United States. 
 
 Dose (mSv y-1) Risk 
Dose limit 50 2.10×10-3a 
Average occupational measurable doseb 1.3 5.46×10-5a 
Dose at the 95th percentilec 5 2.10×10-4a 
Dose at the 99.99th percentiled,e 20 8.40×10-4a 
Maximum dose 24.8 1.04×10-3a 
Average dose received from all radiation sources in US 6.2 3.53×10-4f 
a Risk estimates were calculated on the basis of the risk coefficient for adults, 4.2×10-5 per 
mSv, which was given in ICRP Publication 103. 
b Average dose to occupational individuals with a measurable dose. 
c The value is the average for the doses at the 95th percentiles of occupational dose 
distributions during the years 2003-2012. 
d The value is the average for the doses at the 99.99th percentiles of occupational dose 
distributions during the years 2003-2012. 
e Average ICRP dose limit over 5 years. 
f Risk estimates were calculated on the basis of the risk coefficient for whole population, 
5.7×10-5 per mSv, which was given in ICRP Publication 103. 
 
 
 
Annual risk levels of 10-3 are ordinarily accepted by most workers in any industry 
and are generally regarded as the demarcation between tolerable and unacceptable risk 
levels for any large part of a work environment (HSE 1992). On this basis, the ICRP has 
recommended the annual occupational dose limit of 50 mSv, with a limit of 100 mSv in 
five years (NCRP 1993; ICRP 2007). To compare risk levels associated occupational 
exposures in NPPs, the previous chart of probability of death for an individual per year of 
exposure to hazards was used again as shown in Fig. 20 (Wilson 1984). Compared to the 
risk level of the dose limit in this chart, the excess risks for average measurable and 
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maximum doses and individual doses at the 95th and the 99.99th percentiles of the actual 
individual dose distribution around NPPs were regarded as acceptable. 
In addition, the fraction of workers that would be affected by the dose at the 99.99th 
percentiles will be negligible and the economic cost for such collective dose (S*) reduction 
will have no net benefit. This can be also expressed as 
 
(
𝑑𝑋
𝑑𝑆
)
𝑆∗
> −(
𝑑𝑌
𝑑𝑆
)
𝑆∗
and (16) 
(
𝑑𝑋
𝑑𝑆
)
𝑆∗
≈ 0, (17) 
 
where X is the cost of protection and Y is the cost of detriment. Therefore, there is no net 
cost-benefit that can be achieved by implementing a dose constraint for occupational 
workers in the U.S. NPPs.  
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Fig. 20. Risk of death for an individual per year of exposure to hazards in terms of 
acceptable and unacceptable risk (orders of magnitude) showing the corresponding 
associated risk for occupationally-exposed workers in NPPs. 
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CONCLUSION 
This research was conducted as a preparation of the revision of current NRC 
regulations according to ICRP Publication 103, which requires the implementation of 
concept of dose constraints for members of the public and for occupationally-exposed 
workers at the U.S. nuclear power plants (NPPs). Under the paradigm of regulatory 
science, the use of dose constraints is still highly debatable.  
This research addressed two objectives. The first objective was determining 
whether or not dose constraints are necessary for members of the public and 
occupationally-exposed workers at the U.S. NPPs. The second objective was determining, 
if dose constraints were needed, the optimal numerical values of dose constraints at the 
U.S. NPPs. To achieve these objectives, several areas were investigated and analyzed: 1) 
the establishment of a regulatory-science framework; 2) a system of radiation protection 
which would incorporate the concept of dose constraints; 3) methodologies and 
regulations for public and occupational dose assessment; 4) approaches to the 
establishment of dose constraints; 5) the actual doses and corresponding excess risk for 
members of the public living around NPPs; and 6) the range of doses and corresponding 
excess risk for occupationally-exposed workers in NPPs.  
An analysis was carried out using exposure data obtained from the NRC from the 
years 2007 to 2009 for members of the public and from the years 2003 to 2012 for 
occupational workers. The analysis data finds that the dose distributions for a maximally-
exposed individual (MEI) for members of the public and occupationally-exposed workers 
were lognormal. For members of the public, the annual median and maximum doses to a 
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MEI were 10-4 mSv and 10-1 mSv, respectively. The doses at the 95th and the 99.99th 
percentiles were 10-2 mSv and 10-1 mSv, respectively. The corresponding annual excess 
risks (ER) for the median and maximum doses were calculated to be on the order of 10-8 
and 10-6, respectively. These excess risks are very low and should be considered 
acceptable. The relative increase in excess risk for median dose accounted for only 0.03% 
and less than 6% for maximum dose. These findings indicate that the relative increase in 
risk due to radiation exposure from NPPs is trivial compared to the average dose from 
natural background in the United States of 3.1 mSv. It is concluded that a dose constraint 
is not necessary for members of the public.  
For occupationally-exposed workers, the average and maximum measurable doses 
were 1.3 mSv and 24.8 mSv. The doses at the 95th and the 99.99th percentiles were 
calculated as 5 and 20 mSv, respectively. The annual excess risk for the average and 
maximum doses were on the order of 10-5 and 10-3, respectively. These excess risks are 
also acceptable from the perspective of occupational risks. This analysis showed that some 
individuals received relatively higher annual doses than others. However, the fraction of 
the workers in this category was negligible (0.01%) and the economic cost of further dose 
reduction based on dose constraints will have no net positive benefit. Thus, it is concluded 
that a dose constraint for occupational workers is not necessary at the U.S. NPPs. 
The implementation of dose constraints, as proposed by the ICRP Publication 103, 
for NPPs was found to be unsupported based on an analysis of the impact of dose 
constraints in the reduction of annual doses to members of the public and occupationally-
exposed workers. The use of dose constraints had no impact on radiation safety at NPPs 
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in the United States. This conclusion is based on the negligible increase in excess risk. 
The dose distributions were found to be lognormal and significantly skewed to very low 
doses. However, it is imperative that dose constraints be put into perspective as the present 
analysis was made exclusively for the nuclear power industry (NPPs). Dose constraints, 
however, for other scenarios or industries, such as the medical industry, may require a 
similar analysis as doses received by occupationally-exposed workers and members of the 
public (patients) are likely to have different distributions.     
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APPENDIX  
Comparison of regulatory organizations and their regulations 
In terms of nuclear safety, national regulations are influenced by the safety 
standards of the International Atomic Energy Agency (IAEA). The IAEA is an 
autonomous organization established through its own international treaty, the IAEA 
Statute. It provides safety standards to protect the public and environment from harmful 
effects of nuclear activities (IAEA 2014b). Even though regulating nuclear safety is a 
national duty, and there is no compulsory obligation for the IAEA member nations to 
adopt the IAEA safety standards. Nevertheless, regulatory bodies in many member nations 
use IAEA safety standards in their regulations. The IAEA Safety Standards Series consist 
of three categories: Safety Fundamentals, Safety Requirements, and Safety Guides (IAEA 
2014a). Safety Fundamentals provide the basic objectives and principles of safety. Safety 
Requirements provide the necessities that must be fulfilled to ensure the protection of 
people and environment. Last, Safety Guides provide guidance on how to meet the safety 
requirements. The general process for establishing IAEA safety standards is as follows. 
First, the United Nations Scientific Committee on the Effects of Atomic Radiation 
(UNSCEAR) produces the scientific evaluations of the research data about effects of 
exposure to ionizing radiation, which is submitted by United Nations (UN) member 
nations (UNSCEAR 2015). The ICRP uses these scientific evaluations for developing the 
basic recommendations on radiological protection. These ICRP recommendations are 
based, not only on scientific results, but also value judgments about balancing of risks and 
benefits, taking into account societal expectations and experiences (ICRP 2007). The 
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IAEA applies these recommendations to establish its own safety standards for practical 
use in the field.  
The IAEA safety standards reflect an international agreement on what establishes 
a high level of safety for protecting people and the environment from detrimental effects 
of radiation exposure (IAEA 2014a). There are multiple entities involved in the process 
of developing an IAEA safety standard. These entities are 1) the IAEA Secretariat, 2) the 
safety standards committees for nuclear safety (NUSSC), radiation safety (RASSC), 
radioactive waste safety (WASSC) and the safe transport of radioactive material 
(TRANSSC), and 3) Commission on Safety Standards (CSS). These committees are 
involved in the review and approval of a standard as shown in Fig. 21 (IAEA 2014a). All 
IAEA member nations can appoint specialists for the safety standards committees, and 
they provide remarks on draft standards, taking into account social considerations of their 
nations. The members of Commission on Safety Standards are also composed of 
governmental representatives from member nations, and they balance the benefits and 
risks of new or revised standards for application to their national regulations. 
Even though the primary goal of this process is providing impartial criteria for 
nuclear safety, the judgment is made through a consensus between technical findings and 
social values. In terms of relationship between the IAEA and the ICRP, especially for 
radiation protection regulations, the IAEA has established the International Basic Safety 
Standards (BSS) based on the recommendations of the ICRP. For example, the ICRP has 
continuously published its recommendations on radiological protection since 1958 with 
Publication 1. Following updated recommendations were made in 1966 with Publication 
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9, 1977 with Publication 26, 1990 with Publication 60, and 2007 with Publication 103. 
The IAEA has also provided the BSS in 1962, 1967, 1982, 1996, and 2014 based on the 
corresponding editions of the ICRP recommendations (Czarwinski 2011). Many member 
nations adopt these standards in their regulations. In particular, the application of these 
standards by EU member nations is required by the European Atomic Energy Community 
(Euratom) legislation which is regularly updated in collaboration with the development of 
IAEA BSS (IAEA 2014a). 
 
 
 
 
 
 
Fig. 21. Development process for IAEA safety standards.  
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In the United States, the national regulatory system for nuclear safety consists of 
three bodies: the Department of Energy (DOE), the U.S. Environmental Protection 
Agency (EPA) and the U.S. Nuclear Regulatory Commission (NRC). The DOE is in 
charge of the development of nuclear energy policy and the promotion of research 
programs about reactors, fuel cycles, nonproliferation, etc. (USDOE 2015). The EPA 
establishes standards and guidance to regulate the offsite releases of radioactive materials 
from the nuclear facilities (USEPA 2014). Finally, the NRC has a responsibility to regulate 
commercial application of nuclear materials (USNRC 2012b). Consequently, the NRC 
regulates most nuclear activities, including NPPs. The NRC provides regulations and 
guidance to obtain the appropriate protection of workers, the public, and the environment 
from nuclear related activities. The main components of the development of NRC 
regulatory requirements are four activities: rulemaking, guidance development, generic 
communication, and standards development (USNRC 2014c). First, rulemaking is the 
process of developing and amending regulations with which nuclear licensees must 
comply to attain or retain a license to use nuclear materials or operate a nuclear facility. 
Second, guidance development is the process of developing and revising guidance 
documents, including regulatory guides, standard review plans, and NRC inspection 
manual to help licensees comply with safety requirements. Third, generic communication 
is the process of asking applicants and licensees for information about events or regulatory 
requirements, some of which need response. Last, standards development is the process 
of developing consensus standards about systems, apparatus, or materials used by the 
nuclear industry. For developing these standards and guides, the NRC conducts regulatory 
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research programs for three areas: nuclear reactors, nuclear materials, and nuclear waste 
(USNRC 2014f). The research conducted by the NRC is normally considered 
confirmatory research focusing on the regulatory mission, not exploratory research that is 
research into the unknown. The technical findings and information obtained from the 
research are published as NUREG-series reports and are used in developing regulatory 
guides. As mentioned above, a negotiation process between technical findings and social 
values is necessary for regulatory science to arrive at a consensus on regulations. The NRC 
also collaborates with standards organizations to have consensus standards (USNRC 
2014g). A standards organization uses committees to reach an agreement on the standard. 
Generally, these committees consist of various stakeholders such as technical specialists 
from the utilities, vendors, government officials, and, if necessary, the general public. 
Therefore, it can be said that the regulation is the result of compromising between science 
and policy.  
 
Evolution of the system of radiation protection 
The system of radiation protection has originated in the early attempts to protect 
people from X-rays (Boyd 2012). After the discovery of X-rays by Wilhelm Roentgen in 
1895, X-rays quickly achieved widespread medical and scientific use. Soon after being a 
popular tool in medicine and scientific research, X-rays, especially for large or repeated 
exposures to human bodies, caused various harmful effects, such as skin burns among 
patients (Turner 2007). The reports on harmful effects by X-ray exposures increased 
concern about the application of ionizing radiation and many scientists and medical 
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professionals recognized the need for actions to protect patients and operators from 
excessive exposure. This is considered the beginning of radiation health protection (Turner 
2007). As part of this effort, the foundation of the International Commission on 
Radiological Units and Measurements (ICRU), which was originally known as the 
International Committee on X-ray and Radium Protection and later as the International 
Committee for Radiological Units, was proposed by the First International Congress of 
Radiology (ICR) in 1925 and officially came into being in 1928 (ICRP 2015). The primary 
goal of the ICRU is to provide recommendations on radiation-related quantities and units, 
measurement procedures, and reference data for the safe and efficient application of 
ionizing radiation. In 1928, the ICRP was also established during the second meeting of 
the ICR, and today, the ICRP plays a crucial role in the development of the system of 
radiation protection for people and the environment by providing international 
recommendations and guidance (ICRP 2015a). The most important publications of the 
ICRP are Publication 2 (the basis of 10 CFR Part 50), Publication 26 (the basis of 10 CFR 
Part 20), Publication 60 (the basis of current regulations on radiological protection by most 
IAEA member nations), and Publication 103 (the latest ICRP recommendations, which 
are supposed to be adopted by most IAEA member nations, including the United States) 
(USNRC 2015f). 
 
Introduction of the International Commission on Radiological Protection 
The ICRP is an international, independent, and non-governmental organization for 
the radiological protection of people and the environment from ionizing radiations. The 
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ICRP was formerly the International X-ray and Radium Protection Committee (IXRPC), 
which was established in 1928 to protect people from the harmful effects of X-rays (Clarke 
and Valentin 2009). In 1950, the name of the IXRPC was changed to its present name: 
ICRP. The ICRP consists of a main commission, a scientific secretariat, five committees, 
and a series of task groups and working parties (ICRP 2015b). The main commission and 
the scientific secretariat collaborate to organize the work of the ICRP. In particular, the 
main commission approves the publication of all ICRP reports, and it is technically 
advised by five committees: 1) radiation effects, 2) doses from radiation exposure, 3) 
protection in medicine, 4) application of the ICRP recommendations, and 5) protection of 
the environment (ICRP 2015b). The committees normally assign the work of task groups 
that are formed to conduct a specific task such as making a particular ICRP Publication. 
Sometimes, working parties are established by committee members to solve particular 
issues. The names of the ICRP committees and their work scope are summarized in Table 
35 (Clarke and Valentin 2009; ICRP 2015b). 
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Table 35. Work scopes of the ICRP Committees. 
 
Number Name Work scope 
Committee 1 Radiation effects Risk assessment of the occurrence of 
cancer and genetic disease (stochastic 
effects) along with the underlying 
mechanisms of radiation action; 
Evaluation of the risks, severity, and 
mechanisms of occurrence of tissue 
and organ damage and developmental 
defects (deterministic effects) 
Committee 2 Doses from radiation exposure Development of dose coefficients for 
the internal and external radiation 
dose assessments; 
Development of reference biokinetic 
and dosimetric models; 
Development of reference data for 
workers and members of the public 
Committee 3 Protection in medicine Development of the protection of 
persons and unborn children from 
ionizing radiation during diagnosis, 
therapy, or biomedical research; 
Assessment of the medical 
consequences of accidental exposure 
Committee 4 Application of the 
commission’s 
recommendations 
Provision of advice on the application 
of the recommended system of 
protection for occupational and 
public exposure; 
Communication channel with other 
international organizations and 
professional societies focused on 
protection against ionizing radiation 
Committee 5 Protection of the environment Development of the radiological 
protection of the environment 
 
 
 
The ICRP primary work provides international recommendations and guidance on 
radiological protection against ionizing radiations. In preparing its recommendations that 
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cover the overall system of radiological protection, the ICRP focuses on the basic 
principles and numerical bases on which proper radiological protection measures can be 
set up, while leaving to national regulatory bodies the duty of developing the specific 
guidance or regulations that are best suited to the necessities of their individual nations 
(ICRP 2015b). The ICRP system of radiological protection is a product of regulatory 
science that involves the social and economic considerations. This system is based on the 
current knowledge of the science of radiation exposure and value judgements. These value 
judgements consider socio-economic factors, such as societal expectations, morals, and 
experience obtained from application of the system. Since the knowledge of the science 
and the societal expectations has evolved over time, the system of radiological protection 
has also evolved. 
The ICRP provides its recommendations continuously to regulatory bodies and 
advisory agencies, and these recommendations have been used for providing regulations 
and guidance for radiation protection in most nations in the world. The ICRP develops 
recommendations on radiological protection using the technical data of scientific studies 
provided by the UNSCEAR. The IAEA has used these recommendations as a primary 
source of information for developing its standards, BSSs. Finally, most of the IAEA 
member nations adopt the IAEA BSS for making their own regulations for radiation 
protection. The relationship between different organizations for the use of ICRP 
recommendations on radiological protection is shown in Fig. 22 (Clarke and Valentin 
2009). 
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Fig. 22. Development process of ICRP recommendations and their application in various 
organizations. 
 
 
 
Like the ICRP, the National Council on Radiation Protection and Measurements 
(NCRP) is a non-governmental organization, and it was established by the U.S. Congress 
in 1964 to distribute information and provide guidance and recommendations on radiation 
protection and measurements (NCRP 2015). The NCRP also develops its publications to 
provide guidance for the setting of criteria, standards, and practices of radiation protection 
in regulatory agencies in the United States (Turner 2007). Therefore, the work of the 
NCRP work is much similar to that of the ICRP. The main difference between the ICRP 
and NCRP is that the NCRP aspects of radiation application and exposure environments 
are unique to the United States (Boice 2012). The NCRP has 100 members and 
approximately 20 scientific committees that draft recommendations on specific topics 
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related to radiological protection (NCRP 2015). These recommendations are finally 
reviewed and approved by the full NCRP council before publication. 
 
Introduction of the major ICRP Publications 
The ICRP has issued four major publications of radiological protection: ICRP 
Publication 2 in 1959, ICRP Publication 26 in 1977, ICRP Publication 60 in 1990, and 
ICRP Publication 103 in 2007, whose methodology is the basis of current regulations on 
radiation protection. To estimate the internal radiation exposure, ICRP Publication 2 
provided the values of maximum permissible body burden (MPBB) of radionuclide and 
maximum permissible concentrations (MPC) of these nuclides in air and water (ICRP 
1959; PMJ 1960). The MPBB and MPC are defined, respectively, as the maximum amount 
(inside the body) and the maximum concentration (in air or water) of radioactive material 
that will produce a dose equivalent to the allowable occupational exposure, such as 
maximum permissible dose (ICRP 1959; Cember and Johnson 2009). The current 
requirements of Appendix I to 10 CFR Parts 50 are based on dosimetric methodology in 
ICRP Publication 2, such as the critical organ dose concept and dosimetric models 
(USNRC 2015f). The critical organ is the organ that receives the highest dose from the 
intake of a radionuclide, and this concept was used for the calculation of the MPBB and 
MPC in ICRP Publication 2. In particular, the MPC values of airborne particulate 
radioactivity in the workplace were based on the dosimetric model of the respiratory tract, 
which considered only aerosol radionuclides and two classes of particle solubility, 
“soluble” and “insoluble,” and modeled the lung as a two-compartment system: the upper 
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respiratory tract and the deep respiratory tract (Cember and Johnson 2009). All MPC 
values for occupational exposure were calculated on the condition that the critical organ 
dose was 3 mSv w-1, corresponding to one-third of the average external occupational 
exposure 1 mSv w-1 or 50 mSv y-1  (ICRP 1959). However, in terms of public exposure, 
the MPC values were not provided in ICRP Publication 2 for members of the public, while 
it is suggested, in the case of prolonged exposure of a large population, to decrease the 
permissible level for radionuclides accepted for occupational exposure by a factor of 10 
(Clarke and Valentin 2009). The MPC values in ICRP Publication 2 were included in the 
IAEA’s first edition of its BSS in 1962 and in the national regulations for radiation 
protection, including the United States (Cember and Johnson 2009). 
The ICRP issued its 1977 Recommendations as ICRP Publication 26, which first 
introduced the quantified risks of stochastic effects of radiation and proposed a dose 
limitation system (ICRP 1977; Clarke and Valentin 2009). In ICRP Publication 26, the 
scope of radiological protection focused only on activities involving human exposure 
since the ICRP, at that time, stated that if a man is properly protected then other species 
are also likely to be adequately protected (ICRP 1977). In terms of protection of human 
health, the ICRP recognized that most decisions about human activities are based on 
balancing costs and benefits both in monetary and societal terms (OECD NEA 2011). The 
ICRP also stated that the formulation of these decision-making procedures could be 
possible for the radiation protection of all human activities. This led to introduction of the 
new system of dose limitation with three principles of protection, including 1) no practice 
shall be adopted unless its introduction produces a positive net benefit, 2) all exposures 
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shall be kept as low as reasonably achievable, economic and social factors being taken 
into account, and 3) the doses to individuals shall not exceed the limits recommended for 
the appropriate circumstances by the Commission (ICRP 1977). Later, these principles 
became known as justification, optimization, and application of dose limits, respectively. 
The principle of justification requires that activities involving human exposure should do 
more good than harm, and that of optimization is used for maximizing the margin of good 
over harm for the exposed individual or society as a whole. However, the principle of 
application of dose limits prevents the individual from being exposed to an excessive level 
of harm even if the benefits exceed the costs. In particular, the application of the principle 
of optimization was regarded as a more important job by the ICRP, as well as other 
international and national regulatory bodies, because it required balancing costs and 
benefits of activities involving human exposure (Clarke and Valentin 2009). 
In ICRP Publication 26, the ICRP was also aware that different organs and tissue 
have different chances of radiogenic cancers occurring. Although the ICRP did not use the 
term ‘effective dose equivalent,’ this knowledge of different chances of occurrence led to 
the introduction of the concept of effective dose equivalent, which reflects the risk of 
stochastic effects from non-uniform exposure relative to the risk from uniform whole-
body exposure (Cember and Johnson 2009). As a result, ICRP Publication 26 
recommended the whole body dose-equivalent limits of 50 mSv in a year for occupational 
exposure and of 5 mSv in a year for public exposure, and these limits include the sum of 
external and internal radiation dose (ICRP 1977). These values in ICRP Publication 26 
were used as the technical basis of the IAEA’s second BSS, which was issued in 1982 
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(Czarwinski 2011). In the United States, the tissue-weighting factors in 10 CFR Part 20 
were based on the values in ICRP Publication 26 (Cember and Johnson 2009). In particular, 
in 10 CFR Part 20, the dose was expressed as the total effective dose equivalent (TEDE) 
that integrates a risk‐based dose, weighted by tissue or organs, as defined in ICRP 
Publication 26 (USNRC 2015f).  
ICRP Publication 26 was superseded by the ICRP 1990 Recommendations as 
ICRP Publication 60 (ICRP 1991). In the 1980s, there were re-assessments of cancer risk 
estimates derived from the survivors of atomic bombs at Hiroshima and Nagasaki in Japan. 
These studies showed that there is a longer latent period for solid tumors compared to 
leukemia, and the radiation-induced tumors corresponded to a multiplicative model rather 
than the additive model that had been used previously in ICRP Publication 26 (OECD 
NEA 2011). This change of model resulted in higher risks of radiation exposure compared 
to those calculated in ICRP Publication 26. Finally, these new technical findings led to the 
revision of the previous ICRP recommendations. 
In ICRP Publication 60, the ICRP introduced two types of assessments for the 
efficacy of protection: source-related and individual-related assessments (ICRP 1991). 
The former focuses on the radiation exposure of all the individuals exposed from a source 
or group of sources, while the latter focuses on the radiation exposure of an individual 
from several sources. The ICRP also approved a process-based system of protection, 
including a “practice,” which causes radiation exposure, and “intervention,” which 
decreases exposure (ICRP 1991). For practices, the system of protection recommended by 
the ICRP was based on the previous general principles given in ICRP Publication 26, but 
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two new concepts were added to those of ICRP Publication 60: the need to consider risk 
for potential exposure and the requirement for a constraint in optimization (OECD NEA 
2011). In particular, the most important change in the principles was the use of dose 
constraints in optimization (Clarke and Valentin 2009). According to ICRP Publication 
60, dose constraints are defined as the source-related values of individual dose used to 
restrict the range of choices considered in the process of optimization (ICRP 1991). The 
ICRP recommended using constraints as individual criteria to ensure that the most exposed 
individuals are not subjected to unreasonable risk from a single source (Clarke and 
Valentin 2009). In spite of introducing the concept of a constraint, the ICRP did not 
provide sufficient guidance on its use and implementation until the issue of ICRP 
Publication 103 in 2007 (OECD NEA 2011). 
In terms of acceptability of risk, ICRP Publication 60 provided three different 
levels to indicate the degree of tolerability of radiation exposure: “unacceptable,” 
“tolerable,” and “acceptable” levels (ICRP 1991; OECD NEA 2011). The first level, 
unacceptable level, means that the radiation exposure would not be acceptable on any 
reasonable basis in the routine operation of a practice. The second level, tolerable level, 
indicates that the radiation exposure was not reviewed as acceptable by the ICRP, but can 
reasonably be tolerated. The last level, acceptable level, was the condition that the 
radiation exposure could be accepted without further improvement or with the 
optimization of protection. In this frame, the dose limit was determined at the boundary 
between unacceptable level and tolerable level, and dose constraint is determined at the 
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boundary between tolerable level and acceptable level. The schematic diagram of the 
acceptability of risk is shown in Fig. 23 (OECD NEA 2011). 
In terms of dose limits, ICRP Publication 60 recommended an average of 20 mSv 
per year over five years (100 mSv in five years) with no more than 50 mSv in a single year 
for occupational exposure, the values of which corresponds to a risk of death of 
approximately 1 in 1000 per year (ICRP 1991). For public exposure, the ICRP has 
recommended a dose limit of 1 mSv in a year, the values of which correspond to a risk of 
death of approximately 1 in 10,000 per year (ICRP 1991; OECD NEA 2011). The change 
of numerical values in ICRP Publication 60 led to the revision of IAEA BSS in 1996. The 
BSS of 1996 had been used by a lot of IAEA member nations to make their own national 
regulatory programs until the issue of IAEA’s fourth BSS in 2014 (IAEA 1996; IAEA 
2014a).   
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Fig. 23. Schematic diagram of the acceptability of risk. 
 
 
 
There were several significant changes in ICRP Publication 60 in comparison with 
ICRP Publication 26. From the perspective of protection philosophy, the “system of dose 
limitation” was expanded to the “system of radiological protection” which reinforces the 
principle of optimization using dose constraints. In terms of technical aspects, the 
carcinogenic risk factors were increased. New organs and tissues were classified and given 
their own tissue-weighting factors. The quality factors were also replaced by radiation 
weighting factors based on relative biological effectiveness (RBE). A summary of the 
numerical values published by the ICRP Publication 26 to ICRP Publication 60 is provided 
in Table 36 (OECD NEA 2011). 
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Table 36. Comparison of protection criteria between ICRP Publication 26 and ICRP 
Publication 60. 
 
Factors Exposures ICRP Publication 26 ICRP Publication 60 
Dose limits Occupational exposure 
including recovery 
operation 
Any individual organ, 
expect: 
 lens of the eye 
 skin 
 hands and feet 
 pregnant women, 
remainder of 
pregnancy 
 
50 mSv y-1 a  
 
500 mSv y-1 b  
 
300 mSv y-1 b  
20 Sv (in a life time)b  
- 
Working condition Bc 
(<15 mSv y-1 a) 
 
50 mSv y-1 d  
(100 mSv over 5 
years) 
Dropped 
 
150 mSv y-1 e  
500 mSv y-1 e  
500 mSv y-1 e  
2 mSv to the surface 
of abdomen or 1 
mSv from intake of 
radionuclides 
Public exposure 
Any individual organ, 
expect: 
 lens of the eye 
 skin 
5 mSv y-1 a, f  
50 mSv y-1 b  
 
- 
- 
1 mSv y-1 d 
Dropped 
 
15 mSv y-1 e  
50 mSv y-1 e  
Dose 
constraints 
Occupational exposure - ≤20 mSv y-1 d  
 
Public exposure - - 
Accident/ 
Emergency 
Occupational exposure 
 life saving 
 other urgent rescue 
operation 
 other rescue 
operation 
 
- 
500 mGy whole body 
5 Gy individual organ 
- 
 
No dose restrictions 
~500 mSvd 
~5 Sve (skin) 
- 
Public exposure 
 foodstuffs 
 stable iodine 
 sheltering 
 evacuation 
 relocation 
 
10 mSva, g 
50-500 mSv(thyroid)b, g 
5-50 mSv in 2 daysa, g 
50-500 mSv in 1 weekb, g 
100 mSv (1st year)a, g 
 
 
 
No change 
a Effective dose equivalent. 
b Dose equivalent. 
c Not exceeding three-tenths of the dose equivalent limits. 
d Effective dose. 
e Equivalent dose. 
f Changed to 1 mSv y-1 after 1985 Paris Statement. 
g Averted dose. 
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Since ICRP Publication 60, subsequent ICRP reports have continuously been 
published on radiological protection with new technical findings. As the number of these 
publications has increased, there is a strong need for the consolidation of these 
publications to improve the ICRP Recommendations. Finally, the ICRP issued their 2007 
recommendations as ICRP Publication 103, which replaced the previous 
recommendations of ICRP Publication 60 (ICRP 2007). Despite the revision of ICRP 
recommendations over 17 years, ICRP Publication 103 is similar to the previous ICRP 
1990 Recommendations in most respects, and its numerical values for dose limits are not 
changed from ICRP Publication 60 (USNRC 2008b). 
ICRP Publication 60 was superseded by the ICRP 2007 Recommendations as 
ICRP Publication 103 (ICRP 2007). These recommendations introduced the situation-
based approach to cover all potential radiation exposure situations, including planned 
exposure situations, emergency exposure situations, and existing exposure situations 
(ICRP 2007; OECD NEA 2011). In particular, ICRP Publication 103  regards the source-
related principle of optimization below the dose constraint or reference level as the most 
effective tool for protection regardless of exposure situations (ICRP 2007).  
In terms of biological risks, the fatal cancer and the total detriment nominal risk 
coefficients are approximately 8-25% lower in ICRP Publication 103 compared to ICRP 
Publication 60 (ICRP 1991; ICRP 2007). These changes are attributed to two main reasons: 
the use of incidence data of cancer rather than mortality data and the changes in the 
estimates of hereditary diseases induced by radiation exposure (OECD NEA 2011). The 
nominal risk coefficients for all cancers in ICRP Publication 60 and ICRP Publication 103 
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are given in Table 37 (ICRP 2007). Even though the risk coefficients in ICRP Publication 
103 are somewhat lower than those in ICRP Publication 60, the ICRP judged that the 
existing dose limits continue to offer an appropriate level of protection, and the values of 
dose limits in ICRP Publication 60 are retained in ICRP Publication 103 (ICRP 2007). 
The ICRP concluded that these slight differences of risk coefficients are not practically 
important in the field of nuclear industry. 
 
 
 
Table 37. Comparison of detriment-adjusted nominal risk coefficients for stochastic 
effects between ICRP Publication 60 and ICRP Publication 103. 
 
Exposed 
population 
Cancer  Heritable effects Total 
Publ. 60 Publ. 103 Publ. 60 Publ. 103 Publ. 60 Publ. 103 
Wholea, b 6.0 5.5 1.3 0.2 7.3 5.7 
Adulta, b 4.8 4.1 0.8 0.1 5.6 4.2 
a Detriment-adjusted risk indicates the probability of the occurrence of a stochastic effect, 
modified to allow for the different components of the detriment to express the severity 
of the consequence. The unadjusted nominal risk coefficients are calculated by averaging 
estimates of the radiation-associated lifetime risk for cancer incidence for a composite 
population of equal numbers of males and females. 
b Unit: percent per Sv (10-2 Sv-1). 
 
 
  
There are three main differences between ICRP Publication 60 and ICRP 
Publication 103: risk estimates, the system of protection, and the use of dose constraints 
and reference levels. The risks from radiation exposure, given in ICRP Publication 103, 
decreased slightly compared to ICRP Publication 60, but there was no change of dose 
limits. The system of protection was also changed from a process-based approach to a 
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situation-based approach with an emphasis on source-related control. Lastly, the 
application of dose constraints and reference levels was not an obligation in ICRP 
Publication 60, but it became a requirement in ICRP Publication 103, and the ICRP has 
strongly recommended using dose constraints and reference levels for decision-making by 
licensees and regulatory bodies. In terms of values for protection criteria, the comparison 
of those values between ICRP Publication 60 and ICRP Publication 103 are shown in 
Table 38 (ICRP 2007; OECD NEA 2011). 
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Table 38. Comparison of protection criteria between ICRP Publication 60 and ICRP 
Publication 103. 
 
Factors Exposures ICRP Publication 60 ICRP Publication 103 
Planned exposure situations 
Individual 
dose limitsa 
Occupational 
exposure including 
recovery operation 
 lens of the eye 
 
 skin 
 hands and feet 
 pregnant women, 
remainder of 
pregnancy 
50 mSv y-1  
(100 mSv over 5 years) 
 
150 mSv y-1 b  
 
500 mSv y-1 b  
500 mSv y-1 b  
2 mSv to the surface of 
abdomen or 1 mSv from 
intake of radionuclides  
No change 
No change 
 
50 mSv y-1 b, c 
(100 mSv over 5 years) 
No change 
No change 
1 mSv to the embryo 
and fetus 
Public exposure 
 lens of the eye 
 skin 
1 mSv y-1 
15 mSv y-1 b  
50 mSv y-1 b 
No change 
No change 
No change  
Dose 
constraintsa 
Occupational 
exposure 
≤20 mSv y-1 No change 
Public exposure 
 general 
 radwaste disposal 
 long-lived 
radwaste disposal 
 prolonged 
exposure 
 prolonged 
component from 
long-lived 
nuclides 
 
- 
≤0.3 mSv y-1 
≤0.3 mSv y-1 
 
≤~1 & ~0.3 mSv y-1 d 
 
≤0.1 mSv y-1 e 
 
 
<1 mSv y-1 
No change 
No change 
 
No change 
 
No change 
Medical exposure 
 volunteers for 
biomedical 
research, if benefit 
to society is; 
minor 
intermediate 
moderate 
substantial 
 comforters and 
caregivers 
 
 
 
 
 
<0.1 mSv 
0.1-1 mSv 
1-10 mSv 
> 10 mSv 
5 mSv per episode 
 
 
 
 
 
No change 
No change 
No change 
No change 
No change 
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Table 38. (continued) 
 
Factors Exposures ICRP Publication 60 ICRP Publication 103 
Emergency exposure situations 
Interventional 
levelsa, f, g 
 
Reference 
levelsa, g 
 Interventional levels Reference levels 
Occupational 
exposure 
 life saving 
 other urgent 
rescue operation 
 other rescue 
  
 
No dose restrictions 
~500 mSv; ~5 
Svh(skin) 
 
 
 
 
No dose restrictionsi 
1000 or 500 mSvi 
 
≤100 mSvi 
Public exposure 
 foodstuffs 
 stable iodine 
 sheltering 
 evacuation 
 relocation 
 overall protection 
strategy 
 
10 mSv 
50-500 mSv(thyroid)h 
5-50 mSv in 2 days 
50-500 mSv in 1 week 
100 mSv (1st year) 
 
 
 
 
 
 
 
20-100 mSv y-1 
(in planning stage) 
Existing exposure situations 
Action levelsa 
 
Reference 
levelsa, j 
 Action levels Reference levels 
Radon 
 at home 
 
 at work 
 
3-10 mSv y-1 
(200-600 Bq m-3) 
3-10 mSv y-1 
(500-1500 Bq m-3) 
 
<10 mSv y-1 
(<600 Bq m-3) 
<10 mSv y-1 
(<1500 Bq m-3) 
a Effective dose unless otherwise specified. 
b Equivalent dose. 
c Values are based on the ICRP Statement on Tissue Reactions in 2011 (ICRP 2011). 
d The dose constraint of no more than about 0.3 mSv would be appropriate. 
e To be considered if dose assessment methodologies to ensure compliance under any 
conceivable situation of combination of doses are not available. 
f Averted dose. 
g Intervention levels refer to averted dose for specific countermeasures.  
h Equivalent dose. 
i Effective doses below 1000 mSv should avoid serious deterministic effects; below 500 
mSv should avoid other deterministic effects. 
j Reference levels refer to residual dose and are used to evaluate protection strategies, as 
opposed to the previously recommended intervention levels which referred to averted 
doses from individual protective actions. 
 
 191 
 
Tritium effluents discharged from nuclear power plants in the United States 
Even though the radionuclides discharged from nuclear power plants (NPPs) differ 
depending on the types of reactor, the major radionuclide for gaseous and liquid effluents 
is tritium, and most of the public doses originate from tritium. In a pressurized water 
reactor (PWR), boric acid is added to the reactor coolant system as a chemical shim to 
control reactivity, and tritium is produced primarily from neutron capture by 10B in a PWR 
(Martin 2009). In contrast, tritium production is lower in boiling water reactors (BWRs) 
than that in PWRs since boric acid is not used to control reactivity in BWRs. For BWRs, 
tritium is mainly generated by neutron activation of the small amounts of deuterium 
present in water.  
In this study, it is found through the analysis of radioactive effluents released from 
NPPs during the years 2007-2009 that most of the activities resulted from tritium. As 
shown in the Results of Analysis chapter, the contribution of tritium activity to the total 
activity of radioactive effluents was significant in both BWRs and PWRs, accounting for 
more than 90%. Since tritium is one of the most important radionuclides in NPPs and its 
contribution to the activity is substantial, the amount of tritium effluents discharged from 
NPPs to the environment was analyzed in detail to understand its effect on NPP effluent 
releases. The total activities depending on the types of effluents and reactors are displayed 
in Table 39 (USNRC 2011b, 2012e, 2013d). As shown in Table 39, the activity in tritium 
effluents discharged from PWRs was 17-22 times higher than that from BWRs due to the 
higher production of tritium in PWRs. In terms of type of effluents, for BWRs, the tritium 
activities in gaseous effluents were higher than those in liquid effluents. Contrary to BWRs, 
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most of tritium activities in radioactive effluents released from PWRs resulted from liquid 
effluents. The main reason why BWRs and PWRs have different contributions of liquid 
and gaseous effluents to the total activity is the recycling of liquid waste at BWRs 
(USNRC 2013d). Many BWRs in the United States reuse either some or all of their liquid 
waste. Furthermore, BWRs do not use boron in the reactor coolant unlike PWRs, and this 
also contributes to reduce liquid effluents from BWRs (USNRC 2013d). Histograms of 
tritium effluents discharged from NPPs during the years 2007-2009 are presented in Figs. 
24-26. 
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Table 39. Activity in tritium effluents discharged from NPPs during the years 2003-2012. 
 
Year Effluent BWR (Bq)    PWR (Bq)    
  Maximum Median Minimum %a Maximum Median Minimum %a 
2007 Liquid 4.85×1012 7.55×108 8.44×105 0.06 6.55×1013 2.04×1013 5.51×1012 94.35 
 Gaseous 2.45×1013 1.30×1012 1.33×1011 99.94 4.35×1013 1.22×1012 1.10×1011 5.65 
 Total 2.94×1013 1.30×1012 1.33×1011 100.00 1.09×1014 2.16×1013 5.62×1012 100.00 
2008 Liquid 4.70×1012 9.07×1010 4.30×107 6.92 6.14×1013 1.95×1013 5.88×1012 94.11 
 Gaseous 1.92×1013 1.22×1012 9.79×108 93.08 5.76×1013 1.22×1012 9.78×1010 5.89 
 Total 2.39×1013 1.31×1012 1.02×109 100.00 1.19×1014 2.07×1013 5.98×1012 100.00 
2009 Liquid 3.89×1012 3.43×1011 4.41×106 27.31 7.66×1013 2.06×1013 3.56×1012 93.03 
 Gaseous 3.60×1013 9.14×1011 6.80×1010 72.69 1.58×1014 1.54×1012 5.15×1010 6.97 
 Total 3.99×1013 1.26×1012 6.80×1010 100.00 2.35×1014 2.21×1013 3.61×1012 100.00 
a Percentages are based on median values. 
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Fig. 24. Tritium effluents discharged from NPPs in 2007. 
 195 
 
 
Fig. 25. Tritium effluents discharged from NPPs in 2008. 
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Fig. 26. Tritium effluents discharged from NPPs in 2009. 
